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Abstract 
Enantiomerically pure α-stereogenic carboxylic acids are encountered in a variety 
of natural products and pharmaceuticals and are useful substrates for various 
transformations. The direct synthesis of such motifs via catalytic asymmetric α-
functionalization remains challenging in both metal- and organocatalysis. A general 
approach toward α-functionalization can be envisioned via formation of bis-silyl 
ketene acetal intermediates followed by functionalization with an electrophilic 
counterpart. This thesis focuses on the development of enantioselective 
transformations with bis-silyl ketene acetals, exploring the generality of this strategy 
within Brønsted and Lewis acid catalysis for a variety of enantioselective C–H and C–
C bond forming reactions, using simple and unactivated substrates. This strategy 
was successfully applied to the deracemization of α-branched aryl carboxylic acids 
via catalytic asymmetric protonation of bis-silyl ketene acetals with water or methanol 
as a proton source, delivering valuable products with high enantiomeric purity and 
high yields, including non-steroidal anti-inflammatory arylpropionic acids, such as 
Ibuprofen. Furthermore, this strategy showed great potential under Lewis acidic 
conditions for a direct aminomethylation, allowing the first asymmetric organocatalytic 
synthesis of β2-amino acids from aliphatic and aromatic unactivated substrates, in 
very good enantioselectivities and excellent yields. This work opens the field of 
catalytic asymmetric transformations with bis-silyl ketene acetals for the direct access 
of enantioenriched α-branched carboxylic acids. 
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KURZZUSAMMENFASSUNG 
Enantiomerenreine α-stereogene Carbonsäuren kommen in einer Vielzahl von 
Naturstoffen und Pharmazeutika vor und sind nützliche Substrate für verschiedene 
Transformationen. Die direkte Synthese solcher Motive durch katalytische 
asymmetrische α-Funktionalisierung der entsprechenden Carbonsäuren ist sowohl in 
der Metall- als auch in der Organokatalyse eine Herausforderung. Ein möglicher 
allgemeiner Ansatz zur α-Funktionalisierung kann über die Bildung von bis-
Silylketenacetal-Intermediaten und anschließende Funktionalisierung mit einem 
Elektrophil erfolgen. Diese Dissertation befasst sich mit der Entwicklung 
enantioselektiver Transformationen mit bis-Silylketenacetalen und untersucht die 
Allgemeingültigkeit dieser Strategie unter Brønsted- und Lewis-sauren-Bedingungen 
in einer Vielzahl enantioselektiver C–H- und C–C-Bindungsbildungsreaktionen unter 
Verwendung einfacher und nicht aktivierter Substrate. Diese Strategie wurde 
erfolgreich auf die Deracemisierung von α-verzweigten Arylcarbonsäuren durch 
katalytische asymmetrische Protonierung von bis-Silylketenacetalen mit Wasser oder 
Methanol als Protonenquelle angewendet, wobei wertvolle Produkte mit hoher 
Enantiomerenreinheit und hohen Ausbeuten, einschließlich nichtsteroidaler 
entzündungshemmender Arylpropionsäuren wie beispielsweise Ibuprofen, erhalten 
wurden. Darüber hinaus ermöglichte diese Strategie, unter Lewis-sauren-
Bedingungen, die erste asymmetrische organokatalytische Synthese von β2-
Aminosäuren durch direkte Aminomethylierung aliphatischer und aromatischer 
Substrate in guten Enantioselektivitäten und ausgezeichneten Ausbeuten. 
Zusammenfassend eröffnet diese Arbeit das Gebiet der katalytischen 
asymmetrischen Transformationen mit bis-Silylketenacetalen für den direkten 
Zugang zu enantiomerenangereicherten α-verzweigten Carbonsäuren. 
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1 Introduction  
 Carboxylic Acids in Organic Synthesis 1.1
Carboxylic acids are ubiquitous structural motifs in biologically active compounds 
and are among the most common functionalities in organic chemistry.[1] For organic 
synthesis, carboxylic acids are convenient raw materials and intermediates, as they 
are commercially available in a wide structural variety, easy to store and to handle, 
and preparatively accessible by a variety of established routes.[2] The reactivity of the 
carboxylic group depends on its protonation state: (a) the protonated form as 
carboxonium ion, (b) neutral, in the acid form, (c) anionic, in the carboxylate form, 
and (d) di-anionic, in the form of the enediolate (Scheme 1.1). Addition of a 
nucleophile (NuH) at the partially positively charged carbon of the acid allows a 
variety of functional group modifications upon condensation, giving access to acyl 
chlorides, anhydrides, esters and amides (mode A). The same functional group 
modification can be envisioned via the initial formation of the carboxonium ion, 
followed by addition of a nucleophile, condensation and, ultimately, deprotonation to 
the corresponding acyl derivative. Carboxylates can be activated in a very similar 
way, however having a carboxylate–catalyst complex as the reactive intermediate. 
This can either still react as a carboxyl O-nucleophile, giving ester derivatives, or, on 
the other hand, it can undergo decarboxylation forming a highly nucleophilic 
organometallic intermediate; this latter reactive intermediate readily reacts with 
available electrophiles[3] or with radicals[4] (mode B). Lastly, the di-anionic form, 
accessed using an excess of a strong base, can react with a large variety of 
electrophiles, allowing the direct functionalization at the α-carbon (mode C).[5] 
Noteworthy, the α–functionalization erases the stereochemical information of the 
starting carboxylic acid; hence the stereogenic information of the obtained product 
depends only on the nucleophilic attack onto the electrophile. 
Introduction 
 
 
4 
 
 
O
O
H
δ
+
δ-
O
O
O
O
HH
E
O
Nu
H
- H2O
O
OH
E
cat.
O
O
H
cat.
- H+
+ H+
- H+
+ H+
α-functionalization
cat.
H
- CO2
E
H- cat.
acid carboxylate enediolate
mode A mode B mode C + H+
E
NuH
O
O
H
E
- cat.
E
O
O
H
H
- H+
+ H+
carboxonium ion
NuH
H
O
Nu
H
- H+
+ H+
H
- H2O carboxylate activation
Nu
functional group
modification
 
Scheme 1.1 Versatile reactivity of the carboxylic acid group. 
Despite the importance and the versatility of carboxylic acids as synthetic 
intermediates, their application in catalytic transformations is rather limited. In recent 
years, progress in metal-catalysis has allowed the functionalization of unbiased and 
unprotected carboxylic acids.[3] However, enantioselective transformations remain 
scarce and, more surprisingly, the direct and enantioselective α-functionalization is 
still elusive.  
 
 Asymmetric α-Functionalization of Carboxylic Acids  1.1.1
The most applied and reliable strategy to access α-functionalized carboxylic acids 
consists of multi-step procedures, taking advantage of chiral auxiliaries (Scheme 
1.2). In such a sequence, the acid is first derivatized with an enantiopure auxiliary 
(step 1), followed by the desired, strong base-mediated functionalization in a 
diastereoselective fashion (step 2), and finally deprotected to furnish the desired 
enantioenriched product (step 3).[6] The auxiliary can be recovered; however, this 
requires an additional purification step.  
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Scheme 1.2 Multi-step asymmetric α-functionalization using a chiral auxiliary. 
A possible direct α-functionalization, in an ideal case, would require a catalyst 
which is able to deprotonate the carboxylic acid twice, at the OH group and at its α–
position, to afford the bis–enolate. Simultaneously, the catalyst would provide a chiral 
environment to control the enantioselectivity of the nucleophilic attack onto a given 
electrophile (Scheme 1.3). Such a transformation has not been reported so far, 
however a patent exists claiming the benzylation of glycine using (R)-2-amino-2'-
hydroxy-1,1'-binaphthyl (NOBIN) as the catalyst.[7] 
 
Scheme 1.3 Direct asymmetric α-functionalization with a chiral catalyst. 
In pioneering studies by Shioiri[8] and Koga,[9] and more recently further developed 
by Zakarian,[10] the authors described an alternative solution to this challenge by 
using stoichiometric C2–symmetric diamine reagents as chiral ligands (Scheme 1.4). 
This strategy is based on the in situ coordination of the bis-lithium enolate to the 
chiral amine; this complex directly enables the enantioselective functionalization, 
furnishing the targeted free carboxylic acid upon acidic workup. Moreover, the 
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stoichiometric chiral amine as the non-covalent auxiliary can be quantitatively 
recovered upon extraction. Furthermore, the whole sequence does not require the 
isolation of covalently bonded chiral intermediates or subsequent deprotection steps.  
O
OH
Ph
O
O
Ph
H
Li
Li
NR2
∗
NR2
∗
O
OH
Ph
R
N
HN
Ph
NH
Ph
N
(R)-A
chiral amine
(R)-A
(1.03 equiv.)
nBuLi (4 equiv.)
THF, –78 °C
R–X
X = Br or I
up to 96% yield
up to 99:1 er
(R)-A recovered in 99% yield by extraction with HCl  
Scheme 1.4 α-Functionalization with a traceless stoichiometric auxiliary. 
The in situ formation of the bis-lithium enolate from the carboxylic acid requires at 
least two equivalents of a strong base (pKa > 30) (Note: pKa values of bases refer to 
the corresponding conjugate acid). Therefore, lithium diisopropylamide (pKa ≅ 35) or 
n-butyl lithium (pKa ≅ 50) are the most commonly used reagents. The highly reactive 
bis-lithium enolates have several disadvantages as they can undergo decomposition 
and cannot be isolated as stable intermediates. Furthermore, these harsh conditions 
are incompatible with a large variety of functional groups. Therefore, in order to 
develop a general asymmetric and catalytic strategy, a less reactive and more stable 
enediolate equivalent is required.  
 
 Bis-Silyl Ketene Acetals as Carboxylic Acid Equivalents 1.2
Silicon-based protecting groups are among the most frequently employed of all 
protecting groups.[11] Furthermore, silyl enol ethers, silyl ketene acetals (SKAs), and 
bis-silyl ketene acetals (bis-SKAs) are the protagonists in a large variety of 
transformations since they represent stable and accessible enol and enolate 
equivalents of ketones, esters and carboxylic acids respectively (Figure 1.1). While a 
wide selection of catalytic asymmetric transformations has been developed using silyl 
enol ethers and SKAs,[12] enantioselective transformations using bis-SKAs are 
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rare.[13] The main advantage of bis-SKAs is that they allow direct access to carboxylic 
acids upon simple hydrolysis and, due to the absence of E/Z-diastereomers, their 
synthesis and purification is more facile compared to SKAs. However, bis-SKAs are 
challenging substrates as they are highly prone to hydrolysis and, in order to achieve 
high enantioselectivities, a chiral catalyst would have to differentiate the two relatively 
similar enantiotopic faces (Figure 1.1). Despite their challenges, bis-SKAs would be 
ideal substrates for accessing functionalized α-branched carboxylic acids. 
 
Figure 1.1 Stereochemical considerations of enolate equivalents and selected 
examples of silicon-based protecting groups.  
In the following chapters, an overview of asymmetric catalytic reactions is 
presented, with particular focus on organocatalytic transformations under Brønsted 
and Lewis acidic conditions, followed by the discussion of the investigation 
conducted during these doctoral studies on the asymmetric transformations toward α-
branched carboxylic acids. 
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2 Background 
 Asymmetric Catalysis 2.1
A catalyst is a component of the reaction mixture which is not consumed during 
the reaction and is able to increase the reaction rate by lowering the activation 
energy of a chemical transformation. It does not modify the energy of the reagents or 
products, but interacts with reagents and reaction intermediates, allowing the same 
reaction to occur via a different and less energetic pathway (Figure 2.1). In the case 
of enantioselective transformations, stereogenic elements may assemble in a 
selective fashion through the action of a chiral catalyst and the two enantiomers are 
obtained through energetically non-equivalent diastereomeric reaction pathways. 
 
Figure 2.1 General energy diagram of non–catalyzed and catalyzed reactions. 
The field of asymmetric transition metal catalysis was opened with the 
independent work of Horner,[14] Knowles,[15] Kagan,[16] Noyori[17] and Sharpless,[18] in 
which the authors disclosed (transition) metal–catalyzed transformations in the 
presence of chiral ligands (Scheme 2.1). Despite the poor enantioselectivities 
achieved, these seminal discoveries were recognized by the scientific community as 
milestones for catalytic enantioselective synthesis and thus were awarded with the 
Nobel Prize in Chemistry in 2001. Soon after these first reports, chemical industries 
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implemented the use of enantiopure ligands in catalytic processes underlining their 
importance.[19] 
 
Scheme 2.1 Knowles and Noyori´s pioneering achievements in asymmetric catalysis. 
In the 1960s, bioengineering emerged as a parallel approach to overcome the 
challenge of controlling chemo- and enantioselectivity in chemical transformations.[20] 
Today, the use of enzymes or even whole cells finds wide application across the 
chemical industries.[21] Hence, by the beginning of the 21st century, the field of 
catalytic transformations was dominated by two independent approaches: metal- and 
biocatalysis.  
However, few isolated examples were not fitting in either one of the two 
categories and have been considered for a long time as mere curiosities. Those 
examples had a small organic chiral molecule acting as the catalyst, inducing low[22] 
to moderate enantioselectivities.[23] For example, in 1960 Pracejus showed that O–
acetylquinine 1 catalyzeed the addition of methanol to ketenes and enabled chirality 
transfer in the protonation step, giving the targeted esters in moderate 
enantioselectivities (Scheme 2.2).[23]  
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Scheme 2.2 Pracejus´ pioneering achievement in asymmetric organocatalysis.  
Another remarkable example was reported by Hajos and Parrish[24] at Hoffmann-
La Roche and Eder, Sauer, and Wiechert[25] at Schering. In this case, using (S)-
proline (2) as catalyst, the reported intramolecular aldol reaction afforded the 
cyclization products in good to excellent yields with moderate to very high 
enantioselectivities (Scheme 2.3).  
 
Scheme 2.3 The Hajos–Parrish–Eder–Sauer–Wiechert reaction. 
Only in the early 2000s, the rationalization of the basic concepts of 
organocatalysis allowed the establishment of this new research field (Figure 2.2). 
Nowadays, organocatalysis is widely accepted as the third pillar of catalysis, 
complementing metal- and biocatalysis.[26] In fact, in terms of numbers of papers, 
organocatalysis is number one in asymmetric synthesis. 
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Figure 2.2 Chart exported from SciFinder on “organocatalysis” as “Research topic”, 
September 2019.  
 
 Asymmetric Organocatalysis 2.2
 Introduction  2.2.1
The groundbreaking simultaneous reports of List[27] and MacMillan[28] opened the 
field of organocatalysis. They independently showed that small organic molecules 
without any metal in their active site are potent and general catalysts for asymmetric 
transformations. In particular, the former described the proline-catalyzed aldol 
reaction of acetone with different aldehydes via enamine catalysis (remarkably, 
elimination to the corresponding enone did not take place under these reaction 
conditions),[29] while the latter reported an asymmetric Diels–Alder reaction of 
cyclopentadiene and unsaturated aldehydes via iminium ion catalysis (Scheme 2.4). 
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Scheme 2.4 Pioneering reports on secondary amine-catalyzed enantioselective 
reactions. 
In the following years, the field was rationalized by well-defined interactions 
(covalent or non-covalent) and specific modes of action,[30] thus allowing rational 
reaction design. A comprehensive classification was reported by Seayad and List,[31] 
organizing the field based on the role of the catalyst and its mode of action: Brønsted 
acid, Brønsted base, Lewis acid and Lewis base (Figure 2.3).  
 
Figure 2.3 Classification of organocatalytic transformations based on the role of the 
catalyst.  
Lewis base catalysis covers the majority of the reported transformations. Here, 
the catalyst promotes the reaction by donating one (or more) electrons to a substrate. 
Indeed, enamine[32] and iminium ion catalysis,[33] SOMO[34] and carbene catalysis[35] 
operate through this type of mechanism. 
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This classification should be considered flexible, as many of the reported catalysts 
exploit multiple activation modes. Those catalysts are defined as “bifunctional”, as 
their activation modes depend on different functionalities. For example, the above-
mentioned proline-catalyzed aldol reaction is promoted both by a Lewis base 
(secondary amine) for the enamine formation and simultaneously by a Brønsted acid 
(carboxylic acid) for the activation of the aldehyde.  
 Chiral Acids for Asymmetric Synthesis 2.2.2
In 1923 Brønsted[36] and Lowry[37] independently published a theory in which 
bases are defined as proton acceptors and acids as proton donors. Accordingly, a 
Brønsted acid (HA) reacts by releasing a proton (H+), thereby generating the 
corresponding anion, defined as the conjugated base (A−). In the same year, Lewis 
gave a broader definition: 
“It seems to me that with complete generality we may say that a basic substance 
is one which has a lone pair of electrons which may be used to complete the stable 
group of another atom, and that an acid substance is one which can employ a lone 
pair from another molecule in completing the stable group of one of its own atoms. In 
other words, the basic substance furnishes a pair of electrons for a chemical bond, 
the acid substance accepts such a pair."[38] 
In contrast to the Brønsted–Lowry definition, the Lewis definition covers acid-base 
reactions in which no proton transfer is involved, and it concludes that a proton is the 
smallest possible Lewis acid. 
In the context of asymmetric transformations, a close similarity can be envisioned 
between enantioselective Lewis- and Brønsted-acid activation. On one hand, Lewis 
acidic metals or metalloid centered atoms (M) are coordinated to enantiopure ligands 
(L*) guiding asymmetric transformations; on the other hand, in the Brønsted acid 
activation, the proton can be envisioned as the smallest centered element and the 
backbone of an organic catalyst (X*) may be the effective source of stereoselectivity 
(Scheme 2.5). 
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Scheme 2.5 Lewis acid and Brønsted acid electrophile activation. 
Depending on the acidity of the Brønsted acid, a more specific differentiation can 
be made: general and specific catalysis. In the first case, the neutral or weakly acidic 
functionality activates the substrate by weak interactions. This category includes 
(thio)ureas, alcohols and phenols, and those functionalities are also referred to as 
hydrogen-bond donors. In the second case, the stronger acidic functionalities 
activate the substrate by direct protonation of the substrate. This class includes 
phosphoric acids and derivatives, carboxylic acids, sulfonamides, sulfonic acids, C–H 
acids, and phosphorimidate derivatives, which are generally referred to as Brønsted 
acid catalysts (Figure 2.4).  
 
Figure 2.4 General and specific Brønsted acid catalysts.  
The first application of chiral hydrogen bond donors as catalysts in an 
enantioselective transformation was serendipitously discovered by Sigman and 
Jacobsen while investigating a combinatorial approach to an enantioselective 
Strecker reaction.[39] Surprisingly, among the many ligand-metal combinations tested, 
the control experiments using “ligand” 4 in absence of a transition-metal gave the 
highest enantioselectivity. Key interactions were identified in the hydrogen bonding 
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ability of the thiourea moiety. A few years later, Rawal and co-workers identified 
chiral TADDOL-derived diols 5 as effective catalysts for an asymmetric hetero-Diels–
Alder reaction,[40] proving that small molecules can control enantioselectivity solely by 
having hydrogen bond interactions with the corresponding substrate (Scheme 2.6). 
 
Scheme 2.6 Strecker reaction catalyzed by chiral thiourea[39] and hetero–Diels-Alder 
reaction catalyzed by chiral TADDOL.[40] 
Following these seminal works, the incorporation of various acidic functionalities 
(Figure 2.4) within different chiral scaffolds allowed the rapid development of 
enantioselective organocatalytic transformations.  
Among the many possible sources of chirality, axially chiral molecules, for 
instance the binaphthyl structure b1, appear to be a privileged scaffold for 
organocatalysts. Many modifications have been explored on the naphthyl moiety, 
such as (a) modification of the 6,6ʹ-position,[41] (b) partial saturation of the backbone 
(b2),[42] (c) addition and/or removal of benzene rings in either direction (b3 and 
b4),[43] or (d) formation of analogs such as 1,1ʹ-spirobiindane (b5).[44] The most recent 
development in this field includes the linkage of two binaphthyl units,[45] in particular 
using highly acidic “linkers” (Figure 2.5).[12a, 46]  
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Figure 2.5 Examples of modifications of the chiral binaphthyl backbone. 
An overview of the development of chiral Brønsted- and Lewis-acids for 
organocatalytic transformations is presented in the following sections, alongside with 
the discovery and the application of the concept of “asymmetric counteranion-
directed catalysis” (ACDC).  
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 Asymmetric Counteranion-Directed Catalysis (ACDC) 2.2.3
In general, the majority of asymmetric reactions proceed through partially charged 
or completely ionic intermediates. This feature is exploited and widely applied in the 
field of phase transfer catalysis (PTC), in which a negatively charged intermediate 
undertakes coulombic interaction with an enantiopure cationic catalyst.[47] These ionic 
interactions are sufficient to create a chiral environment for the desired 
transformation. Asymmetric induction upon ion-pair formation may also proceed with 
a corresponding chiral anionic partner. In the concept of asymmetric counteranion-
directed catalysis (ACDC), a cationic species, including but not being limited to a 
protonated intermediate from Brønsted acid activation, forms an ion pair with a chiral 
anion, determining the enantiodifferentiation of the desired transformation (Figure 
2.6).[48] 
HS HX
RP
NR4
*
*
NR4
* SX
S
RP
*
*
EX ACDC
*
XE S
Phase transfer catalysis Asymmetric counteranion-directed catalysis
PTC
 
Figure 2.6 Schematic representation of PTC and ACDC. (S = substrate; X- = anion; 
X*- = chiral anion; NR4* = chiral ammonium ion; R = reactant; P* = chiral product; E
+ 
= achiral cation) 
The term itself was introduced by Mayer and List, giving the proof of concept by 
developing the enantioselective amino-catalyzed transfer-hydrogenation of enals, 
using a Hantzsch ester as the reductant (Scheme 2.7).[49] A general definition was 
given as:  
“Asymmetric counteranion-directed catalysis refers to the induction of 
enantioselectivity in a reaction proceeding through a cationic intermediate by means 
of ion pairing with a chiral, enantiomerically pure anion provided by the catalyst.”[48]  
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The authors showed the generality of this concept by employing the morpholinium 
salt of tri-isopropylphenyl phosphoric acid (TRIP) 6. The BINOL-based phosphate 
anion was the only given source of chirality and, upon proposed coulombic 
interactions with the cationic iminium ion intermediate 8, it directed the approach of 
the hydride source 7 with excellent stereoinduction. The absence of additional 
“coordination” sites besides coulombic interactions, or assisting obvious hydrogen-
bonding in the substrate, renders this example as a clear showcase of ACDC 
(Scheme 2.8).  
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Scheme 2.7 Proof of concept of asymmetric counteranion-directed catalysis.[49] 
Since this groundbreaking publication, this concept has been extensively explored 
in context of chiral Lewis- and Brønsted-acid organocatalysis, as well as in metal-
catalyzed transformations.[50]  
 Chiral Brønsted Acids 2.2.4
In 2004, two groups independently reported the synthesis and application of 
axially chiral phosphoric acids derived from enantiopure 1,1ʹ-bi-2-naphthol (BINOL) 
as chiral Brønsted acid catalysts. Akiyama and co-workers developed an 
enantioselective Mannich-type reaction of SKAs with imines,[51] while Terada and co-
workers reported an enantioselective addition of acetylacetone to imines[52] (Scheme 
2.8). However, Ishihara group later showed that the catalytic species in Terada´s 
report was not the free acid, but the corresponding calcium salt formed during 
purification.[53] 
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Scheme 2.8 Inital reports using BINOL-based Brønsted acid catalysts.[51-52] 
In the following years, several research groups focused their endeavors on the 
development of chiral phosphoric acid catalysts.[54] The most prominent approach is 
the variation of the substituents at the 3,3ʹ-positions of the binaphthyl backbone. 
These substituents create steric bulk around the active site and additionally, 
depending on their electron-donating or -withdrawing behavior, influence the electron 
density of the entire catalyst. The choice of the substituent has to be optimized for 
each individual enantioselective transformation. To date, the most successfully 
applied catalyst is the 2,4,6-triisopropylphenyl substituted phosphoric acid (TRIP) 
initially developed by List and co-workers.[55]   
Despite the success and generality of BINOL-derived phosphoric acids, two major 
challenges have to be considered: (a) the requirement for relatively (Lewis-)basic 
substrates to provide sufficient activation, and (b) the low stereoinduction with small, 
unbiased substrates. In order to tackle these challenges, efforts within the scientific 
community have been devoted to develop (a) more acidic catalysts, able to protonate 
less reactive substrates and (b) catalysts able to provide a more confined chiral 
environment around the active site. 
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2.2.4.1 Toward More Acidic Catalysts 
The acidity of BINOL-derived acids can be tuned by three individual approaches: 
(a) changing the electronics of the 3,3ʹ-substituents, (b) introducing electron-
withdrawing groups (EWGs) in the BINOL-backbone and (c), the most effective, 
changing the acidic functionality in the active site.[56] Considering that high acidity 
implies particularly mild conjugated bases, improved charge delocalization in the 
conjugate base is expected to have the largest impact on acidity. Yagupolskii et al. 
showed that the substitution of oxygen atoms with N(H)Tf (trifluoromethylsulfonyl) in 
benzoic acid increases the acidity by several orders of magnitude (Figure 2.7).[57]  
 
Figure 2.7 Yagupolskii’s principle to increase acidity by substituting O with N(H)Tf. 
Yamamoto and co-workers reported the expansion of this concept to BINOL-
derived phosphates, introducing phosphoramide 11. The increased acidity allowed 
the development of a catalytic enantioselective Diels–Alder reaction of α,β-
unsaturated ketones with silyloxydienes (Scheme 2.9, Eq. a).[56c] The same authors 
could further increase the acidity by introduction of a sulfur atom, resulting in 
thiophosphoramide catalyst 12. This catalyst enabled the first organocatalytic 
enantioselective protonation of silyl enol ethers (Scheme 2.9, Eq. b). At the same 
time, List and co-workers reported several examples with BINOL-based 
thiophosphoramide-derivatives.[58] Almost a decade later, Kaib and List further 
expanded the application of Yagupolskii’s principle to chiral phosphates, reporting the 
synthesis and synthetic application of highly acidic phosphoramidimidate 13. The 
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superior acidity enables more challenging reactions, such as the Friedel-Crafts 
alkylation of isophytol 15 and hydroquinone 14, giving α-tocopherol (16).[59] The 
outstanding acidity was not complemented by sufficient diastereodifferentiation, 
achieving only moderate diasteromeric ratios (Scheme 2.9, Eq. c).  
 
Scheme 2.9 Synthetic application of BINOL-phosphoric acid derivatives with 
increased acidity achieved by applying Yagupolskii´s principle.  
An alternative approach to increase the acidity by changing the active site of the 
catalysts was reported by List.[60] In these reports, a strong increase of acidity was 
achieved by substituting the phosphate moiety to the significantly more acidic 
disulfonimide (DSI). The main field of application of these structures is as highly 
potent precatalysts for silicon Lewis acid catalysis (vide infra). However, some 
reports exploiting their application as strong Brønsted acids also exist. In particular, 
Lee and co-workers applied DSI 17a to the aminoalkylation of indoles.[61] More 
recently, List and co-workers reported an asymmetric Torgov cyclization and applied 
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the method to the so far shortest reported total synthesis of (+)-estrone.[62] In this 
case, an additional increase in acidity was achieved by introduction of strong EWGs 
on the 3,3ʹ-substituents (SF5 groups) and on the 5,5ʹ-positions of the binaphthyl 
scaffold (NO2 groups) (18) (Scheme 2.10).  
 
Scheme 2.10 Application of chiral DSI as Brønsted acid catalysts. 
Even higher acidities have been achieved when the disulfonimide unit was 
substituted with bis(sulfuryl)imides (JINGLE), introduced by Berkessel et al.,[63] or 
with disulfonic acid (BINSA), introduced by List et al..[64] BINSA could only be 
successfully applied in asymmetric transformations as either the pyridinium salt as 
reported by Ishihara et al.,[65] or as ligands in the presence of Lewis acidic metals.[66] 
However, the most acidic catalysts in this series have not found application in highly 
enantioselective catalysis,[12b] as presumably the space around the active site is not 
confined enough to allow efficient enantiodifferentiation. 
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2.2.4.2 Toward More Confined Catalysts 
In 2012, Čorić and List reported an innovative solution to increase the 
confinement around the catalytically active site.[46a] The catalyst design included the 
expansion of the anion delocalization, by introducing the imidodiphosphate anion, 
and the restriction of the rotational freedom around the P–N bond, by introducing an 
additional BINOL unit. The combination of two identical BINOLs bearing 3,3ʹ-
substituents, which are large enough to block the rotation of the imidodiphosphate 
unit, maintains the C2-symmetry. This leads to a reduced amount of catalytically 
active conformations, which can stabilize only few and selected transition states, 
therefore resulting in higher selectivity (Figure 2.8).  
 
Figure 2.8 Design of conformationally locked imidodiphosphates with C2-symmetry. 
These newly designed confined imidodiphosphates (IDPs) allowed the 
spiroacetalization of electronically and sterically unbiased substrates, in high yields 
and very high enantioselectivities.[46a] The power of the IDP scaffold can be 
highlighted by a direct comparison with the subsequently reported example of 
enantioselective spiroacetalization by Nagorny et al..[67] In this case, specific 
modifications had to be added to the substrate in order to apply (S)-TRIP (20) as the 
chiral catalyst. In particular, the addition of two germinal phenyl groups (highlighted in 
red) were required in order to achieve good reactivity (Thorpe–Ingold effect) and high 
enantioselectivity (Scheme 2.11). 
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Scheme 2.11 Comparison of IDP 19a and TRIP (20) as chiral catalysts for the 
enantioselective spiroacetalization. 
Furthermore, IDPs proved to be very efficient catalysts for a large selection of 
reactions (Scheme 2.12) and showed outstanding results also for unbiased, namely 
aliphatic, substrates.[68] The main limitation of IDPs is their acidity (pKa ≅ 11), which is 
far lower than the phosphoramidates and dwells between phosphoric acids and DSIs.  
 
Scheme 2.12 Initial reports using chiral IDPs as catalysts. 
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2.2.4.3 Toward More Acidic and Confined Catalysts 
A higher acidity in the confined pocket of the IDPs was needed to activate and 
functionalize less reactive substrates. Increased reactivity was initially achieved by 
the incorporation of EWGs in the BINOL backbone,[69] however the key to success 
was again the application of Yagupolskii´s principle (Figure 2.7): the substitution of 
the P=O unit with P=NTf (iIDP and IDPi).[12a] These new classes of catalysts have 
complementary activation modes; iIDPs have moderate acidities (pKa in CH3CN ≅ 7–
9) and maintain a bifunctional character (whereas P=O is the basic site, and P=NTf is 
the acidic site), while IDPis are exclusively strongly acidic (pKa in CH3CN ≅ 2–5) 
(Figure 2.9). 
 
  
Figure 2.9 Evolution of the active site of the IDP, iIDP and IDPi reported by List et al. 
The significantly increased acidities attained with the IDPis allowed the activation 
of unbiased and highly unreactive functionalities. Excellent enantioselectivities have 
been already shown in the hetero-Diels–Alder reactions,[70] vinylogous Prins 
cyclizations[71] and Nazarov cyclizations.[72] Furthermore, the frontiers of asymmetric 
Brønsted acid catalysis have been expanded to the activation of simple and unbiased 
olefins[73] (Scheme 2.13). 
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Scheme 2.13 Transformations with IDPis as Brønsted acids. 
Figure 2.10 gives a general overview of the historic development of the BINOL-
based Brønsted-acid organocatalysts alongside with the experimental pKa.  
 
Figure 2.10 Development of BINOL-based Brønsted-acid organocatalysts and 
corresponding pKa values (TTP = 1,1,3,3-Tetratriflylpropene).   
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 Chiral Lewis Acids 2.2.5
Strong Brønsted acids can be converted into potent organic silylium Lewis 
acids[74] upon treatment with a suitable silylating agent.[75] The silylated forms of triflic 
acid (trimethylsilyl triflate, TMSOTf)[76] and triflimide (trimethylsilyl bis-triflimide, 
TMSNTf2),
[77] for instance, are well established highly reactive Lewis acid catalysts.[78] 
Regarding asymmetric transformations involving silicon-protected enol equivalents, 
(transition-)metal-derived Lewis acid catalysts strongly suffer from the competition 
between the anticipated chiral Lewis acid itself and “silylium” background catalysis, a 
non-enantioselective off-cycle pathway.[79]  
 
2.2.5.1 Disulfonimides as Lewis Acid Catalysts   
The silylation of a suitable enantiopure strong organic Brønsted acid allows an 
asymmetric transformation through ACDC. Taking advantage of the silylium 
background catalysis, List and coworkers reported the first example of a catalytic 
enantioselective transformation exploiting “silylium” ions as potent Lewis acids in 
2009. DSI 17 served as the precatalyst and, upon silylation, acted as the Lewis acid 
catalyst in the Mukaiyama–aldol reaction of aromatic aldehydes and SKAs (Scheme 
2.14).[60a] 
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Scheme 2.14 Chiral DSI-catalyzed Mukaiyama–aldol reaction.  
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A generalized mechanism for disulfonimide-catalyzed reactions is depicted in 
Scheme 2.15. Initially, a Brønsted acid catalyst (pKa usually < 11) is activated by a 
silylating agent to give the active Lewis acid catalyst. In case of residual water in the 
reaction mixture, the active catalyst is hydrolyzed and re-silylated until all the water is 
converted into the corresponding silyl ether (or hexamethyldisiloxane); even R3SiOH 
substrates would still desilylate the catalyst, so that ultimately only (R3Si)2O is 
formed. The ability of the catalyst to regenerate is referred to as self–healing. As no 
catalytic activity can be observed until the reaction solution is anhydrous, this period 
is referred to as the dormant period. The first step of the catalytic cycle consists of 
silylation of the electrophilic substrate (E), presumably forming a tight ion pair 
between the enantiopure anion (catalyst) and the cationic electrophile. In this induced 
asymmetric environment, the nucleophile (Nu) attacks onto the electrophile giving the 
silylated product. Finally, the lower affinity of the product (P) for the catalyst leads to 
silicon transfer back onto the catalyst releasing the desired product and completing 
the catalytic cycle (Scheme 2.15).   
 
Scheme 2.15 General catalytic cycle for disulfonimide ACDC in silylium Lewis acid 
catalysis using SKAs. 
Exploring the concept of ACDC, chiral DSIs were successfully applied as 
catalysts in numerous enantioselective transformations.[12b] Aromatic aldehydes and 
imines were preferred substrates reacting with a variety of silylated nucleophiles. In 
Background 
 
 
30 
 
 
analogy to the Mukaiyama–aldol reaction (Scheme 2.14), the vinylogous,[80] bis-
vinylogous[80] and alkynylogous[81] variants were reported. Other examples include: 
the hetero-Diels–Alder reaction using Danishefsky-type dienes and their 
alkynylogous analogs,[82] the Mukaiyama–Mannich reaction with SKA[83] and its 
vinylogous variant to access α-amino-β-ketoesters in the presence of 
silyloxydienes,[84] the cyanosilylation with TMSCN in the presence of 0.005 mol% (50 
ppm) of catalyst,[85] and the Abramov reaction with silylated phosphites to access α-
hydroxy phosphonates.[86] The asymmetric Hosomi–Sakurai allylation was 
achieved[87] with highly nucleophilic (2-methylallyl)trimethylsilanes (N = 4.41),[88] 
however, the use of allyltrimethylsilane (N = 1.68)[89] proved to be challenging. This 
limitation was overcome using the in situ generated N-fluorenylmethoxycarbonyl 
(Fmoc) imines as electrophiles (Scheme 2.16).[90]   
 
Scheme 2.16 Overview of DSI-catalyzed asymmetric transformations using aromatic 
aldehydes and imines reported so far. 
Background 
 
 
31 
 
 
In summary, the high acidity of the DSI motif enables a variety of enantioselective 
silylium-catalyzed transformations via ACDC. However, in order to achieve high 
levels of enantioiduction, the reported systems were limited to aromatic starting 
materials, presumably due to π/π–stacking between the 3,3ʹ-substituents of the 
catalyst and the substrate. Therefore, the design of a more confined active site would 
be the next step toward generalizing silylium ACDC. 
 
2.2.5.2 IDPis as Lewis Acid Catalysts   
The transformation of small, unbiased aliphatic substrates is a major challenge in 
asymmetric Lewis acid organocatalysis, as a highly acidic functionality in a well-
defined and confined environment is required. BINOL-based imidodiphosphates 
(IDPs) ensure a confined pocket; however, their reduced acidity (pKa ≅ 11.5) as 
compared to DSIs (pKa ≅ 8.5) renders them incompatible with “silylium” Lewis acid 
catalysis. The profoundly enhanced acidity of the IDPis (pKa < 4.5) encapsulated 
inside the C2-symmetric BINOL dimer makes them promising candidates for the 
exploration of new reactivities in Lewis acid catalysis. 
In 2016 the List group reported the development and application of IDPis in 
organic Lewis acid catalysis. A general Hosomi–Sakurai allylation of aromatic and 
aliphatic aldehydes with excellent enantioselectivities and yields was presented 
(Scheme 2.17).[46b] Noteworthy, at even low catalyst loadings (down to 0.5 mol%) the 
less reactive allyltrimethylsilane (N = 1.68) readily reacted.    
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Scheme 2.17 Silylium Lewis acid-catalyzed Hosomi–Sakurai allylations using 
allyltrimethylsilane derivatives. 
Following this groundbreaking work, the power of IDPi catalysts for the activation 
of small and unbiased substrates with high selectivity has been shown in several 
reports. Namely, the Mukaiyama–aldol reaction was made possible with catalyst 
loadings approaching the ppb levels;[91] both the Mukaiyama–Michael reaction[92] and 
the Diels–Alder reaction[93] were performed exploiting a wide substrate scope. The 
latter allowed access to previously inaccessible cycloaddition products via Lewis acid 
catalysis. Furthermore, the synthesis and functionalization of the tetrahydrofuran 
moiety through stereoselective control of the corresponding oxocarbenium ion was 
reported.[94] Last, the single addition of acetaldehyde derived silyl enol ethers to 
aldehydes[95] proved that the chiral Lewis acid controls the chemo- and the 
enantioselectivity of the transformation, avoiding engineered substrates and 
undesired polymerization products (Scheme 2.18).  
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Scheme 2.18 Overview on applications of “silylium” IDPi-catalyzed asymmetric 
transformations. 
The wide success of the IDPi scaffold can be attributed not only to the high acidity 
and the confinement of the catalytic active site, but also to the many structural 
diversifications achievable upon modification of the 3,3´-substitutents (Ar) and the 
sulfonimidic residue (R). Indeed, in comparison the DSI motif offers limited 
possibilities of structural modifications; the explored ones are different 3,3′-
substituents (electron-rich or electron-poor, aromatic and aliphatic substituents) 
which affects the enantioselectivity with its close proximity to the active site, or 
different positions in the backbone, with the introduction of EWG (e.g. nitro groups) or 
EDG (alkyl chains), usually influencing mainly the reactivity of the catalyst. IDPis, on 
the other hand, in addition to all the above mentioned modifications, can be further 
modified in proximity to the catalytic active site, upon variation of the sulfonimidic 
residue (R) (Figure 2.11).   
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Figure 2.11 Structural diversity of DSI vs IDPi. 
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 Bis-Silyl Ketene Acetals 2.3
The first reports on the synthesis and characterization of bis-SKAs appeared in 
the early 1970s.[96] Bis-SKAs and silyl enol ethers differ both on electronic and 
structural properties. Moving from silyl enol ethers to SKAs, the nucleophilicity N at 
the α-position increases by several orders of magnitude.[88] The presence of a 
second silicon group shifts N further toward higher nucleophilicity, implying a more 
facile reaction with an electrophilic partner.[97] Structurally, bis-SKAs bearing the 
identical silyl groups do not exhibit E/Z stereoisomer isoforms; this reduces the 
amount of diastereomeric transition states when reacting with an electrophile in the 
presence of a chiral catalyst (Figure 2.12). Furthermore, the absence of E/Z 
stereoisomers enables facile synthesis and purification of the starting material.   
OTMS
OTMSOTMS
OTMS
OPh
OTMS
OMe
OTMS
O
OTMS
O
OTMS
3.94
5.41
8.23
9.00
10.38
10.61
12.56
3 4 5 6 7 8 9 10 11 12 13
silyl enol ethers and silyl ketene acetals bis-silyl ketene acetals
N
E [Si]
O
1
2
3
[Si]E
E [Si]
1
2
O
[Si ]E
3
with E and Z stereoisomers
four diastereotopic transition states are possible
E
[Si]
O
1
2
O
2
[Si]E
without E and Z stereoisomers
two diastereotopic transition states are possible
*
* * *
* *
 
Figure 2.12 Comparison of electronic and structural properties of silyl enol 
ethers/SKAs and bis-SKAs. 
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 Bis-SKAs in the Synthesis of α-Functionalized Carboxylic Acids  2.3.1
Significant attention has been devoted towards the exploration of the synthetic 
potential of bis-SKAs as surrogates of α-enolizable carboxylic acids. In this section, 
the different transformations so far developed with bis-SKAs are presented. Initial 
studies were performed with highly electrophilic reagents, such as trifluoromethyl 
hypofluorite,[98] fluorine[99] and nitrosobenzene[100] or oxidants such as m-
chloroperbenzoic acid.[101] These reagents enabled the direct formation of C–F, C–N 
and C–O bonds, respectively, providing a formal α-functionalization of carboxylic 
acids (Scheme 2.19). 
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Scheme 2.19 Bis-SKAs in C–heteroatom bond forming reactions. 
The pioneering work of Reetz et al. paved the way for several C–C bond forming 
reactions under Lewis acidic conditions.[102] In this first example, an α-alkylation in the 
presence of catalytic ZnCl2 and tertiary haloalkanes or tertiary acetates was reported. 
Recently, Baba et al. reported that InBr3 was a competent Lewis acid for the α-
alkylation of bis-SKAs in the presence of benzyl chloride.[103] The first α-
aminomethylation was reported by Morimoto et al. in 1985, where TMSOTf was 
chosen to catalyze the in situ formation of a reactive iminium ion, which is 
quantitatively trapped by the bis-SKA to afford the tris-silylated β2-amino ester. Upon 
protic workup, the free β2-amino acid is formed.[100] An extension of this work was 
reported by Karoyan in 2007, in which various preformed iminium salts bearing 
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different protecting groups were used as reagents for the α-aminomethylation of bis-
SKAs[104] (Scheme 2.20).  
 
Scheme 2.20 C–C bond forming reactions: α-alkylation and α-aminomethylation of 
bis-SKAs.  
One of the most explored reactions for this class of substrates is the Mukaiyama–
aldol reaction in the presence of a Lewis acid. Wissner reported the first example in 
1979 in the presence of SnCl4 and O-trimethylsilyl bis-SKA affording 2,3-dihydroxy 
carboxylic acid.[105] Dubois et al. showed a moderately diastereoselective example in 
the presence of α-monosubstituted bis-SKA and a catalytic amount of TiCl4.
[106] 
Skarek et al. used N-methyl-N- trimethylsilyl bis-SKA as a glycine surrogate and 
TMSOTf as the Lewis acidic catalyst, to obtain the α-functionalized β-hydroxy-α-
amino acid, albeit with poor diastereoselectivities.[107] More recently, Bellassoued 
showed that, when the bis-SKA has a TMS group in the α-position, the Mukaiyama-
aldol product eliminates and selectively forms the (E)-cinnamic acid derivative 
(Scheme 2.21).[108]  
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Scheme 2.21 Mukaiyama-aldol reactions with bis-SKA nucleophiles. 
Rudle et al. reported several examples of α-arylations of bis-SKAs, catalyzed by 
Pd(PPh3)4. Successful coupling partners were tricarbonylchromium complexes of aryl 
ethers,[109] tungsten(0) alkylidene complexes stabilized as pyridinium ylides[110] and 
allylic acetates, albeit with poor regioselectivity. Recently, Hartwig et al. reported a 
general arylation of carboxylic acids and amides via the in situ formation of bis-SKA 
with a stoichiometric base (LiHMDS) and a catalytic amount of Pd(dba)2 and 
tBu3P 
(Scheme 2.22).[111]  
 
Scheme 2.22 Cross-coupling reactions with bis-SKAs. 
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The transformations shown above are summarized in the following timeline, giving 
a general overview for the transformations achieved so far with bis-SKAs as 
substrates for the α-functionalization of carboxylic acids (Figure 2.13). Until today, the 
only reported enantioselective transformation using bis-SKAs is their enantioselective 
protonation using stoichiometric quantities of an enantiopure BINOL–Sn complex, 
reported by Yamamoto et al..[112] Recently, Ooi and co-workers expanded the 
portfolio of this reaction, reporting two catalytic examples using asymmetric phase-
transfer catalysts.[13b, 13c] A comprehensive overview on enantioselective protonation 
of bis-SKA is presented in the following section. 
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Figure 2.13 General overview of the transformations reported with bis-SKAs. 
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 Enantioselective Protonation of bis-SKAs  2.4
 Introduction  2.4.1
The abundance of tertiary carbon centers at the α-position of carbonyl 
compounds in biological and natural products encouraged many scientists to 
investigate enantioselective transformations to access the enantiopure α-chiral 
carbonyl motif in an efficient and highly selective manner. The asymmetric 
protonation of preformed or catalytically generated transient enol equivalents 
enables straightforward access to these valuable scaffolds (Scheme 2.23). As the 
high reactivity of the proton and the basicity of the enolate result in a fast reaction, 
control of the enantioselectivity is very challenging. Inhibition of the background 
reactivity is usually overcome by performing the reactions under cryogenic 
conditions, with slow addition of either reagent, and using bulky PSs as for instance 
DMP.[113] The enantiocontrol of the proton transfer highly depends on the enolate 
geometry; therefore, many examples are reported using cyclic substrates, in which 
the geometry of the enolate is restricted to the E-form. In the case of metal-derived 
Lewis acid-catalyzed transformations, the stability of the catalyst can be affected by 
simple proton sources, such as water or methanol, due to their mild Lewis basic 
character (Scheme 2.23).   
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Scheme 2.23 Catalytic asymmetric protonation strategies and challenges. 
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The previously mentioned report from Pracejus (Scheme 2.2) represents an early 
example of a catalytic asymmetric protonation.[23] Indeed, upon the nucleophilic 
addition of methanol to the ketene, the transient enolate is protonated to afford the 
corresponding enantioenriched ester. Despite this successful pioneering work, it was 
not until the late 1980s that significant developments for asymmetric protonation of 
metal enolates with the aid of stoichiometric chiral Brønsted acids began to 
emerge.[114] Catalytic approaches started appearing in the early 1990s employing 
chiral catalysts for the protonation of lithium enolates by slow addition of an achiral 
PS.[115] Since then, an increased interest in asymmetric protonation led to successful 
reports starting from silyl enolates,[56d, 116] β-keto acids,[117] ketenes,[118] α,β-
unsaturated carbonyl compounds,[119] and many others.[120] Furthermore, enzymes 
have also been employed in biocatalytic processes, including esterases[121] and 
decarboxylases,[122] for the protonation of enol esters or the decarboxylative 
protonation of malonic acid derivatives. 
 
 Catalytic Asymmetric Protonation of Enolate Derivatives 2.4.2
The first catalytic enantioselective protonation of silyl enolates was developed by 
Yamamoto et al., exploiting Lewis acid-assisted Brønsted acid (LBA) catalysis.[123] 
This concept is based on the association of an enantiopure BINOL-based Brønsted 
acid ((R)-Me-BINOL) and an achiral Lewis acid (e.g. SnCl4), leading to an increased 
acidity of the BINOL proton.[13a, 124] The transformation afforded the products in very 
high yields and enantioselectivities, however, a bulky PS (e.g. 2,6-dimethylphenol 23, 
DMP) and very low temperatures (e.g. –80 °C) were required. Thus, the major 
drawbacks of LBA catalysis are the poor stability of the catalyst towards moisture and 
mild Lewis bases (e.g. simple alcohols), requiring strictly anhydrous conditions in 
order to perform efficiently.[113a] The same author reported an improved LBA catalyst 
(25), which was formed by complexation of La(OTf)3 with an (S)-HOP (2-hydroxy-2ʹ-
diphenylphosphino-1,1ʹ-binaphthyl) scaffold, allowing methanol to be used as the 
stoichiometric achiral PS at room temperature, without the need of slow addition of 
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either reagent. Only cyclic substrates were tolerated attaining moderate 
enantioselectivities, thus, not exceeding the first generation of LBAs[125] (Scheme 
2.24).  
 
 
Scheme 2.24 Development of LBA catalysis to Lewis base tolerant systems. 
A major advance in the field of catalytic enantioselective protonation of silyl enol 
ethers and SKAs was achieved by Toste and co-workers, who further exploited the 
LBA catalysis concept.[113b] The cationic (R)-BINAP (2,2'–bis-(diphenylphosphino)–
1,1'–binaphthyl) gold(I) complex, combined with equimolar amount of AgBF4, 
tolerates an excess of EtOH at room temperature, enabling very high 
enantioselectivities for a wide selection of cyclic and acyclic silyl enolates. The 
highlight of this system is the ability of the LBA catalyst to discriminate between the 
Z- and E-diastereomers approaching the silyl enol ether from the same enantiotopic 
face. This leads to a stereoconvergent asymmetric protonation, erasing the challenge 
of selective Z or E synthesis of the starting material (Scheme 2.25). 
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Scheme 2.25 Gold(I) LBA catalysis for asymmetric protonation of acyclic silyl 
enolates. 
Many organometallic catalysts have been reported, providing excellent levels of 
enantioselectivity with wide substrate scopes. Metal-free solutions began to appear in 
2007, with the first report from Levacher, in the presence of a chiral tertiary amine 
and a stoichiometric PS (XH).[116a] In those systems, the Lewis basic anion (X-) 
activates the silyl enol ether towards enantioselective protonation by the chiral 
ammonium salt (see TS, Scheme 2.26). Initially, only a limited substrate scope was 
reported, however, further developments included different PSs (bulky, highly acidic 
or generated in situ) and a variety of chiral bases (Scheme 2.26).[126]   
 
Scheme 2.26 Chiral ammonium salts for enantioselective protonation of silyl enol 
ethers.  
The first organocatalytic Brønsted acid-catalyzed example was reported by Cheon 
and Yamamoto in 2008, using BINOL-based N-triflyl thiophosphoramide 12 in the 
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presence of phenol as the achiral PS (Scheme 2.27).[56d] This report represents an 
important achievement in the field of organocatalytic asymmetric protonations, even 
though only cyclic substrates with aromatic substituents were successfully employed. 
Recently, Li and co-workers aimed to use the simplest PS available, H2O, in 
combination with pentacarboxycyclopentadiene (PCCP) as the chiral acid. Only cyclic 
substrates have been reported and only moderate enantioselectivities were 
achieved, thus showing the challenges associated with using water as the PS 
(Scheme 2.27).[127] 
 
Scheme 2.27 Organocatalytic protonation of cyclic silyl enol ether with PhOH and 
H2O. 
Additional examples of enantioselective organocatalytic protonations, enabled by 
chiral Brønsted acids, have been reported in the context of deracemization 
sequences of α-alkyl-α-arylnitriles (26) and α-aryl-substituted hydrocoumarins (28). In 
the first case, the protonation of silyl ketene imines occurred in the presence of 
MeOH and (R)-TRIP (20) as the catalyst,[128] while in the second case, the 
enantioselective protonation of the intermediate ketene dithioacetals occurred with 
phosphoric acid 30 (Scheme 2.28).[129] Both examples highlight the importance of this 
transformation, particularly when included in a deracemization sequence. Indeed, the 
racemic starting material was almost exclusively converted to a single enantiomer 
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without tedious purification of the intermediates. Stoichiometric reagents enabled the 
initial planarization of the stereogenic center to the protected ketene intermediates 
(27 and 29). A catalytic amount of chiral acid was sufficient to protonate the 
intermediate from only one enantiotopic face, reforming the sp3-configured carbon in 
high enantioselectivity. 
 
Scheme 2.28 Examples of deracemization sequences via asymmetric protonation of 
the corresponding ketene intermediate. 
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 Catalytic Asymmetric Protonation of bis-Silyl Ketene Acetals 2.4.3
The deracemization strategy of carboxylic acids via an intermediate (or 
catalytically formed) enolate has already been mentioned in the context of direct α-
functionalizations (Chapter 1, Scheme 1.3). This strategy involves the transformation 
of racemic carboxylic acids into their corresponding enediolates. Subsequent 
asymmetric protonation can then afford the starting carboxylic acid as a single 
enantiomer. A similar sequence can be envisioned by stabilizing the intermediate 
enediolate with two silicon groups (Scheme 2.29).   
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Scheme 2.29 Deracemization of carboxylic acids via a sequence of bis-SKA 
generation and subsequent enantioselective protonation. 
Despite the similarity compared to SKAs, different considerations must be taken 
into account while envisioning catalytic enantioselective protonations of bis-SKAs. 
The higher nucleophilicity generally associated with bis-SKAs leads to faster 
background reactions with the achiral PS. Hence, the catalyst, in order to avoid high 
catalyst loadings, should be acidic enough to protonate the substrate faster than the 
stoichiometric reagent. Furthermore, the catalyst must deliver the proton with high 
selectivity, discriminating the two enantiotopic faces of the bis-SKA.  
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2.4.3.1 Stoichiometric Reagents  
Significant effort has been dedicated to address the challenges encountered with 
the enantioselective protonation of bis-SKAs. The first example was reported in 1994 
by Yamamoto et al. using stoichiometric amounts of a chiral complex generated in 
situ by reacting equimolar amounts of enantiopure BINOL and SnCl4. Noteworthy, the 
acidity of the Brønsted acid was enhanced by the combination with a Lewis acid, thus 
named Lewis acid-assisted Brønsted acid (LBA). Although high levels of 
enantioselectivity were observed, the selection of substrates was limited only to β-
methyl-β-aryl substituted bis-SKAs, as any alkyl group (R) other than methyl group 
resulted in low or moderate enantioselectivities. The authors derived a 
stereochemical model for the proposed transition state (Scheme 2.30), explaining the 
limitations in the substrate scope.[112] Different ligands have been designed for the 
same transformation,[130] howeover the limitations on the substrates scope tolerance 
remained.  
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Scheme 2.30 Enantioselective protonation with a stoichiometric chiral reagent. 
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2.4.3.2 Catalytic Asymmetric Protonation  
A proposed mechanism for the reaction described in the previous section is 
depicted in Scheme 2.31 (route 1) in which the chiral PS (HOAr*), upon 
enantioselective protonation, is ultimately silylated (Me3SiOAr*) and the Lewis acid 
(e.g. SnCl4) is regenerated. A catalytic version requires that HOAr* is regenerated 
from an achiral PS (HOAr). In this case, the SnCl4 needs to be preferentially 
coordinated to HOAr* and the reactivity of HOAr*•SnCl4 has to be greater than of 
HOAr•SnCl4 in order to avoid the background reaction (Scheme 2.31). In fact, HOAr 
can react with two nucleophiles, the anion -OAr* and the bis-SKA, leading to the 
completion of the catalytic cycle (route 2) or to the undesired background reaction 
(route 3). A common strategy to minimize route 3 consists of keeping the ratio 
between the chiral and the achiral PS (HOAr*/ HOAr) as high as possible. This can 
be realized by slow addition of HOAr or by using biphasic systems (e.g. liquid/liquid 
or solid-liquid).[131] Another strategy consists of designing an achiral PS which is less 
associated to the substrate, for example by reducing the accessibility of the 
transferred proton, as for example in the more strically hindered 2,6-dimethylphenol 
(DMP). 
 
 
Scheme 2.31 Stoichiometric vs catalytic enantioselective protonation of bis-SKAs. 
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In summary, careful control of the reaction conditions is needed to avoid 
background reactivity, including a strictly inert atmosphere, very low temperatures 
and slow addition of the PS. Furthermore, tailored design of the PS is particularly 
crucial to avoid the undesired pathways. DMP appears to be particularly suitable to 
suppress background reactivity. In fact, the steric bulk of the methyl groups ortho to 
the phenol functionality disfavored both the formation of achiral Lewis acids and the 
direct protonation of silyl enol ether. 
Yamamoto and co-workers showed that using (R)-Me-BINOL as the ligand, the 
above-mentioned transformation can be performed in the presence of a catalytic 
amount of Lewis acid (SnCl4), maintaining the same high enantioselectivity (Scheme 
2.32).[113a] Unfortunately, the limitations of the system remained unsolved, such as 
slow addition of the bis-SKA, and the requirement for a sterically hindered PS (23) as 
well as strictly anhydrous conditions. Furthermore, only substrate 31a was reported 
as single example. 
 
Scheme 2.32 First catalytic asymmetric protonation of bis-SKA via LBA catalysis. 
Ooi et al. reported two remarkable examples of catalytic enantioselective 
protonation of bis-SKA derivatives. The axially chiral Brønsted acid catalyst, P-spiro 
diaminodioxaphosphonium barfate 33, showed high levels of enantioinduction for the 
protonation of α-amino acid-derived [13b] and for α-halo and α-alkoxy acid-derived bis-
SKAs.[13c] However, it still required a bulky PS in order to inhibit both the background 
reaction with the substrate and the decomplexation of the catalytic system, leading to 
the formation of HBArF, which is itself a highly reactive achiral PS. This was 
prevented by addition of a scavenger (34) neutralizing this side reaction (Scheme 
2.33). In this system, the enantiofacial discrimination depended predominantly on the 
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electronic bias of the substrate and was independent on the steric features of the 
substituents. 
 
Scheme 2.33 Catalytic asymmetric protonation of bis-SKA via organic LBA catalysis; 
BARF = Tetrakis[3,5-bis(trifluoromethyl)phenyl]borate. 
To date, a catalytic asymmetric protonation of bis-SKAs from electronically 
unbiased carboxylic acids in the presence of water as the simplest PS has not been 
reported.
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 Enantioselective α-Aminomethylation  2.5
 Introduction  2.5.1
Over the last decades, catalytic and enantioselective C–C bond forming reactions 
at the α-position of carbonyl compounds have been an ambitious target, approached 
by many scientific groups. However, the direct, enantioselective α-functionalization of 
carboxylic acids still remains an unsolved challenge. The following chapter will give a 
concise overview of asymmetric α-functionalization reactions of carbonyl compounds 
in the context of direct aminomethylation reactions.  
The high abundance of β-amino carbonyl compounds in biological and natural 
products (Scheme 2.34) drove the interest toward the investigation of 
enantioselective transformations to efficiently access this motif.[132] β-Amino acids are 
naturally present in important co-factors, such as panthotenic acid (vitamin B5), and 
β-lactam antibiotics. The key feature of this scaffold relies on the close structural 
similarity to the corresponding α-amino acid, maintaining their main functionality but 
increasing their metabolic stability by several orders of magnitude.[133]      
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Scheme 2.34 Examples of biologically active compounds containing β-amino acid-
derived functionalities. 
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Peptide-containing molecules are highly unstable in the presence of proteases, 
which are ubiquitous enzymes designated for the digestion of proteins by hydrolyzing 
the peptide bond. The binding selectivity of the β-amino acid substrate to the active 
site of the proteases remains, but the catalytic activity is inhibited, rendering those 
substrates as metabolically stable (Scheme 2.35, a).[134] The success of the β-amino 
acid functionality is also attributable to the ability of β-peptides (short sequence β-
amino acids) to self-assemble into secondary structures such as α-helices or β-
sheets, in close relationship to the analogous natural α-peptides (Scheme 2.35, 
b).[135]  
 
Scheme 2.35 a) Schematic representation of the binding of an α-peptide and a β-
amino acid-containing peptide to the active site of a protease; b) structural similarity 
of a β-turn in natural occurring α-peptides and unnatural β-peptides. 
The introduction of an aminomethyl group into small organic molecules has 
recently attracted a great deal of attention, particularly toward the synthesis of β-
amino acids (Scheme 2.36). β3-Amino acids can be obtained by enantiospecific 
homologation of the natural α-amino acids, and the catalytic asymmetric synthesis of 
β3-amino acids, although not discussed in this section, has delivered remarkable 
progress in the last years.[39, 83, 136] Few diastereoselective syntheses of β2,3-amino 
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acid derivatives have recently been reported,[52, 137] however, only in the presence of 
directing protecting groups or activated substrates. On the other side, β2-amino acids 
cannot be obtained through enantiospecific transformations of the corresponding α-
amino acids; currently, the use of chiral auxiliaries for a diastereoselective α-
aminomethylation of the carboxylic acid derivative is a common and reliable synthetic 
alternative. The catalytic enantioselective synthesis of β2-amino acids via 
aminomethylation remains a challenge,[138] particularly in protecting group-free 
approaches and using unbiased substrates.  
 
Scheme 2.36 Retrosynthetic analysis of β-amino acids from the parent α-amino acid 
or via aminomethylation reaction. 
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 Asymmetric Synthesis of β2,3-Amino Acids  2.5.2
Organocatalytic asymmetric syntheses of β2,3-amino acids have been reported 
both in the field of Lewis base and Brønsted acid catalysis. Inspired by the pioneering 
discovery of a proline-catalyzed direct Mannich reaction by List in 2000,[139] the 
combination of an enolizable aldehyde and an aromatic imine, bearing aromatic 
protecting groups, was reported by Barbas et al. in 2002 to give syn β2,3-amino 
aldehydes [140] and, in 2006, to give anti-β2,3-amino aldehydes.[141] In 2007, List et al. 
reported the Mannich reaction of simple alkyl aldehydes with N-Boc-protected aryl 
imines catalyzed by (S)-proline.[137] The corresponding syn-β2,3-amino aldehydes 
were obtained in high yields as well as enantio- and diastereoselectivities. Finally, an 
additional oxidation step provided access to the desired enantioenriched β-amino 
acids (Scheme 2.37).  
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Scheme 2.37 Enantioselective synthesis of β2,3-amino aldehydes with (S)-Proline as 
catalyst. 
An asymmetric synthesis of β2,3-amino acids in the field of Brønsted acid catalysis 
has been already mentioned in chapter 2.2.4 (Scheme 2.8): Akiyama et al. reported a 
Mannich-type reaction of SKAs with N-(2-hydroxyphenyl)-arylimines, affording the 
corresponding syn-β-amino esters in high yields, diastereo- and 
enantioselectivities.[51] The 2-hydroxyphenyl substituent is crucial, as the H-bonding 
to the catalyst is a pre-requisite for the high selectivity of the reaction. However, the 
protecting group limits the utility of the transformation. Recently, Zhou, Yamamoto et 
al. reported an expansion of the substrate scope by applying the more acidic 
phosphoramide 35 as the catalyst.[142] The wider scope includes disubstituted SKAs 
and aliphatic imines, having either the same protecting group (2-hydroxyphenyl) or 
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simply a phenyl group. However, additional steps are required to obtain the desired 
β-amino acids (Scheme 2.38).    
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Scheme 2.38 Asymmetric synthesis of β2,3-amino esters via Brønsted acid catalysis. 
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 Asymmetric Synthesis of β2-Amino Acids  2.5.3
Several synthetically equivalent transformations can be envisioned for the 
synthesis of β2-amino acids, in which the NH2–CH2 synthon can act as 
electrophile,[138] nucleophile[143] or carbenophile.[144] Among those, Mannich-type 
reactions are the most explored ones (Scheme 2.39). 
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Scheme 2.39 Retrosynthetic analysis for the highlighted disconnection of β2-amino 
acids. 
More than one century ago,[145] Mannich found that β-amino acids could be 
formed by combining enolizable carboxylic acid derivatives, formaldehyde and 
ammonia.[146] Despite the availability of these starting materials, asymmetric variants 
of this transformation have been developed only with more reactive substrates, such 
as enolizable aliphatic aldehydes,[144] or preformed enolates,[83, 147] such as SKAs. In 
the case of β2-amino acid derivatives, the three-component one-pot procedure would 
require formaldehyde, ammonia and an enolizable carboxylic acid derivative. The 
first two reagents are difficult to handle themselves, as they irreversibly form 
urotropine, the tetramer of the highly reactive unsubstituted iminium ion.  
Therefore, this iminium ion can only be applied in protected form: A common 
precursor is bis-benzyl protected tertiary amine having a leaving group in the α-
position.[148] The protected methylene iminium ion is then liberated in situ under the 
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reaction conditions (Scheme 2.40). Protecting groups (e.g. benzyl groups) and 
activated substrates (aldehydes or SKAs) facilitate the design of asymmetric 
transformations; however, they imply additional steps (deprotection and functional 
group manipulation) before achieving the desired target β2-amino acid. 
 
Scheme 2.40 Mannich reaction for the synthesis of β2-amino acids. 
In 2006, Gellman et al. reported a remarkable example of a catalytic 
enantioselective transformation toward β2-amino acid precursors.[138] In this case, the 
authors combined aliphatic aldehydes with N,N-dibenzyl-1-methoxymethanamine 
(36) as the iminium ion precursor and the Jørgensen–Hayashi catalyst (37). The 
hindered silyl ether prevents any hydrogen-bonding or ion-pairing interactions and, 
thus, directs the nucleophilic attack from the opposite face compared to (S)-Proline, 
however, the role of the additives remained unclear. The intermediate β2-amino 
aldehydes were immediately reduced to avoid epimerization. From the obtained 
enantioenriched β-amino alcohols, a recrystallization and three additional steps 
where required to obtain N-Boc-β2-homonorvaline (38) (Scheme 2.41). 
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Scheme 2.41 Enantioselective synthesis of β2-amino acids by Gellman. 
Enantioselective transformations directly affording the unprotected amino acids, 
hence containing the unprotected amine and acid functionalities, have not been 
reported to date. However, in 1985 Morimoto et al. demonstrated the principal 
feasibility of this transformation in a non-asymmetric fashion.[100] Pre-activating a 
carboxylic acid as the corresponding bis-SKA in combination with the iminium ion 
precursor 38, and a catalytic amount of Lewis acid yielded the targeted unprotected 
β2-amino acids, upon exposure to protic conditions (Scheme 2.42).  
 
Scheme 2.42 Direct non-enantioselective synthesis of β2-amino acids. 
Noteworthy, an enantioselective aminomethylation reaction exploiting a similar 
strategy was recently reported by Xu, Hu et al.[127] The transformation was enabled 
by asymmetric counteranion-directed catalysis in the presence of a [PdCl(η3-C3H5)]2 
catalyst and pentacarboxycyclopentadiene (PCCP) acid as the chiral counteranion. 
The metal-based catalyst promotes the in situ formation of reactive enolate 42 from 
Background 
 
 
61 
 
 
diazo compound 40 and an alcohol. PCCP activates the aminomethylating reagent 
36, forrming the iminium ion 41, and provides the chiral environment for the 
asymmetric Mannich-type reaction (Scheme 2.43). Despite the relevance of this 
transformation, the authors did not report a synthesis of β2-amino acids from the 
obtained β2,2-amino acids.   
 
Scheme 2.43 Asymmetric Counter-Anion-Directed Aminomethylation to α-alkoxy-β-
amino esters. 
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3 Objectives 
A direct enantioselective α-functionalization of carboxylic acids still remains 
elusive, both in metal-, bio- and organocatalysis. Only a few systems using in situ 
generated enediolates taking advantage of chiral auxiliaries have been reported.[10a, 
10d, 149] A highly attractive alternative for a versatile catalytic approach to the α-
functionalization of carboxylic acids, circumventing the use of moisture-labile and 
highly reactive enediolates, could rely on the formation of bis-SKA intermediates 
followed by functionalization with an electrophilic partner (Figure 3.1).  
 
Figure 3.1 α-Functionalization of carboxylic acids via activation to the bis-SKA 
intermediate. 
Despite the potential of this transformation, exclusively the catalytic asymmetric 
protonation of bis-SKAs has been reported so far, affording enantioenriched α-
branched carboxylic acids by employing (Lewis acid-assisted) Brønsted acid 
catalysts. In order to achieve high enantioselectivities, the systems were limited to 
bulky proton sources[113a] and electronically-biased bis-SKAs.[13b, 13c] Furthermore, 
cryogenic conditions, inert atmosphere and slow addition of the reagents were 
needed, rendering these methods less practical. In this context we speculated if we 
could find a general solution for electronically-unbiased substrates, using a simple 
proton source, such as water (Figure 3.2). Furthermore, we envisioned the 
application of this method in a one-pot deracemization sequence of α-branched 
carboxylic acids-containing drugs, such as Ibuprofen®.  
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Figure 3.2 Envisioned enantioselective protonation of electronically-unbiased bis-
SKAs using water as the proton source. 
A catalytic enantioselective C–C bond formation for the α-functionalization of bis-
SKAs has not been reported so far. Several reports have focused on the utilization of 
SKAs for the functionalization of various electrophilic species; in those systems, an 
enantiopure catalyst enables the nucleophilic attack selectively onto one of the 
enantiotopic faces of the electrophile, forming the stereogenic center in the β-position 
of the acid derivative.[12b, 51] In this thesis, we aimed to reverse the roles: The 
employed catalyst should discriminate the enantiotopic faces of the nucleophile and 
install selectively the stereogenic center in the α-position of the carboxylic acid. With 
this aim in mind, we selected the α-aminomethylation of bis-SKAs as the targeted 
reaction, as this would lead to synthetically-valuable unprotected β2-amino acids, 
since those valuable motifs are not accessible via straightforward catalytic 
asymmetric transformations yet. This reaction was reported by Morimoto et al. under 
Lewis acidic conditions, using TMSOTf as the catalyst.[100] We envisioned that we 
could exploit the ACDC concept and, after the in situ formation of the iminium ion, 
control the enantiotopic discrimination on the bis-SKA (Figure 3.3).  
  
Figure 3.3 Proposed enantioselective aminomethylation of bis-SKAs via ACDC. 
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In summary, the goal of this thesis is to explore the use of bis-SKAs as potent 
starting materials for the catalytic enantioselective synthesis of α-functionalized 
carboxylic acids under Brønsted or Lewis acidic conditions by developing conditions 
for an α-protonation and α-aminomethylation. 
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4 Results and discussion 
 Asymmetric α-Protonation with H2O and α-Deuteration with 4.1
D2O 
The work presented in this section was performed in cooperation with Dr. Thomas 
James, Dr. Aurélie Blond and Dr. Hyejin Kim. 
4.1.1.1 Synthesis and Handling of bis-SKAs 
The purity of the employed bis-SKA, which has to be >99% as determined by 1H 
NMR, is a crucial factor for the success of the targeted α-functionalizations. Traces of 
water are potent enough to protonate the starting material in the absence of an 
appropriate catalyst resulting in racemic product. Furthermore, after the protonation, 
one molecule of silanol (R3SiOH) is released, which is itself a potent proton source 
reacting with the employed bis-SKA ultimately forming (R3Si)2O. Therefore, full 
conversion of the bis-SKA has to be ensured in order to determine the performance 
of a chiral catalyst, as partial conversion leads to background reactivity upon quench 
or exposure to the atmosphere. An additional crucial factor is the absence of bases, 
as they would react with the acidic catalyst forming very stable and unproductive 
salts. Moreover, low catalyst loadings (1 mol% or lower) are a crucial goal for the 
relevance of any catalytic transformation, thus the starting material has to be base-
free (at least within the sensitivity of 1H NMR). Due to these requirements, particular 
attention and effort had to be dedicated to synthesis, purification and storage of the 
bis-SKAs. 
Commonly, bis-SKAs are synthesized by the original procedure reported by 
Ainsworth et al. in which the carboxylic acid is first reacted with base (usually NaH or 
pyridine) and TMSCl to the corresponding silyl ester. This is then subsequently 
treated with an additional base (e. g. LDA) and more TMSCl to give the desired 
products (Scheme 4.1).[96] The speed of addition of the reagents is a crucial and 
tedious step influencing the yield of the reaction and consequently the efficiency of 
Results and Discussion 
 
 
68 
 
 
the purification, particularly in the case of mono-substituted bis-SKAs (R2 = H). 
However, during our studies we discovered a more facile and higher yielding single 
step procedure using an excess of LDA (2.1 equiv.) and TMSCl (2.2 equiv.). By 
premixing the carboxylic acid and the TMSCl at low temperatures, a faster addition of 
the base was the key to a cleaner reaction profile. This observation can be explained 
by the competition between kinetic and thermodynamic product: the O,O-bis-silylated 
ketene acetal (bis-SKA 31b) is the kinetic product while the C-silylated trimethylsilyl 
ester 44 is the thermodynamic product and the main side reaction observed for 
mono-substituted bis-SKAs. The rapid “internal quench” of the bis-Li enolate by the 
constant high excess of TMSCl favored the kinetic product and thus resulted in a 
cleaner reaction profile and higher yield. A similar strategy was adopted by Corey et 
al. while developing E- or Z-selective synthesis of silyl enol ethers of SKAs.[150] 
Interestingly, the migration of the TMS group from oxygen to carbon could be 
observed upon storage of bis-SKAs at ambient temperature. Noteworthy, additional 
precautions were required including the use of freshly distilled diisopropylamine, 
accurate butyl lithium titration, strict inert conditions and very low pressures for the 
purification via distillation.     
 
Scheme 4.1 Original and improved procedure for the preparation of bis-SKAs.   
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 Reaction Design and Optimization Studies 4.1.2
In an initial experiment, bis-SKA 31a was added to a stoichiometric amount of 
methanol in dichloromethane with (S)-DSI (17a) as the catalyst. Gratifyingly, the 
desired product was obtained after full conversion in 82:18 er (Scheme 4.2) (Note: 
Conversion was monitored via 1H NMR of the crude reaction mixture prior to 
treatment with SiO2). Compared with previous results by Yamamoto et al. (95:5 er 
using 2,6-DMP as the PS),[113a] this result indicated promising enantioselectivity in the 
presence of a non-bulky PS.  
OTMS
OTMS
17a (5 mol%)
CH2Cl2, 1 h, rt.
then SiO2, rt, 10 min
O
OH
+ MeOH
1.1 equiv.
SO2
NH
SO2
F3C
CF3
CF3
F3C
17a
(S)-DSI
full conv
82:18 er
31a 32a
 
Scheme 4.2 Initial result for the asymmetric protonation of bis-SKA in the presence 
of methanol. 
These results prompted us to evaluate the catalytic ability of different Brønsted 
acid catalysts, exploring different ranges of acidities and confinements (Scheme 4.3). 
Catalysts with lower acidities, such as (S)-TRIP 20 (pKa in CH3CN = 13.6), (S,S)-IDP 
19b (pKa in CH3CN = 11.3) and (S,S)-iIDP 46 (pKa in CH3CN = 9.1), catalyzed the 
reaction with very low enantioselectivity (52:48 er; 51:49 er and 51:49 er 
respectively). Catalysts with higher acidities, such as the BALT catalysts 45a and 45b 
(pKa in CH3CN = ~2.8), did not show any level of enantioselectivity (both 50:50 er). 
The combination of great acidity and confined active site as in IDPi 47a (pKa in 
CH3CN = 4.5) also did not show any level of enantioselectivity (51:49 er), presumably 
because bis-SKA (31a) may be too sterically congested and therefore not able to 
interact/to intercept the acidic proton of the IDPi. Exclusively, the intermediate 
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acidities of the DSIs 17a (pKa = 8.5) and 17b, which have more open active sites, 
gave the desired products in improved enantioselectivities (82:18 er and 85:15 er 
respectively) (Scheme 4.3). 
 
Scheme 4.3 Screening of catalysts.  
As DSIs were identified as the ideal class of Brønsted acids for this 
transformation, initial screenings were performed using catalyst 17a. Remarkably, the 
use of different PSs had no influence on the enantioselectivity of the transformation ( 
Table 4.1). From the bulkiest PS in the series (Entry 5) to the smallest one (Entry 
1), the enantioselectivity remained unchanged. These results indicate that the 
background reactivity is not a major concern under this condition and the catalyst is 
the exclusive proton source.  
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Table 4.1 Effect of the PS. aTime required to reach full conversion    
    
Lowering the temperature to 0 °C did not improve the enantioselectivity and, 
interestingly, lower temperatures such as –20 °C and –40 °C were even detrimental. 
This result suggests that the activity of the catalyst is reduced, making the 
background reaction predominant (Table 4.2). 
Table 4.2 Effect of temperature. aTime required to reach full conversion 
 
A solvent screening revealed that choice of solvent mainly affected the 
enantioselectivity, whereas reactivity remained similar (Table 4.3). Due to higher 
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enantioinduction obtained with it, dichloromethane was used as solvent for further 
studies. 
Table 4.3 Effect of solvent. aTime required to reach full conversion    
    
The optimal concentration was identified to be at 0.2 M (Table 4.5, Entry 3), since 
lower concentrations did not improve the enantioselectivity (Entries 1 and 2) and 
higher concentrations were detrimental (Entries 4 and 5).  
Table 4.4 Effect of the molarity on the DSI-catalyzed protonation of bis-SKA 
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Using these optimized conditions, the catalyst loading could be reduced to 
1 mol%, without deteriorating yield or enantioselectivity (Entries 1 and 2). Lower 
catalyst loadings however, gave worse and less reproducible results (Entries 4 
and 5).   
Table 4.5 Effect of the catalyst loading 
 
Taking the best reaction conditions, the catalytic activities of various DSI catalysts 
bearing different 3,3′-substituents were evaluated (Scheme 4.4). Modifications of the 
substituents in the meta-position slightly improved the enantioselectivity (17b 85:15 
er and 17c 87:13 er), however not to sufficient levels. The expansion of the aromatic 
surface to a naphthalene moiety was not sufficient (17e 78:22 er and 17f 65:35 er). 
However, high enantioselectivity was achieved with the catalyst containing the 
phenanthrene (17g) and anthracene substituents (17h), which gave 89:11 er and 
95:5 er respectively.  
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NH
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Ar
Ar
17a
82:18 er
OTMS
OTMS
Catalyst (1 mol%)
MeOH (1.1 equiv.), 
CH2Cl2, 1 h, rt
then SiO2, rt, 10 min
O
OH
F3C CF3
17b
85:15 er
F3C
F3C CF3
CF3
17c
87:13 er
F5S SF5
17d
63:37 er
O2N NO2
17e
78:22 er
17f
65:35 er
17g
89:11 er
17h
95:5 er
Ar =
17
31a 32a
 
Scheme 4.4 Effect of the 3,3′-substituents of the DSI catalyst. 
 
 Preliminary Substrate Scope 4.1.3
Despite the promising result, a preliminary substrate scope showed that, in the 
presence of 17h as the catalyst, the reaction scope lacked generality (Scheme 4.5). 
Whereas the model substrate 32a could be obtained with very good 
enantioselectivities (95:5 er), modifications of the R1 group from methyl to isopropyl 
(32c) or benzyl groups (32d) were detrimental for the enantioselectivity (72:28 er and 
75:25 er). In particular, ortho-substituents at the aromatic group (32e and 32h) of the 
substrate led to racemic products (both 50:50 er), and meta- (32f 88:12 er; 32i 94:6 
er) and para-substituents (32g 94:6 er) gave high but overall not sufficient 
enantioselectivities.  
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OTMS
OTMS
R1
17h (1 mol%)
MeOH (1.1 equiv.) 
CH2Cl2, 1 h, rt
then SiO2, rt, 10 min
O
OH
R1
OH
O
Cl
32j
95:5 er
OH
O
Cl
32i
94:6 er
OH
O
32e
50:50 er
OH
O
Me
32f
88:12 er
OH
O
32g
94:6 er
Me
Me
OH
O
32h
50:50 er
Cl
OH
O
32a
95:5 er
Et
OH
O
32b
95:5 er
i-Pr
OH
O
32c
72:28 er
Bn
OH
O
32d
75:25 er
R R
31 32
 
Scheme 4.5 Preliminary substrate scope. 
 
 Fine-Tuning of the Catalyst Design 4.1.4
In order to achieve a more general system, further catalyst development was 
required. Therefore, the synthetic focus on the catalysts structures was divided into 
two branches. Firstly, maintaining the anthracene unit and functionalizing possible 
positions (17i-17k), and secondly, reinvestigating the second best catalyst (17g) and 
modifying the present phenanthrene group (17l-17p) (Figure 4.1).  
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Figure 4.1 DSI 3,3′-substituents design: tetraphene derivatives and phenanthrenyl 
derivatives. 
In the 17i-17k series, the particular challenge was the functionalization of position 
6 with a suitable boron reagent (acid or ester) in order to enable Suzuki cross 
coupling reactions with the corresponding 3,3′-I2-DSI (48). Neither the envisioned 
boronic acids nor the corresponding bromides (54a-c) are commercially available or 
reported in literature, therefore a suitable synthetic sequence was designed (Scheme 
4.6). The sequence consisted of an initial Diels–Alder reaction between an in situ 
formed benzyne and furane, followed by metal-catalyzed deoxygenation using TiCl4 
and Zn.[151] After conversion of 50 to the bromo-aldehyde 51 with iPrMgCl•LiCl (turbo 
Grignard)[152] and DMF,[153] the Suzuki coupling with three different boronic acids 
afforded intermediates 54a, 54b and 54c. The formyl group was used as a handle to 
install the required alkyne 53, which was achieved by a Corey–Fuchs reaction.[154] 
The newly introduced aryl group and the ortho-alkyne functionality underwent an 
Au(I)-catalyzed cycloisomerization in which a 1,2-halide shift occured. This can be 
explained by assuming a metal vinylidene species as the reactive intermediate.[155] 
Unfortunately, the desired boronic acids could not be synthetized, as intermediates 
54a and 54b were extremely insoluble and additionally highly unstable in the 
presence of oxygen or light. Intermediate 54c was not formed, as the Au(I)-catalyzed 
cyclization does not tolerate electron deficient ring systems.  
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Scheme 4.6 Synthetic sequence toward tetraphene derivatives 54a, 54b and 54c. 
Further efforts were therefore dedicated toward the preparation of functionalized 
phenanthrene derivatives (Scheme 4.7). In this case, the same synthetic strategy 
was applied starting from the commercially available 2-bromo-arylaldehydes (55, 57, 
58) in combination with different boronic acids (56, 59, 60). Finally, the obtained 
boronic acid intermediates (65a–65e) were reacted with 48 via a Suzuki cross-
coupling reaction, affording the desired DSI catalysts (17l–17p). 
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Scheme 4.7 Synthesis of phenanthrene boronic acid derivatives 65a–65e. 
To our delight, the newly designed catalysts led to higher enantioselectivities 
when compared to the parent catalyst 17g in the asymmetric protonation of the 
model substrate 31a (Scheme 4.8). In particular, a significant increase of 
enantioselectivity was achieved when position 1, 3 and 6 were substituted with a 
methyl group (17o and 17p, 96:4 er).  
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17l 17m 17n 17o 17p17g
85:15 er 94:6 er 94:6 er 95:5 er89:11 er 95:5 er
SO2
NH
SO2
Ar
Ar
OTMS
OTMS
17 (1 mol%)
MeOH (1.1 equiv.)
CH2Cl2, 1 h, rt
then SiO2, rt, 10 min
O
OH
Ar =
17
31a 32a
 
Scheme 4.8 Evaluation of differently substituted phenantrenes in the 3,3’-positions of 
the DSI. 
 Substrate Scope 4.1.5
Encouraged by these promising results, we explored a variety of differentially-
substituted bis-SKAs (Scheme 4.9). Various alkyl substituents were well tolerated in 
the asymmetric protonation, including a longer alkyl chain (32b, 96:4 er) and a benzyl 
group (32d, 95:5 er). However, substitution of the alkyl unit with an isopropyl group 
(32c) resulted in diminished enantioselectivity (70.5:29.5 er), suggesting that the 
enantioinduction of this catalytic system is extremely sensitive to the size of R1 and 
R2. Ortho- (32e, 97:3 er, and 32h, 95:5 er) and para-substitution (32g, 95:5 er) on the 
aromatic unit proved to be superior to meta-substitution (32f, 92:8 er). Both electron-
rich (32e-32g) and electron-deficient (32h–32j) aromatic substituents displayed a 
similar position-dependent selectivity pattern. Non-steroidal anti-inflammatory drugs 
(NSAIDs)-derived bis-SKAs showed an analogous trend, where para-substituted 
starting materials (32o and 32p) gave slightly higher enantioselectivities than meta-
substituted ones (32l and 32n). As observed in previous DSI-catalyzed 
transformations, the enantioselectivity of this method is dependent on an α-aromatic-
α-alkyl substitution pattern, as α,α-dialkyl substrates, such as carboxylic acid 32k, 
were obtained in essentially racemic form.[12b]  
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Scheme 4.9 Substrate scope of the enantioselective protonation of bis-SKAs. 
As already mentioned in Table 4.1, consistent results were also obtained when 
using water as a PS (3a, 95:5 er, and 3m, 95.5:4.5 er) (Table 4.6). However, initial 
results were non reproducible because the addition of 0.55 equiv. of water (6 µL, in a 
0.2 mmol scale of 31a) in CH2Cl2 (1 mL) in a single portion resulted to a 
heterogeneous system (liquid/liquid). Therefore, the 0.55 equiv. of water were initially 
dissolved in CH2Cl2 reaching a saturated solution. The stock solution of water in 
CH2Cl2 was then added via syring pump to the reaction mixture. Reproducible and 
consistent results could be obtained with this setup. 
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Table 4.6 Enantioselective protonation of bis-SKAs using water as the PS. 
OH
O
H
Ibuprofen 32o
82%
95.5:4.5 er
32a
89%
95:5 er
H
OTMS
OTMS
R1
17o (1 mol%)
H2O (0.55 equiv.)
CH2Cl2, 1 h, rt
then SiO2, rt, 10 min
O
OH
R1
R R
H
31 32
OH
O
 
 
 Mechanistic Investigations 4.1.6
To gain insight into the reaction mechanism, we studied the effect of the PS on 
the conversion and stereochemical outcome (Table 4.7). In the absence of a PS, a 
conversion equal to the catalyst loading was observed (Entries 1 and 2), suggesting 
that the substrate is only protonated by the catalyst. Turnover was only observed 
upon adding a stoichiometric amount of PS (Entries 3 and 4). Notably, 
enantioselectivities consistently proved to be independent of the PS (Entries 4-6), 
suggesting that the stoichiometric PS is not involved in the enantiodetermining step. 
Furthermore, a sub-stoichiometric amount of water also enabled full conversion 
(Entry 7), as the 0.5 equiv. of silanol, formed during the protodesilylation of the SKA, 
acts as an efficient PS, ultimately generating hexamethyldisiloxane. 
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Table 4.7 Reaction mechanism investigation         
        
We speculate that the high efficiency of our catalytic system, compared to that of 
the racemic background reaction, is a result of a relatively fast protodesilylation event 
depicted in the proposed transition state (TS) (Scheme 4.10), which likely exploits the 
bifunctionality of the DSI with its high N–H acidity and concomitant Lewis basicity of 
the S=O bond, in combination with the oxophilicity of the silicon group. An analogous 
protodesilylation event can be envisioned for the re-protonation of 66 by the achiral 
PS, overall resulting in a fast and efficient enantioselective protonation. In this 
scenario, the background reaction between 31a and the achiral PS is avoided by the 
high efficiency of the catalytic system without the need of a bulky PS, thereby 
improving the atom economy of the protonation step. 
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bifunctional activation mode
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Scheme 4.10 Proposed catalytic cycle. 
 
 Enantioselective Deuteration of bis-SKAs 4.1.7
The robustness of this catalytic system to any PS also provided direct access also 
to the corresponding deuterated products (67a, 95.5:4.5 er, and 67b, 95.5:4.5 er), 
achieving the first organocatalytic enantioselective deuteration of bis-SKAs with D2O 
or CD3OD (Scheme 4.11). Moderate enantioselectivity was obtained with a 
monosubstituted bis-SKA, furnishing enantioenriched α-deuterated phenylacetic acid 
67c with an er of 81:19.  
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OH
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67c
92%
81:19 er
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95.5:4.5 er
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95.5:4.5 er
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Scheme 4.11 Enantioselective deuteration of bis-SKAs. 
 Deracemization Sequence 4.1.8
To illustrate the practicality of our method, a late stage deracemization of 
Ibuprofen® (32o) was performed on a multigram scale (Scheme 4.12). Starting from 
5 g of (±)-32o, stoichiometric amounts of TMSCl and LDA were added. The resulting 
suspension was concentrated and LiCl was filtered, furnishing ketene acetal 31o in 
>95% purity (determined by 1H NMR), which was used without further purification. 
Subsequently, solvent and catalyst (1 mol%) were directly added to bis-SKA 31o and 
1.1 equiv. of MeOH was added over 30 min. Upon extraction, the final product was 
isolated in 95% yield and 95:5 er; furthermore, the catalyst could also be recycled 
upon extraction, followed by acidification, in quantitative yield. 
(S)-32o
95% [4.8 g] 
95:5 er
no chromatography
OH
O
OH
O
rac-32o
[5.2 g scale]
31o
OSiMe3
OSiMe3
a) LDA (2.1 equiv.)
Me3SiCl (2.2 equiv.)
THF (0.2 Μ) 
–78 °C to rt, 3 h
filtration, no distillation
b) DSI-17o
(1 mol%, 200 mg)
MeOH (1.1 equiv.)
CH2Cl2 (0.2 Μ)
rt, 30 min
quantitative 
catalyst recycling
 
Scheme 4.12 Chromatography-free preparative deracemization of (±)–Ibuprofen® 
(32o). 
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 Conclusions 4.1.9
In summary, we have developed a deracemization of α-branched aryl carboxylic 
acids based on the asymmetric Brønsted acid-catalyzed protonation of the 
corresponding bis-SKAs in the presence of methanol or water. The operationally 
simple protocol allows a facile transformation under mild reaction conditions and 
exclusively furnishes the enantioenriched products in almost quantitative yields 
starting from the corresponding racemic acids without the need for additional 
purification. We suggest that the bifunctional activation mode of the DSI catalyst 
enables a highly efficient catalytic cycle that in turn circumvents racemic background 
reactivity with the achiral, stoichiometric PS. The late stage deracemization of 
NSAIDs on gram scale and the simple direct enantioselective deuteration of bis-
SKAs using CD3OD or D2O as deuterium source demonstrate the applicability of the 
developed system. 
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 Asymmetric α-Aminomethylation for the Direct Synthesis of 4.2
Unprotected β-Amino Acids 
The work presented in this section was performed in collaboration with Dr. 
Chendan Zhu. 
 Reaction Design and Optimization 4.2.1
Inspired by the work of Morimoto et al.,[100] an initial experiment was conducted 
using bis-SKA 31q and bis-silylated hemiaminal 38 in the presence of a catalytic 
amount of (S)-DSI 17a as the pre-catalyst. An apolar solvent (toluene) was chosen to 
enable the formation of a tight ion pair between the iminium ion formed in situ and the 
chiral counteranion, as proposed in an ACDC scenario. A small excess of the bis-
SKA (1.2 equiv.) was added to a solution containing the catalyst 17a, in order to (a) 
ensure the full activation of the catalyst by silylation and (b) convert each available 
source of protons to TMS2O according to the self-healing cycle (see section 2.2.5.1). 
Subsequently, the electrophilic aminomethylating reagent was added. The targeted 
reaction (Scheme 4.13) proceeded within 1 hour in quantitative yield (Note: yield was 
determined by 1H NMR analysis of the crude reaction mixture using mesitylene as an 
internal standard) and moderate yet promising enantioselectivity (61:39 er). 
 
Scheme 4.13 Initial result for the asymmetric aminomethylation of bis-SKA 31q; 
[a] NMR yield measured with mesitylene as internal standard. [b] The enantiomeric 
ratio of the product was determined by chiral phase HPLC analysis, without further 
derivatization using Chirobiotic T2 (for further details, see Experimental Part). 
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These results motivated us to explore the catalytic ability of different Brønsted 
acid pre-catalysts (Scheme 4.14). In the case of (S)-TRIP 20 (pKa in CH3CN = 13.6), 
IDP 19b (pKa in CH3CN = 11.3) and iIDP 46 (pKa in CH3CN = 9.1) no reaction 
occurred, as due to their low acidity presumably an irreversible silylation of the 
corresponding catalysts takes place. BALT catalysts 45a and 45b (pKa in CH3CN = 
~2.8) and IDPi 47a (pKa in CH3CN = 4.5) catalyzed the targeted reaction, however 
without any induction of enantioselectivity. Gratifyingly, DSIs 17a (pKa = 8.5) and 17g 
gave the desired products in moderate enantioselectivities (61:39 er and 59:41 er 
respectively). We therefore decided to continue our investigations with the DSI motif 
(17a).  
 
Scheme 4.14 Initial screening for the most suitable catalyst motif. 
 
4.2.1.1 Exploration of DSI Catalysts 
The initial screening of solvents and temperatures showed that apolar solvents 
were required and lowering the temperature down to –60 °C improved the 
enantioselectivity of the transformation. In particular, the targeted product was 
obtained in an enantioselectivity up to 78.5:21.5 er, in toluene at –60 °C. Using n-
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hexane as the solvent resulted in comparable 76.5:23.5 er at –40 °C. However, at –
60 °C, the enantioselectivity decreased to 69:31 er, probably due to the lower 
solubility and hence lower reactivity of the catalyst under these conditions (Table 
4.8). In each case, the reaction profile was very clean and the substrates converted 
exclusively to the desired product. Therefore, yields will not be reported for all the 
initial screenings, unless they do not match with the conversion. 
Table 4.8 Effect of temperature and solvent.  
 
Additional parameters were tested, including molarity (0.01, 0.05, 0.1, 0.5 and 
1 M) (Table 4.9), catalyst loading (0.1, 0.5, 1, 2 and 5 mol%) (Table 4.10) and 
different stoichiometries of 31q (2, 5 and 10 equivalents) (Table 4.11). However, 
these parameters had no particular effect on the enantioselectivity of the reaction.  
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Table 4.9 Effect of molarity in toluene. [a] NMR yield measured with mesitylene as 
internal standard.          
    
 
Table 4.10 Effect of the catalyst loading. [a] NMR yield measured with mesitylene as 
internal standard.          
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Table 4.11 Effect of the stoichiometry of the bis-SKA. [a] NMR yield measured with 
mesitylene as internal standard. 
 
Thus, the same reaction conditions were maintained to evaluate the effects of the 
substituents in the 3,3′-positions of the DSI catalyst (Scheme 4.15). Modifications of 
the substituents in the meta-positions decreased the enantioselectivity (17c 71:29 er 
and 17q 62:38 er) and any substituent in para-position resulted in either low 
enantioselectivity (17r 58:42 er) or racemic products (17s 51:49 er). Catalysts with 
lower acidities, such as the ones with extended aromatic substituents, gave lower 
enantioselectivities (17g 70:30 er, 17h 68:32 er and 17t 69:31 er) and yields (usually 
in the range of 10–15% NMR yield). In these cases the aminomethylating reagent 
was fully decomposed forming the tris-silylated 1,3,5-triazine 70 and unreacted bis-
SKA 31q remained in the reaction mixture. A possible explanation for the observed 
side-reaction could be that the nucleophilic attack of the bis-SKA is slowed down due 
to the decreased Lewis acidity, giving the in situ generated iminium ion 69 more time 
to react with itself. In agreement with this explanation, the presence of EWGs (17b) 
increased the acidity of the catalysts and resulted in quantitative yields, however 
without improving the enantioselectivity (71:29 er). 
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Scheme 4.15 Effects of the substituents in the 3,3′-positions of the DSI catalysts. 
NMR yield measured with mesitylene as internal standard. 
The observed levels of enantioselectivity were only moderate to good at this point 
and there was no clear direction on how to improve them. On the other hand, the 
results were encouraging as the model substrate was aliphatic, and DSI catalysts 
have typically been only successful with aromatic substrates (as mentioned in section 
2.2.5.1). However, when aromatic substrate 31r was tested, lower reactivity but 
similar enantioselectivity was observed. The lower reactivity could be explained by 
the decreased nucleophilicity of the substrate, as the HOMO of 31r is stabilized by 
conjugation. Higher temperatures were required as no conversion of the starting 
material could be observed below –20 °C. Regarding the substituents on the catalyst, 
Results and Discussion 
 
 
93 
 
 
a similar trend as for the previous substrate was observed: Whereas different meta-
substituted aryl groups gave similar or lower enantioselectivities (17c 60:40 er and 
17q 58:42 er), para-substituted ones afforded only racemic product (17r and 17s). 
The moderate enantioselectivity of 17g was accompanied by mainly decomposition 
of 38 and thus low yield. Similar behavior could be observed for 17h and 17t. The 
best result is this series was obtained using 17b (quantitative yield, 63:37 er), 
however, this result could not be improved by further optimizations (Scheme 4.16). 
 
Scheme 4.16 Effect of substituents in the 3,3′-positions of the DSI catalysts. [a] NMR 
yield measured with mesitylene as internal standard. 
As already pointed out in section 2.2.5.2, the DSI motif has structural limitations 
compared to the IDPis. Indeed, DSI can bear different 3,3′-substituents and 
modifications on 5,5′- and 6,6′-positions have been reported. In addition to all the 
previously mentioned possibilities of modification, IDPis can be further modified in 
proximity to the catalytically active site, by variation of the sulfonimidic residue in the 
core of the catalyst. Based on our initial results, we concluded that IDPis were 
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sterically too confined to incorporate the intermediate iminium-ion thus resulting in 
low or no enantioinduction in the targeted reaction. Reaching this point in our 
investigations, we questioned whether we discarded the IDPi motif too early, as it 
offers an additional possibility for modifications at the catalyst’s core, allowing a more 
accurate design of the required key chiral counteranion. We therefore decided to 
reinvestigate and further explore the catalytic abilities of the IDPi motif by testing 
different combinations of substituents in the 3,3´-positions and sulfonimidic residues.   
 
 Examination of IDPi Catalysts  4.2.2
We began our investigations by comparing the reactivity of IDPi 47f and DSI 17a 
using 31r as the starting material. A series of reaction parameters (e.g. solvent 
polarity, concentration, catalyst loading and reaction time) were evaluated for both 
catalysts in parallel (Table 4.12). When performed in toluene (0.5 M) at room 
temperature, a clean reaction profile was observed using 2 mol% of DSI 17a, giving 
the targeted product in 91% yield and 60:40 er (Entry 1). Using IDPi 47f under the 
same reaction conditions resulted in significant formation of by-products, mainly due 
to Claisen condensation. The desired product could be obtained in 75% yield, 
however in racemic form. Decreasing the temperature had different impact on the 
two catalytic systems: With 17a no significant change in enantioselectivity was 
observed, however the reactivity decreased until no reaction could be obtained below 
–40 °C (Entries 2–4). Gratifyingly, with 47f, the lower temperatures decreased the 
amount of side products, resulting in a cleaner reaction profile and the 
enantioselectivity increased to 60:40 er (Entries 3 and 4). Further modifications of the 
reaction parameters for DSI 17a, such as the catalyst loading, molarity or solvent 
polarity did not improve the enantioselectivity (Entries 5–9). With IDPi 47f on the 
other hand, increased catalyst loading lead to by-product formation (Entry 5, 93% 
yield instead of 99% yield of Entry 4), a higher concentration decreased the 
enantioselectivity (Entry 6, 56:44 er) and a lower concentration slowed down the 
reaction rate, yet with a cleaner reaction profile (Entry 7, 41% yield at 42% 
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conversion, 62:48 er). As already previously shown, the choice of the solvent was not 
a determining parameter for the enantioselectivity (Entries 4, 8 and 9). 
Table 4.12 Parallel screening of reaction conditions using DSI 17a and IDPi 47f; 
[a] NMR yield measured with mesitylene as internal standard.  
Entry mol% yield (%) a
1 2
2 2
3 2
4 2
5 5
6 2
er
7 2
0.5
0.5
0.5
0.5
0.5
1
0.05
8 2
9 2
0.5
0.5
Conc. ( )
Et2O
CHCl3
solvent yield (%) a er
IDPiDSI 17a
OTMS
OTMS
Catalyst (xx mol%)
solvent (xx ), 16 h
then MeOH/H2O
O
OH
Ph
Ph +
1.0 equiv.
OMeN
TMS
TMS
1.2 equiv.
91
69
13
70
64
60:40
60:40
61:39
nd nd
61:39
58:42
26 61:39
90
86
60:40
60:40
75
86
99
93
99
50:50
50:50
60:40
99 60:40
61:39
56:44
41 62:38
99
86
62:38
62:38
T (°C)
0
–20 °C
–40 °C
–40 °C
–40 °C
rt
–40 °C
–40 °C
–40 °C
T (°C)
0
–20 °C
–40 °C
rt
rt
rt
rt
rt
rt
NH2
PhMe
PhMe
PhMe
PhMe
PhMe
PhMe
PhMe
31r 38 68r
47f
 
With these reaction conditions in hand, a screening of IDPi catalysts employing a 
variety of aryl-substituents in the 3,3´-positions (Ar) and sulfonimidic residues in the 
core of the catalyst (R) (Scheme 4.17) was performed. In order to obtain a 
comprehensive overview of the electronic and steric effects of the substituents in the 
3,3′-positions of the catalyst, aryl-groups having ortho,meta- (47b and 47g), mono-
meta- (47c), para-EDGs (47d and 47h), and para-(47e) or meta, meta-EWGs (47f 
and 47i) were tested in combination with CF3- or C6F5- groups in the catalyst core. It 
could be shown that catalysts containing aromatic sulfonamide-derived cores 
afforded either lower yields (47g, 19% yield, full degradation of 38 to undefined 
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polymers according to 1H NMR analysis of the crude reaction mixture) or lower 
enantioselectivity (47i, 50:50 er). 
 
Scheme 4.17 Evaluation of different aromatic substituents in the 3,3′-positions (Ar) 
and cores (R). [a]Reactions quenched with Et3N after 16 hours; 
[b]Reactions quenched 
with Et3N after 3 days. 
As no clear lead could not be identified due to the generally low obtained 
enantioselectivities, systematic investigations of each individual structural and 
electronic parameter were performed. Catalysts having electron-withdrawing para-
substituents (47e), meta,meta-substituents (47f) and electron-donating para-
substituents (47d) at the aryl-groups in the 3,3′-positions were combined with a 
variety of sulfonimidic substituents. Due to the high acidity and therefore increased 
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reactivity of the resulting IDPis, they were tested at –60 °C, in contrast to catalysts 
(47s–47v) equipped with aromatic cores, which were tested at room temperature 
(Scheme 4.18). Changing the p-CF3-substituent to a p-SF5-group had no impact on 
the enantioselectivity (47l, 62:38 er). To our delight, modifications of the catalyst’s 
core to a longer perfluorinated alkyl chain (47m, 69:31 er), to an electron-poor aryl 
group (47n, 76:24 er) or to an electron-poor terphenyl group (47o, 79:21 er) 
increased the enantiomeric excess of the desired product. Similar modifications of 
47f did not influence the enantioselectivity in the same amount (47p, 53:47 er and 
47r, 61:39 er), thus further catalysts in this series were not tested. The combination 
of para-tert-butyl-substituted aryl-groups in the 3,3′-positions and aromatic cores 
diminished the reactivity, however the enantioselectivity was increased (47s, 20% 
conv. and 64.5:35.5 er, 47t, 1% conv. and 78:22 er, 47u, 20% conv. and 61:39 er). 
Due to the low reactivity of the latter catalysts, the temperature had to be raised to 
room temperature in order to obtain some conversion of the starting material. IDPi 
47s in particular showed the same level of enantioselectivity under these reaction 
conditions as 47t at –60 °C, yet only with 1% yield. We therefore concluded that the 
catalyst should include electron-rich 3,3´-substituents; therefore, acidity and reactivity 
should be adjusted by suitable modification of the core. We envisioned that ideally 
we could identify a catalyst which would be reactive enough to allow us to improve 
enantioselectivity by decreasing the temperature.   
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Scheme 4.18 Evaluation of different cores for 47e, 47f and 47d. NMR yield 
measured with mesitylene as internal standard. 
We identified 2-fluorenyl as a promising substituent at the 3,3′-positions of the 
IDPi catalyst (a selection of the tested catalysts is shown in Scheme 4.19). A library 
of catalysts consisting of (a) various perfluorinated alkyl-chains in the core and (b) 
fluorenyl-derived spiro-substituents were prepared and evaluated using bis-SKA 31r 
as the starting material. Based on the obtained results, we concluded that an 
increased length of the perfluorinated alkyl chain leads to a slight increase in 
enantiomeric excess. When comparing different fluorenyl-substituents, the 5-
membered ring-containing motif was consistently more selective than the other ones 
tested. Moreover, the majority of the catalysts afforded full conversion and 
quantitative yields within 3 days. The only catalysts that showed lower conversions 
were those containing a perfluorinated aromatic ring in the core (48f, 49f and 50f). 
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The best result within this series was obtained using the catalyst with the fluorenyl-
3,3′-substituents 49 and n-C8F17 as perfluorinated alkyl chain in the core (49e), giving 
the desired product in 92% yield and 82:12 er.   
Ar =
R =
90% conv.
53% yield
81:19 er
45% conv.
11% yield
80:20 er
full conv.
83% yield
78:22 er
98% conv.
92% yield
82:18 er
92% conv.
86% yield
68:32 er
full conv.
96% yield
65:35 er
full conv.
98% yield
69:31 er
50% conv.
17% yield
62:38 er
70% conv.
64% yield
73:27 er
CF3 C8F17
F5
C6F13C4F9C2F5
full conv.
99% yield
72:28 er
66% conv.
65% yield
75:25 er
14% conv.
13% yield
84:16 er
full conv.
99% yield
63:37 er
full conv.
99% yield
72.5:27.5 er
full conv.
99% yield
80.5:19.5 er
92% conv.
92% yield
58:42 er
30% conv.
28% yield
70.5:29.5 er
OTMS
OTMS
71 (2 mol%)
PhMe (0.1 )
–60 °C, 3 days
then MeOH/H2O
O
OH
Ph
Ph +
1.0 equiv.
OMeN
TMS
TMS
1.2 equiv.
Ar
N
O
O
P
N
ArSO2
R
O
O
P
N
Ar O2S
R
H
Ar
not available
NH2
31r 38 68r
71a 71b 71c 71d 71e
71f 71g 71h 71j 71k
71l 71m 71n 71p 71q
71i
71o
 
Scheme 4.19 Screening of the fluorenyl-based IDPi library. NMR yield measured 
with mesitylene as internal standard given. 
A similar series of screenings were performed using the aliphatic substrate 31q 
(Scheme 4.20). To our delight, enantioselectivities obtained with this substrate were 
overall higher when compared with the aromatic bis-SKA 31a. Nevertheless, this 
system follows the same trends as previously observed: Increased enantioselectivity 
was achieved upon elongation of the perfluorinated alkyl chain, reaching a maximum 
using n-C6F13 and n-C8F17 (88:12 er for both, 71i and 71j).  
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Scheme 4.20 Screening of 5-membered ring containing fluorenyl-derived IDPi 
catalysts with substrate 31q. NMR yield measured with mesitylene as internal 
standard. 
As the best catalyst (71j) strongly differs by means of sterics and electronics from 
the catalyst (47f) used for the initial optimization, we decided to reevaluate the 
reaction conditions by rescreening some crucial reaction parameters (Table 4.13). To 
our delight, using n-pentane (Entry 4) and n-hexane (Entry 5), the desired product 
was obtained in quantitative yield and improved enantioselectivity (93:7 er and 
93.5:6.5 er respectively). 
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Table 4.13 Optimization of the reaction conditions using 71j. [a] NMR yield measured 
with mesitylene as internal standard.       
    
Regarding concentration and catalyst loading, we could confirm our previous 
findings with the catalytic system having an optimum at 0.2 M and 1 mol% of 71j 
(Table 4.14, Entry 2). The use of lower catalyst loadings was possible without 
deterioration of the enantioselectivity; however, the reaction rate was reduced 
(Entry 6).  
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Table 4.14 Optimization of the reaction conditions using 71j. [a] NMR yield measured 
with mesitylene as internal standard.       
   
As the target level of enantioselectivity (> 95:5 er) could not be achieved by 
further optimization of the reaction conditions, we focused our attention back on 
optimizing the catalysts structure by further modification of core and/or the 3,3′-
substituents. An easily accessible modification of the core was the extension of the 
length of the alkyl chain to n-C10F21 (Scheme 4.21). The required sulfonamide 75 was 
synthesized starting from the commercially available iodide 72 by first transforming it 
into the corresponding sulfinic acid 73. Oxidation in the presence of an electrophilic 
fluorine source and subsequent treatment with ammonia gave 75. Finally, catalyst 
71r could then be obtained using the established IDPi synthesis, by the reaction of 
phosphazene reagent 76, resulting from the reaction of 75 and PCl5, and BINOL-
derivative 77.  
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Scheme 4.21 Synthesis of C10F21 core-containing catalyst (71r). 
Unfortunately, the newly designed core did not improve the enantioselctivity of the 
reaction (Table 4.15). 
Table 4.15 Asymmetric aminomethylation using 71j. [a] NMR yield measured with 
mesitylene as internal standard. 
 
Due to low commercial availability of alternative precursors for synthetizing 
perfluorinated alkyl chains, we decided to focus on the modification of the fluorenyl 
substituents. However, before investing additional tedious efforts into multi-step 
synthesis of new catalysts, we initiated preliminary investigations of the reaction 
mechanism, aiming to identify strategic positions for modification. 
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 Mechanistic Insights Lead to a New Catalyst Design  4.2.3
A proposed catalytic cycle is depicted in Figure 4.2, including a schematic 
representation of the catalyst in which the 3,3′-fluorenyl substituents are highlighted 
in black and the perfluoroalkyl chain on the sulfonimidic residue in purple. After the 
initial drying/self-healing cycle (introduced in Section 2.2.5.1), the key steps are (a) 
the activation of the electrophilic substrate (38), forming a tight ion pair between the 
anionic catalyst (49f) and the cationic electrophile (iminium ion 69) and (b) the 
enantiodetermining step in which the bis-SKA 31q attacks onto the electrophile, 
giving the silylated product (79) and the silylated catalyst (78).  
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Figure 4.2 Proposed catalytic cycle. 
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In the first step, the silylium ion in the active site of the catalyst is attacked by the 
oxygen of the electrophile, and TMSOMe is liberated, leaving the bis-silylium iminium 
ion coordinated to the IDPi. In support of this mechanism, an additional 
aminomethylating reagent (80) was prepared and subjected to the reaction 
conditions. Following the proposed reaction mechanism, after the initial activation of 
38 or 80, the formed iminium ion (69) and the derived ion pair should be the same, 
and the enantioselectivity of the reaction should not be affected. Indeed, the use of 
38 (R = Me) or 80 (R = Bn) afforded very similar enantioselectivities (93:7 er and 92:8 
er, respectively) (Scheme 4.22).  
 
Scheme 4.22 Preliminary mechanistic studies: use of 38 or 80 as aminomethylating 
reagent. NMR yields measured with mesitylene as internal standard given. 
The proposed stereochemical model depicted in Figure 4.3 supports the observed 
trends in catalyst design, namely (a) a clear influence of the size of the spiro-cycle in 
the fluorenyl substituent (4, 5 or 6 membered ring) and (b) the influence of the 
perfluoroalkyl chain up to a certain length of the residue. Based on this model, we 
reasoned that introducing an additional EDG substituent in 7-position of the fluorenyl 
group might influence the enantioselectivity for two reasons: (1) an electron-rich 
aromatic unit could favor the stabilization of cation in the crucial ion pair, and (2) the 
additional steric bulk may remotely influence the access to the active site or the 
rearrangement of the neighboring groups. 
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Influencing parameters for enantioselectivity
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Figure 4.3 Proposed stereochemical model. 
 
 Final Catalyst Optimization 4.2.4
In order to validate these assumptions, a series of catalysts were prepared in 
which the fluorenyl-substituents were additionally substituted in either the 6- or 7-
positions. C8F17 were chosen as the substituents in the core (Scheme 4.23). To our 
delight, all the modifications performed in position 7 increased the enantioselectivity. 
A methyl group (71s) influenced the steric properties and the electron-density of the 
system enough giving the desired product in 96:4 er. The bulkier tert-butyl-
substituted analogue resulted in the same enantiomeric excess (71t, 96:4 er) and a 
longer alkyl chain (71v) or a phenyl group (71w) did not afford the desired 
enantioselectivity (>95:5 er). Moreover, substitution in position 6 with a tert-butyl 
group even decreased the enantioselectivity to 90.5:9.5 er (71u). 
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Scheme 4.23 Screening of 6- and 7-substituted fluorenyl derivatives. 
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 Substrate Scope 4.2.5
Finally, with this set of catalysts in hand, we set out to explore the scope of this 
transformation. As this is currently under investigation in our laboratory, only 
preliminary results using IDPis 71s and 71t are depicted in Scheme 4.24. Both 
catalysts delivered the desired products in high yields (>90%), however their 
performances differ in selectivity. Whereas the tert-butyl-substituted catalyst 71t 
delivered aliphatic substrates (R=Alk) in slightly higher enantioselectivities, the Me-
substituted catalyst 71s was better with the single tested aryl-substituted substrate 
31a (R=Ph). 
OTMS
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Scheme 4.24 Preliminary substrate scope. NMR yields measured with mesitylene as 
internal standard given. 
While this thesis is being written, experiments to fully investigate the discovered 
process are ongoing and are expected to lead to a successful completion of the 
project in due course. 
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 Outlook and Conclusion 4.2.6
In summary, we have developed the first asymmetric organocatalytic α-
aminomethylation of bis-SKAs, enabling direct access to unprotected β2-amino acids 
under Lewis acidic conditions. The newly designed catalyst, upon activation of the 
aminomethylating reagent, forms a tight ion pair with the bis-silylated iminium ion, 
formed in situ, and controls the enantiotopic differentiation of the nucleophilic bis-
SKA. The enantioenriched silylated products are formed in quantitative yields and a 
mild acidic workup, or simply protic conditions, liberates the unprotected β2-amino 
acid. The final compounds can be isolated quantitatively upon precipitation and 
filtration, without additional purification steps. Currently, investigation of the generality 
of the developed method is under examination; the developed methodology will be 
applied in the synthesis of biologically active compounds, such as Alvimopan® and 
Rhopressa® (Figure 4.4).   
O
N
H
N
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O
OH
Alvimopan 
O
N
H
NH2
NO
O
Rhopressa 
µ-opioid antagonist
postoperative ileus
Rho kinase inhibitor
glaucoma  
Figure 4.4 Candidates for the application of the developed enantioselective 
aminomethylation.
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5 Summary 
Strong Brønsted acids can be converted in strong Lewis acids upon silylation with 
a suitable reagent. This ambivalent feature was fully exploited in this thesis 
(Scheme 5.1).  
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Scheme 5.1 Enantioselective protonation and enantioselective aminomethylation of 
bis-SKAs. 
 
 Catalytic Asymmetric α-Protonation with Water and α-5.1
Deuteration with D2O 
In the first part of this thesis, we exploited this cycle to protonate 
enantioselectively bis-SKAs using simple PSs (e.g. water). We showed that Brønsted 
acid DSI 17o enabled the facial recognition of the bis-SKA and afforded the 
corresponding carboxylic acids in high yields and enantioselectivities (Scheme 5.2).  
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Scheme 5.2 Catalytic Asymmetric α-Protonation with a simple PS. 
The application of this method in the late stage deracemization of Ibuprofen 
proved the potential and utility of this strategy (Scheme 5.3).  
 
Scheme 5.3 Late stage deracemization of NSAIDs with DSI.  
The greater advantage of this methodology relies on the possibility to use any PS; 
this enabled the use of D2O or CD3OD for the enantioselective deuteration of bis-
SKAs and allowed an easier access to enantioenriched α-deuterated carboxylic 
acids. A particularly interesting substrate was 67c, in which we introduced a 
stereogenic center upon deuteration (Figure 5.1). Further development of a highly 
enantioselective deuteration could open the access to this class of compounds, 
which is not particularly explored yet.  
 
Figure 5.1 Enantioselective deuteration of bis-SKAs with CD3OD. 
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 Catalytic Asymmetric α-Aminomethylation   5.2
In the second part of this thesis, we exploited the Lewis acidity of the silylated 
IDPi 71s for the in situ formation of a highly reactive protected iminium ion and 
subsequent reaction with a bis-SKA, affording unprotected β2-amino acids in an 
enantioselective fashion. 
Until now, ACDC was widely applied in enantioselective transformations in which 
the activated electrophile would initially interact in a tight ion pair with the catalyst 
providing a chiral environment. Subsequently, the nucleophile preferentially attacks 
from one side onto the catalyst-electrophile complex, generating a stereogenic center 
on the former electrophile. However, this differs in the reported aminomenthylation. 
While the activation of the electrophile follows the same logic, the stereogenic center 
formed by the attack of the nucleophile is located on the nucleophile itself (Figure 
5.2). The targeted α-aminomethylation of bis-SKAs was achieved by using 71s or 71t 
as the Lewis acid catalyst. The unprotected β2-amino acids were obtained in 
quantitative yields and high enantioselectivities. 
OTMS
OTMS
(S,S)-71s or 71t
(1 mol%)
n-pentane (0.1 Μ)
–60 °C, 3 days
then MeOH/H2O
O
∗
OH
RR + OMeN
TMS
TMS
NH2
Ar
N
O
O
P
N
ArSO2
C8F17
O
O
P
N
Ar O2S
C8F17
H
Ar
R = Ph, Bn, Alk
up to 99% yield
up to 96:4
71s
Ar =
71t
N
TMSTMS
OTMS
OTMSR
*
via
 
Figure 5.2 Enantioselective α-aminomethylation of bis-SKAs.  
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6 Outlook 
We have demonstrated that bis-SKAs are valuable intermediates for the 
enantioselective α-functionalization of carboxylic acids. As mentioned in section 
2.3.1, a wide selection of transformations have been reported in a non-asymmetric 
fashion. We believe that ACDC is a powerful concept that could enable access to 
their enantioselective equivalents. Among the many possible functionalizations, we 
envisioned a few interesting, yet very challenging, transformations:  
(1) The α-amination of bis-SKAs, to access α-amino acids directly from the 
corresponding carboxylic acid. Unfortunately, a successful catalytic system has not 
been identified yet, since the selection of the electrophilic nitrogen source is crucial 
for the turnover of the catalyst. Particularly, under Lewis acidic conditions, any Lewis 
basic functionality (such as amines) forms stable salts with the catalyst and inhibits 
its reactivity.  
(2) The α-trifluoromethylation of bis-SKAs, to directly access the enantioenriched 
α-trifluoromethylated carboxylic acids. In initial experiments we found that this 
transformation is possible under catalytic Lewis acidic conditions, however, only low 
enantioselectivity was observed. A highly Lewis acidic catalyst is required in order to 
outcompete the radical mechanism. Furthermore, the nature of the electrophilic 
trifluoromethylating reagent highly influences the reactivity and feasibility of the 
transformation. 
This thesis opens the field of enantioselective Lewis acid-catalyzed α-
functionalizations of carboxylic acids via the formation of bis-SKAs intermediates. 
Ideally, an enantioselective catalytic system could be envisioned for each of the 
transformations previously reported in Section 2.3.1, exploiting the ACDC concept 
(Figure 6.1), in which the enantiopure Lewis acidic catalyst could control the 
formation of the positively charged electrophilic reagent and the nucleophilic attack 
by the bis-SKA.  
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Figure 6.1 Potentially-accessible compounds from bis-SKAs upon asymmetric 
transformations.  
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7 Experimental Section 
 General Information and Instrumentation 7.1
Chemicals 
Chemicals (Abcr, Acros, Aldrich, Gelest, Fluka, Fluorochem, Strem, TCI) were 
purchased as reagent grade and used without further purification unless indicated 
otherwise. Commercially available carboxylic acids were purchased from Sigma-
Aldrich, Alfa Aesar, Acros Organics, AK Scientific, Apollo Scientific, Key Organics 
and Aronis. n-Butyllithium was purchased from Sigma-Aldrich (2.5 M solution in 
hexanes) and used directly as received. The reagent was titrated before use. 
 
Solvents 
Solvents (CH2Cl2, CHCl3, Et2O, THF, PhMe) were dried by distillation from an 
appropriate drying agent in the technical department of the Max-Planck-Institut für 
Kohlenforschung and received in Schlenk flasks under argon. Other solvents 
(acetone, benzene, cyclohexane, chlorobenzene, 1,4-dioxane, DME, DMF, DMSO, 
EtOAc, EtOH, MeCN, MeOH, MTBE, NMP, n-Bu2O, n-hexane, n-octane, n-pentane, 
pyridine, xylenes) were purchased from commercial suppliers and dried over 
molecular sieves. 
Inert Gas 
Dry argon was purchased from Air Liquide with >99.5% purity. 
Glassware 
All non-aqueous reactions were performed in oven-dried (85 °C) or flame-dried 
glassware under Argon. Solvents were removed under reduced pressure at 40 °C 
using a rotary evaporator and drying under high vacuum (10−3 mbar). 
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Thin Layer Chromatography 
Thin layer chromatography (TLC) was performed using silica gel pre-coated 
plastic sheets (Polygram SIL G/UV254, 0.2 mm, with fluorescent indicator; Macherey-
Nagel), which were visualized with a UV lamp (254 or 366 nm) and phosphomolybdic 
acid (PMA). PMA stain: PMA (20 g) in EtOH (200 mL). Preparative thin-layer 
chromatography was performed on silica gel pre-coated glass plates SIL G-25 
UV254 and SIL G-100 UV254, with 0.25 mm and 1.0 mm SiO2 layers, respectively 
(Macherey-Nagel).  
Flash Column Chromatography  
Flash column chromatography (FCC) was carried out using Merck silica gel (60 Å, 
230−400 mesh, particle size 0.040−0.063 mm) using technical grade solvents. 
Elution was accelerated using compressed air. All reported yields, unless otherwise 
specified, refer to spectroscopically and chromatographically pure compounds.  
Nomenclature  
Nomenclature follows the suggestions proposed by the computer program 
ChemBioDraw (15.0.0.106) of CBD/Cambridgesoft.  
Nuclear Magnetic Resonance Spectroscopy  
1H, 13C, 19F, 31P nuclear magnetic resonance (NMR) spectra were recorded on a 
Bruker AV-500, AV-400 or DPX-300 spectrometer in a suitable deuterated solvent. 
The employed solvent and respective measuring frequencies are indicated for each 
experiment. Chemical shifts are reported with tetramethylsilane (TMS) serving as a 
universal reference of all nuclides and with two or one digits after the marker. The 
resonance multiplicity is described as s (singlet), d (doublet), t (triplet), q (quadruplet), 
p (pentet), hept (heptet), m (multiplet), and br (broad). All spectra were recorded at 
298 K unless otherwise noted, processed with Bruker TOPSPIN 2.1 or MestReNova 
11.0.2 suite of programs, and coupling constants are reported as observed. The 
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residual deuterated solvent signals relative to tetramethylsilane were used as the 
internal reference in 1H NMR spectra (e.g. CDCl3 = 7.26 ppm), and are reported as 
follows: chemical shift δ in ppm (multiplicity, coupling constant J in Hz, number of 
protons). 13C, 19F, 31P NMR spectra were referenced according to Ξ- values (IUPAC 
recommendations 2008) relative to the internal references set in 1H NMR spectra 
(e.g. 13C: Me4Si, 
19F: CCl3F, 
31P: H3PO4; each 0.00 ppm). All spectra are broadband 
decoupled unless otherwise noted.  
Mass Spectrometry  
Electron impact (EI) mass spectrometry (MS) was performed on a Finnigan MAT 
8200 (70 eV) or MAT 8400 (70 eV) spectrometer. Electrospray ionization (ESI) mass 
spectrometry was conducted on a Bruker ESQ 3000 spectrometer. High resolution 
mass spectrometry (HRMS) was performed on a Finnigan MAT 95 (EI) or Bruker 
APEX III FTMS (7T magnet, ESI). The ionization method and mode of detection 
employed is indicated for the respective experiment and all masses are reported in 
atomic units per elementary charge (m/z) with an intensity normalized to the most 
intense peak.  
Specific Rotations  
Specific rotations were measured with a Rudolph RA Autopol IV Automatic 
Polarimeter at the indicated temperature with a sodium lamp (sodium D line, λ = 589 
nm). Measurements were performed in an acid-resistant 1 mL cell (50 mm length) 
with concentrations (g/(100 mL)) reported in the corresponding solvent.  
High Performance Liquid Chromatography  
High performance liquid chromatography (HPLC) was performed on Shimadzu 
LC-20AD liquid chromatograph (SIL-20AC auto sampler, CMB-20A communication 
bus module, DGU-20A5 degasser, CTO-20AC column oven, SPD-M20A diode array 
detector), Shimadzu LC-20AB liquid chromatograph (SIL-20ACHT auto sampler, 
DGU-20A5 degasser, CTO-20AC column oven, SPD-M20A diode array detector), or 
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Shimadzu LC-20AB liquid chromatograph (reverse phase, SIL-20ACHT auto 
sampler, CTO-20AC column oven, SPD-M20A diode array detector) using Daicel 
columns with a chiral stationary phase. All solvents used were HPLC-grade solvents 
purchased from Sigma-Aldrich. The column employed and respective solvent 
mixtures are indicated for each experiment.  
Preparative High Performance Liquid Chromatography  
Preparative high performance liquid chromatography (Prep-HPLC) was performed 
on a Shimadzu LC-8A/10A liquid chromatograph (FRC-10A fraction collector, SPD-
10-AVP diode array detector). All solvents used were HPLC-grade solvents 
purchased from Sigma-Aldrich. The column employed and respective solvent 
mixtures are indicated for each experiment.  
Gas Chromatography  
Gas chromatography (GC) analyses on a chiral stationary phase were performed 
on HP 6890 and 5890 series instruments (split-mode capillary injection system, flame 
ionization detector (FID), hydrogen carrier gas). All the analyses were conducted in 
the GC department of the Max-Planck-Institut für Kohlenforschung. The conditions 
employed are described in detail in the individual experiments.  
Gas Chromatography Mass Spectroscopy  
Gas chromatography-mass spectrometry (GC-MS) analyses were recorded on an 
Agilent Technologies 6890N Network GC System equipped with a 5973 Mass 
Selective Detector, Gerstel Multi-Purpose Sampler MPS2, and a Macherey-Nagel 
Optima 5 column (30 m length, 0.25 mm i. D.), and an Agilent Technologies 7890A 
GC System equipped with a 5975C VL MSD mass selective detector, Gerstel Multi-
Purpose Sampler MPS2, and a Macherey-Nagel Optima 5 column (30 m length, 0.25 
mm i.D.).  
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Liquid Chromatography Mass Spectrometry  
Liquid chromatography-mass spectrometry (LC-MS) was performed on a 
Shimadzu LC-MS 2020 liquid chromatograph. All solvents used were HPLC-grade 
solvents purchased from Sigma-Aldrich. The column employed, the respective 
solvent mixture, and the MS parameters are indicated for each experiment.  
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 Asymmetric α-Protonation with H2O and α-Deuteration with 7.2
D2O 
 Synthesis and Characterization of Racemic Carboxylic Acids 7.2.1
Non-commercially available carboxylic acids where prepared following a reported 
procedure.[10a] 
General Procedure A 
 
OH
O
OH
O
nBuLi (2.1 equiv.)
MeI (1 equiv.)
THF, –78 °C to rt
R R
 
 
n-BuLi (2.54 M in hexanes, 2.1 equiv.) was added dropwise to a solution of acid 
(1.0 equiv.) in THF (0.2 M) at –78 °C and the reaction mixture was allowed to stir at 
this temperature for 15 min. Methyl iodide (1.0 equiv., neat) was added to the 
reaction mixture dropwise over 10 min. The reaction was allowed to stir and warm to 
room temperature overnight. The reaction was quenched with sat. NH4Cl(aq) solution. 
After 5 min, the reaction mixture was diluted with diethyl ether. The aqueous layer 
was extracted with diethyl ether (x3). The combined organic layers were washed with 
sat. Na2S2O3(aq) solution until the organic phase turns to transparent, then washed 
with brine, dried with magnesium sulfate, concentrated under reduced pressure, and 
the solid residue was purified by flash column chromatography (SiO2, 
dichloromethane/methanol = 95:5).  
2-(2-methylphenyl)propanoic acid (32e)  
Prepared according to general procedure A using o-Tolylacetic 
acid (4.8 g, 32 mmol) and obtained as a colorless solid (4.95 g, 30.1 
mmol, 93% yield).  
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1H NMR (501 MHz, CDCl3) δ = 7.29 (d, J = 7.2 Hz, 1H), 7.23–7.15 (m, 3H), 3.99 (q, J 
= 7.1 Hz, 1H), 2.38 (s, 3H), 1.50 ppm (d, J = 7.1 Hz, 3H), [acid proton not visible due 
to fast exchange]. 
13C NMR (126 MHz, CDCl3) δ = 179.69, 138.33, 135.89, 130.56, 127.21, 126.55, 
126.47, 40.96, 19.63, 17.56 ppm.  
HRMS (GC–EI) m/z calculated for C10H12O2 [M–H]: 164.0832; found 164.0837. 
 
2-(3-methylphenyl)propanoic acid (32f) 
Prepared according to general procedure A using m-Tolylacetic 
acid (4.8 g, 32 mmol) and obtained as a colorless solid (4.75 g, 
28.9 mmol, 89% yield).  
1H NMR (501 MHz, CDCl3) δ = 7.26–7.14 (m, 1H), 7.16–7.02 (m, 3H), 3.71 (q, J = 
7.2 Hz, 1H), 2.35 (s, 3H), 1.50 ppm (s, 3H), [acid proton not visible due to fast 
exchange]. 
13C NMR (126 MHz, CDCl3) δ = 167.33, 139.72, 138.38, 128.59, 128.28, 128.16, 
124.58, 45.05, 21.41, 18.16 ppm.  
HRMS (GC–EI) m/z calculated for C10H12O2 [M–H]: 164.0832; found 164.0837. 
 
2-(2-methoxyphenyl)propanoic acid (32m) 
Prepared according to general procedure A from 2-
methoxyphenylacetic acid (5.39 g, 32.4 mmol) and obtained as a 
colorless solid (5.31 g, 29.5 mmol, 90% yield).  
1H NMR (501 MHz, CDCl3) δ = 7.37–7.15 (m, 2H), 6.96 (td, J = 7.5, 1.1 Hz, 1H), 6.89 
(dd, J = 8.7, 1.1 Hz, 1H), 4.09 (q, J = 7.2 Hz, 1H), 3.84 (s, 3H), 1.49 ppm (d, J = 7.2 
Hz, 3H), [acid proton not visible due to fast exchange]. 
13C NMR (126 MHz, CDCl3) δ = 156.78, 128.54, 128.16, 121.04, 110.92, 77.41, 
76.91, 55.68, 39.10, 16.94 ppm.  
HRMS (GC–EI) m/z calculated for C10H12O3 [M–H]: 180.0781; found 180.0781. 
 
 
 
Experimental Section 
 
 
125 
 
 
2-(m-chlorophenyl)propanoic acid (32i) 
Prepared according to general procedure A using 4-
Chlorophenylacetic acid (5.0 g, 29.3 mmol) and obtained as a 
colorless solid (3.54 g, 19.2 mmol, 65% yield).  
1H NMR (501 MHz, CDCl3) δ = 7.32 (s, 1H), 7.28–7.24 (m, 3H), 7.23–7.18 (m, 1H), 
3.72 (q, J = 7.2 Hz, 1H), 1.52 ppm (d, J = 7.2 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ = 179.00, 141.57, 134.50, 129.92, 127.85, 127.65, 
125.87, 44.89, 18.05 ppm. 
HRMS (GC–EI) m/z calculated for C9H9O2ClNa [M–Na]: 207.0183; found 207.0183. 
 Synthesis and Characterization of bis-Silyl Ketene Acetals  7.2.2
Preparation of lithium diisopropyl amine (LDA) solution: To a stirring solution of 
freshly distilled diisopropyl amine (DPA; 50 mmol, 7.0 mL, 1.0 equiv.) in THF (21 mL, 
1 M) under an atmosphere of argon, n-BuLi (2.45 M solution in hexane, 52.5 mmol, 
24.5 mL, 1.05 equiv.) was added dropwise at –78 °C and the resulting reaction 
mixture was stirred for additional 30 min at this temperature.  
Note. n-BuLi was freshly titrated. 
General Procedure B   
OTMS
OTMS
OH
O
R1
R2
R1
R2
LDA (2.1 equiv.)
THF, –78 °C to rt
TMS-Cl
(2.2 equiv.)+
 
A stirring solution of acid (30.0 mmol, 1.0 equiv.) and Me3SiCl (4.6 mL, 33.0 
mmol, 2.2 equiv.) in THF (12 mL) under an atmosphere of argon was cooled to –78 
°C. The LDA solution (2.1 equiv.) was added via cannula. The cooling bath was 
removed after complete addition and the reaction solution was stirred for 1 hour at 
room temperature. The reaction mixture was concentrated in vacuo, and then hexane 
(50 mL) was added to the residue and was filtered under an atmosphere of argon. 
After concentration under reduced pressure, the crude product was purified by 
Experimental Section 
 
 
126 
 
 
distillation under reduced pressure to afford the disilyl ketene acetal as colorless 
liquids, which were stored in Schlenk flasks under an atmosphere of argon at 4 °C.  
 
2-Methyl-2-phenyl-1,1-bis(trimethylsilyloxy)ethane (31a) 
Prepared according to general procedure B using 2-
phenylpropionic acid (6.0 g, 40.0 mmol) and obtained after 
distillation (bp = 65 °C at 5*10-2 mbar) as colorless liquid (8.6 g, 
29.0 mmol, 73% yield). 
1H NMR (501 MHz, CD2Cl2) δ = 7.39–7.34 (m, 2H), 7.26–7.19 (m, 2H), 7.11–7.03 (m, 
1H), 1.89 (s, 3H), 0.27 (s, 9H), –0.05 ppm (s, 9H).  
13C NMR (126 MHz, CD2Cl2) δ = 148.17, 142.51, 129.34, 129.34, 128.27, 128.27, 
125.44, 95.09, 17.13, 0.90, 0.53 ppm.  
HRMS (ESI) m/z calculated for C15H26O2Si2 [M+H]
+: 295.1544; found 295.1544. 
 
3-Ethyl-2-phenyl-1,1-bis(trimethylsilyloxy)ethane (31b) 
Prepared according to general procedure B using 2-
phenylbutanonic acid (5.0 g, 30.5 mmol) and obtained after 
distillation (bp = 71 °C at 5 x10-2 mbar) as a colorless liquid (7.2 
g, 23.0 mmol, 76% yield). 
1H NMR (501 MHz, CD2Cl2) δ = 7.34–7.26 (m, 2H), 7.23 (dd, J = 8.5, 6.9 Hz, 2H), 
7.13–7.05 (m, 1H), 2.37 (q, J = 7.5 Hz, 2H), 0.90 (t, J = 7.4 Hz, 3H), 0.28 (s, 9H), –
0.09 ppm (s, 9H). 
13C NMR (126 MHz, CD2Cl2) δ = 147.20, 140.78, 129.71, 129.71 127.81, 127.81, 
125.14, 101.66, 23.85, 13.59,  0.15, –0.04 ppm.  
HRMS (ESIpos) m/z calculated for C16H28O2Si2 [M+H]
+: 309.1701; found 309.1702. 
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3-Isopropyl-2-phenyl-1,1-bis(trimethylsilyloxy)ethane (31c) 
Prepared according to general procedure B using 3-methyl-2-
phenylbutyric acid (4.0 g, 22.4 mmol) and obtained after distillation 
(bp = 86 °C at 5 x10-2 mbar) as a colorless liquid (5.0 g, 15.5 
mmol, 69% yield). 
1H NMR (501 MHz, CD2Cl2) δ = 7.27–7.21 (m, 2H), 7.21–7.10 (m, 3H), 2.91 (hept, J 
= 7.0 Hz, 1H), 0.94 (d, J = 7.0 Hz, 6H), 0.27 (s, 9H), –0.15 ppm (s, 9H). 
13C NMR (126 MHz, CD2Cl2) δ = 146.68, 139.45, 132.08, 132.08, 127.90, 127.90, 
126.13, 106.27, 29.28, 22.32, 22.32, 0.64, 0.16 ppm.  
HRMS (ESI) m/z calculated for C17H30O2Si2 [M+H]
+: 323.1857; found 323.1857. 
 
3-Benzyl-2-phenyl-1,1-bis(trimethylsilyloxy)ethane (31d) 
Prepared according to general procedure B using 2,3-
diphenylpropionic acid (4.0 g, 17.7 mmol) and obtained after 
distillation (bp = 110 °C at 5 x10-2 mbar) as a colorless liquid (5.3 
g, 14.3 mmol, 43% yield). 
1H NMR (501 MHz, CD2Cl2) δ = 7.30–7.25 (m, 2H), 7.23–7.14 (m, 6H), 7.13–7.07 (m, 
1H), 7.07–7.01 (m, 1H), 3.72 (s, 2H), 0.24 (s, 9H), –0.04 (s, 9H) ppm. 
13C NMR (126 MHz, CD2Cl2) δ = 149.60, 142.62, 141.18, 129.85, 129.85, 128.95, 
128.95, 128.52, 128.52, 128.09, 128.09, 125.93, 125.46, 98.65, 37.09, 0.75, 0.38 
ppm.  
HRMS (ESI) m/z calculated for C21H30O2Si2 [M+H]
+: 371.1857; found 371.1858. 
 
2-(2-methylphenyl)-2-methyl-1,1-bis(trimethylsilyloxy)ethane (31e) 
Prepared according to general procedure B using 2-(o-
tolyl)propanoic acid (1.8 g, 10.7 mmol) and obtained after 
distillation (bp = 68 °C at 5 x10-2 mbar) as a colorless liquid (2.2 g, 
7.1 mmol, 67% yield). 
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1H NMR (501 MHz, CD2Cl2) δ = 7.21–6.98 (m, 4H), 2.24 (s, 3H), 1.80 (s, 3H), 0.27 (s, 
9H), 0.16 (s, 9H) ppm. 
13C NMR (126 MHz, CD2Cl2) δ = 146.54, 141.69, 137.60, 130.69, 130.19, 126.35, 
125.60, 94.00, 20.30, 18.02, 0.80, 0.13 ppm. 
HRMS (GC–CI) m/z calculated for C16H28O2Si2[M]: 308.1622; found 308.1619. 
 
2-m-Tolyl-2-methyl-1,1-bis(trimethylsilyloxy)ethane (31f) 
Prepared according to general procedure B using 2-(m-
tolyl)propanoic acid (1.3 g, 7.6 mmol) and obtained after 
distillation (bp = 65 °C at 5 x10-2 mbar) as a colorless liquid (1.5 
g, 4.8 mmol, 64% yield). 
1H NMR (501 MHz, CD2Cl2) δ = 7.21 (d, J = 1.8, 1H), 7.18–7.06 (m, 2H), 6.94–6.81 
(m, 1H), 2.30 (s, 3H), 1.87 (s, 3H), 0.27 (s, 9H), –0.04 (s, 9H) ppm. 
13C NMR (126 MHz, CD2Cl2) δ = 147.56, 141.80, 137.11, 129.62, 127.65, 125.74, 
125.64, 94.53, 21.47, 16.66 ppm. 
HRMS (GC–CI) m/z calculated for C16H28O2Si2 [M]: 308.1622; found 308.1620. 
 
2-p-Tolyl-2-methyl-1,1-bis(trimethylsilyloxy)ethane (31g) 
Prepared according to general procedure B using 2-(p-
tolyl)propanoic acid (1.5 g, 9.4 mmol) and obtained after 
distillation (bp = 67 °C at 5 x10-2 mbar) as a colorless liquid (2.0 
g, 6.5 mmol, 68% yield). 
1H NMR (501 MHz, CD2Cl2) δ = 7.28–7.22 (m, 2H), 7.09–7.02 (m, 2H), 2.29 (s, 3H), 
1.86 (s, 3H), 0.27 (s, 9H), –0.07 (s, 9H) ppm. 
13C NMR (126 MHz, CD2Cl2) δ = 147.63, 139.13, 134.67, 128.87, 128.87, 128.70, 
128.70, 94.63, 21.28, 16.93, 0.66, 0.34 ppm. 
HRMS (GC–CI) m/z calculated for C16H28O2Si2 [M]: 308.1622; found 308.1619. 
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2-o-Methoxyphenyl-2-methyl-1,1-bis(trimethylsilyloxy)ethane (31m) 
Prepared according to general procedure B using 2-(o-
methoxyphenyl)propanoic acid (1.7 g, 10.6 mmol) and obtained 
after distillation (bp = 98 °C at 5 x10-2 mbar) as a colorless liquid 
(1.5 g, 4.6 mmol, 43% yield). 
1H NMR (501 MHz, CD2Cl2) δ = 7.17–7.09 (m, 2H), 6.87–6.81 (m, 2H), 3.77 (s, 3H), 
1.77 (s, 3H), 0.27 (s, 9H), –0.14 ppm (s, 9H). 
13C NMR (126 MHz, CD2Cl2) δ = 158.50, 147.40, 132.69, 127.87, 120.80, 111.52, 
92.84, 55.95, 17.20, 0.90, 0.35 ppm. 
HRMS (GC–CI) m/z calculated for C16H28O3Si2 [M]: 324.1566; found 324.1572. 
 
2-o-Chlorophenyl-2-methyl-1,1-bis(trimethylsilyloxy)ethane (31h) 
Prepared according to general procedure B using 2-(2-
chlorophenyl)propanoic acid (2.1 g, 11.3 mmol) and obtained after 
distillation (bp = 91 °C at 5 x10-2 mbar) as a colorless liquid (1.2 g, 
3.6 mmol, 33% yield). 
1H NMR (501 MHz, CD2Cl2) δ = 7.34 (dd, J = 7.9, 1.4 Hz, 1H), 7.24 (dd, J = 7.5, 1.9 
Hz, 1H), 7.19 (td, J = 7.4, 1.4 Hz, 1H), 7.13 (ddd, J = 7.8, 7.2, 1.9 Hz, 1H), 1.83 (s, 
3H), 0.30 (s, 9H), –0.09 ppm (s, 9H). 
13C NMR (126 MHz, CD2Cl2) δ = 141.86, 135.68, 133.75, 130.51, 128.55, 127.56, 
125.25, 94.18, 17.74, 1.48, 0.90 ppm. 
HRMS (GC–CI) m/z calculated for C15H25O2Cl1Si2 [M]: 328.1076; found 328.1079. 
 
2-m-Chlorophenyl-2-methyl-1,1-bis(trimethylsilyloxy)ethane (31i) 
Prepared according to general procedure B using 2-(3-
chlorophenyl)propanoic acid (1.5 g, 7.9 mmol) and obtained 
after distillation (bp = 82 °C at 5 x10-2 mbar) as a colorless 
liquid (1.2 g, 3.6 mmol, 46% yield). 
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1H NMR (501 MHz, CD2Cl2) δ = 7.44 (t, J = 1.9 Hz, 1H), 7.27 (ddd, J = 7.9, 1.7, 1.1 
Hz, 1H), 7.18 (m, 1H), 7.05 (ddd, J = 8.0, 2.2, 1.1 Hz, 1H), 1.88 (s, 3H), 0.28 (s, 9H), 
0.00 ppm (s, 9H). 
13C NMR (126 MHz, CD2Cl2) δ = 149.38, 144.84, 134.30, 129.91, 129.60, 127.50, 
125.51, 94.45, 17.05, 1.23, 0.90 ppm. 
HRMS (GC–CI) m/z calculated for C15H25O2Cl1Si2 [M]: 328.1076; found 328.1072. 
 
2-p-Chlorophenyl-2-methyl-1,1-bis(trimethylsilyloxy)ethane (31j) 
Prepared according to general procedure B using 2-(2-
chlorophenyl)propanoic acid (3.5 g, 19.2 mmol) and obtained 
after distillation (bp 86 °C at 5 x10-2 mbar) as a colorless liquid 
(3.9 g, 11.9 mmol, 62%). 
1H NMR (501 MHz, CD2Cl2) δ = 7.37–7.29 (m, 2H), 7.24–7.14 (m, 2H), 1.87 (s, 3H), 
0.27 (s, 9H), –0.02 ppm (s, 9H). 
13C NMR (126 MHz, CD2Cl2) δ = 148.97, 141.45, 130.94, 130.89, 129.05, 128.61, 
128.46, 94.46, 17.18, 1.21, 0.90 ppm. 
HRMS (GC–CI) m/z calculated for C15H25O2Cl1Si2 [M]: 328.1076; found 328.1072. 
 
3-Benzyl-2-methyl-1,1-bis(trimethylsilyloxy)ethane (31k) 
Prepared according to general procedure B using 2-methyl-3-
phenylpropionic acid (5.0 g, 30.5 mmol) and obtained after 
distillation (bp = 72 °C at 5 x10-2 mbar) as a colorless liquid (4.5 
g, 14.6 mmol, 48% yield). 
1H NMR (501 MHz, CD2Cl2) δ = 7.30–7.20 (m, 2H), 7.19–7.10 (m, 3H), 3.27 (s, 2H), 
1.40 (s, 3H), 0.20 ppm (d, J = 1.4 Hz, 18H). 
13C NMR (126 MHz, CD2Cl2) δ = 146.89, 142.45, 129.08, 129.08, 128.57, 128.57, 
126.00, 92.02, 37.81, 15.14, 0.90, 0.88 ppm.  
HRMS (ESI) m/z calculated for C16H28O2 [M+H]
+: 309.1701; found 309.1701. 
 
OTMS
OTMS
Cl
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2-p-isobutylphenyl-2-methyl-1,1-bis(trimethylsilyloxy)ethane (31o) 
Prepared according to general procedure B using 2-(4-
isobutylphenyl)propanoic acid (5.0 g, 24.2 mmol) and 
obtained after distillation (bp = 105 °C at 5 x10-2 mbar) as a 
colorless liquid (6.5 g, 18.5 mmol, 77% yield). 
1H NMR (501 MHz, CD2Cl2) δ = 7.28–7.23 (m, 2H), 7.04–6.99 (m, 2H), 2.42 (d, J = 
7.2 Hz, 2H), 1.87 (s, 3H), 1.84–1.77 (m, 1H), 0.88 (d, J = 6.6 Hz, 6H), 0.26 (s, 9H), –
0.06 ppm (s, 9H). 
13C NMR (126 MHz, CD2Cl2) δ = 147.89, 139.70, 138.92, 129.06, 129.06, 129.02, 
129.02, 94.98, 45.80, 31.15, 22.88, 17.17, 0.90, 0.56 ppm. 
HRMS (ESI) m/z calculated for C19H35O2Si2 [M+H]
+: 351.2171; found 351.2170. 
 
2-(6-methoxynaphthalen-2-yl)-2-methyl-1,1-bis(trimethylsilyloxy)ethane (31l) 
Prepared according to general procedure B using 2-(6-
methoxynaphthalen-2-yl)-propanoic acid (4.0 g, 17.4 
mmol) and obtained after sublimation (sp = 150 °C at 5 
x10-2 mbar) as a colorless solid (4.0 g, 10.8 mmol, 62% yield). 
1H NMR (501 MHz, CD2Cl2) δ = 7.70–7.69 (m, 1H), 7.67–7.64 (m, 1H), 7.63–7.56 (m, 
2H), 7.10 (d, J = 2.6 Hz, 1H), 7.07 (dd, J = 8.8, 2.6 Hz, 1H), 3.90 (s, 3H), 1.98 (s, 3H), 
0.30 (s, 9H), –0.06 ppm (s, 9H). 
13C NMR (126 MHz, CD2Cl2) δ = 137.60, 132.88, 129.53, 129.53, 128.90, 126.64, 
126.03, 118.74, 118.74, 106.02, 106.02, 94.76, 55.77, 16.92, 0.69, 0.34 ppm. 
HRMS (ESI) m/z calculated for C20H30O3Si2Na [M+Na]
+: 397.1629; found 397.1626. 
 
2-(3-fluoro-4-phenyl-phenyl)-2-methyl-1,1-bis(trimethylsilyloxy)ethane (31p) 
Prepared according to general procedure B using 2-(3-
fluoro-4-phenyl-phenyl)-propanoic acid (4.0 g, 16.4 mmol) 
and obtained after distillation (bp = 145 °C at 5 x10-2 mbar) 
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as a colorless liquid (4.0 g, 10.3 mmol, 63% yield). 
1H NMR (501 MHz, CD2Cl2) δ = 7.58–7.54 (m, 2H), 7.46–7.40 (m, 2H), 7.37–7.31 (m, 
2H), 7.30–7.25 (m, 2H), 1.92 (s, 3H), 0.29 (d, J = 1.0 Hz, 9H), 0.06 ppm (s, 9H). 
13C NMR (75 MHz, CD2Cl2) δ = 160.43 (d, J = 244.6 Hz), 149.12, 143.73 (d, J = 8.6 
Hz), 136.74, 130.00 (d, J = 4.3 Hz), 129.41 (d, J = 3.2 Hz), 128.94, 127.81, 124.73 
(d, J = 3.0 Hz), 116.07 (d, J = 23.7 Hz), 93.87, 16.43, 0.72, 0.45 ppm. 
HRMS (ESI) m/z calculated for C21H30O2F1Si2 [M+H]
+: 389.1764; found 389.1763. 
 
2-m-phenoxyphenyl-2-methyl-1,1-bis(trimethylsilyloxy)ethane (31n) 
Prepared according to general procedure B using 2-(3-
phenoxyphenyl)propanoic acid (2.0 g, 8.3 mmol) and 
obtained after distillation (bp = 135 °C at 5 x10-2 mbar) 
as a colorless liquid (1.3 g, 3.4 mmol, 41% yield). 
1H NMR (501 MHz, CD2Cl2) δ = 7.35–7.29 (m, 2H), 7.25–7.20 (m, 1H), 7.17 (d, J = 
7.8, 1H), 7.11 (dd, J = 2.5, 1.7 Hz, 1H), 7.07 (tt, J = 7.4, 1.1 Hz, 1H), 7.01–6.96 (m, 
2H), 6.73 (ddd, J = 7.9, 2.5, 1.2 Hz, 1H), 1.88 (s, 3H), 0.27 (s, 9H), 0.00 ppm (s, 9H). 
13C NMR (126 MHz, CD2Cl2) δ = 158.51, 156.85, 148.37, 144.34, 130.15, 129.18, 
124.44, 123.19, 120.17, 118.76, 116.05, 94.39, 16.76, 0.64, 0.36 ppm. 
HRMS (ESI) m/z calculated for C21H31O2Si2 [M+H]
+: 387.1807; found 387.1806. 
 
4-benzylidene-2,2,6,6-tetramethyl-3,5-dioxa-2,6-disilaheptane (31r) 
Prepared according to general procedure B using phenylacetic 
acid (5.0 g, 36.7 mmol) and obtained after distillation (bp = 59 °C 
at 5 x10-2 mbar) as a colorless liquid (7.6 g, 27.0 mmol, 74%) yield. 
1H NMR (501 MHz, CD2Cl2) δ = 7.40–7.34 (m, 2H), 7.22–7.16 (m, 2H), 6.98 (tt, J = 
7.1, 1.3 Hz, 1H), 4.61 (s, 1H), 0.33 (s, 9H), 0.30 ppm (s, 9H). 
13C NMR (126 MHz, CD2Cl2) δ = 152.73, 138.11, 128.52, 128.52, 126.74, 126.74, 
123.92, 85.58, 0.84, 0.16 ppm. 
HRMS (GC–CI) m/z calculated for C14H24O2Si2 [M]: 280.13053; found 280.13094. 
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 General procedure for the asymmetric protonation of bis-SKAs 7.2.3
31
17o (2 mol%), MeOH (1.1 equiv.)
CH2Cl2 (0.2 Μ), rt, 15 min
R1 CO2H
R2 H
OSiMe3
OSiMe3
R1
R2
32
SO2
NH
SO2
Ar
Ar Ar =
17o
 
An oven dry 2 ml vial was charged with disulfonamide 17o (4.0 µmol, 3.2 mg, 2 
mol%), a magnetic stir bar and, under argon atmosphere, dry CH2Cl2 (0.5 mL) and 
bis-silyl ketene acetal 31 (0.2 mmol, 1.0 equiv.) were added. Then MeOH (9.0 µL, 1.1 
equiv.) in CH2Cl2 (2% solution, v%) was added over 15 min via Hamilton syringe 
using a syringe pump (33 µL/min). Afterwards, the reaction mixture was diluted with 
water, stirred for 5 min and the organic phase was extracted with aq. NaOH (1M). 
The organic phase was acidified with HCl (6M) for 5 min, extracted with CH2Cl2 
(3x5 mL), and the solvent was removed under reduced pressure to fully recycle 
catalyst 17o. The aqueous phase was acidified with HCl (1M) and extracted with 
Et2O (3x3 mL). The combined organic phase was dried over MgSO4 and the solvent 
was removed under reduced pressure to yield the targeted product 32 as a colorless 
solid in >99% purity (analyzed by 1H-NMR). The obtained product was dissolved in 
HPLC grade Heptane:iPrOH (1:1, v/v) and directly used for the determination of the 
enantiomeric ratio.  
 
(S)-2-phenylpropanoic acid (32a)  
Prepared according to the general procedure using 2-methyl-2-
phenyl-1,1-bis(trimethylsilyloxy)ethane (31a) (59 mg, 59 µL, 0.2 
mmol) and obtained after extraction as a colorless liquid (22 mg, 
0.15 mmol, 73% yield, 95.5:4.5 er).  
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1H NMR (501 MHz, CDCl3) δ = 7.38–7.30 (m, 4H), 7.28 (ddd, J = 6.3, 3.1, 1.8 Hz, 
1H), 3.74 (q, J = 7.1 Hz, 1H), 1.52 ppm (d, J = 7.2 Hz, 3H), [acid proton not visible 
due to fast exchange].  
13C NMR (126 MHz, CDCl3) δ = 180.36, 139.75, 128.69, 127.60, 127.40, 45.31, 
18.11 ppm.  
HRMS (GC–EI) m/z calculated for C9H10O2 [M]: 150.0678; found 150.0675. 
The enantiomeric ratio was determined by HPLC analysis using Daicel Chiralpak OD-
3, n-Heptane/iPrOH/TFA = 97.9:2:0.1 (v/v/v), flow rate = 1 mL/min, 25 °C, λ = 210 
nm, tR = 6.57 min (minor) and tR = 7.62 min (major). 
[α]D
25 = 69.2 (c 1.0, CHCl3). Lit [α]D
20 = 75.0 (c 1.6, CHCl3). (obtained from Sigma-
Aldrich) 
 
(S)-2-phenylbutanoic acid (32b)  
Prepared according to general procedure using 3-Ethyl-2-phenyl-1,1-
bis(trimethylsilyloxy)ethane (31b) (62 mg, 60 µL, 0.2 mmol) and 
obtained after extraction as a colorless solid (26 mg, 0.16 mmol, 
82% yield, 95:5 er).  
1H NMR (501 MHz, CDCl3) δ = 7.36–7.26 (m, 5H), 3.47 (t, J = 7.7 Hz, 1H), 2.11 (m, 
1H), 1.82 (m, 1H), 0.92 ppm (t, J = 7.4 Hz, 3H), [acid proton not visible due to fast 
exchange].  
13C NMR (126 MHz, CDCl3) δ = 180.00, 138.38, 128.63, 128.07, 127.43, 53.18, 
26.31, 12.09 ppm.  
HRMS (GC–EI) m/z calculated for C10H12O2 [M]: 164.0834; found 164.0832. 
The enantiomeric ratio was determined by HPLC analysis using Daicel Chiralpak OD-
3, n-Heptane/iPrOH/TFA = 97.9:2:0.1 (v/v/v), flow rate = 1 mL/min, 25 °C, λ = 210 
nm, tR = 5.68 min (minor) and tR = 7.54 min (major). 
[α]D
20 = 32.5 (c 1.1, CHCl3). Lit
[10a]  
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(S)-3-methyl-2-phenylbutanoic acid (32c)  
Prepared according to general procedure using 3-isopropyl-2-phenyl-
1,1-bis(trimethylsilyloxy)ethane (31c) (65 mg, 59 µL, 0.2 mmol) and 
obtained after extraction as a colorless solid (32 mg, 0.18 mmol, 
89% yield, 70.5:29.5 er).  
1H NMR (501 MHz, CDCl3) δ = 7.35–7.29 (m, 4H), 7.30–7.23 (m, 1H), 3.15 (d, J = 
10.5 Hz, 1H), 2.33 (dp, J = 10.6, 6.6 Hz, 1H), 1.08 (d, J = 6.5 Hz, 3H), 0.71 ppm (d, J 
= 6.7 Hz, 3H), [acid proton not visible due to fast exchange].  
13C NMR (126 MHz, CDCl3) δ = 179.85, 137.73, 128.59, 128.54, 127.46, 59.95, 
59.91, 31.56, 21.47, 20.11 ppm.  
HRMS (GC–EI) m/z calculated for C11H14O2 [M]: 178.0990; found 178.0988. 
The enantiomeric ratio was determined by HPLC analysis using Daicel Chiralpak OD-
3, n-Heptane/iPrOH/TFA = 97.9:2:0.1 (v/v/v), flow rate = 1 mL/min, 25 °C, λ = 210 
nm, tR = 5.09 min (minor) and tR = 6.88 min (major). 
[α]D
25 = 23.4 (c 0.95, CHCl3). Lit
[156]  
 
(S)-2,3-diphenylpropanoic acid (31d)  
Prepared according to general procedure using 3-benzyl-2-phenyl-
1,1-bis(trimethylsilyloxy)ethane (32d) (74 mg, 68 µL, 0.2 mmol) and 
obtained after extraction as a colorless solid (43 mg, 0.19 mmol, 
96% yield, 95:5 er).  
 
1H NMR (501 MHz, CDCl3) δ = 7.42–7.15 (m, 8H), 7.14–7.08 (m, 2H), 3.87 (dd, J = 
8.4, 7.0 Hz, 1H), 3.42 (dd, J = 13.8, 8.4 Hz, 1H), 3.05 ppm (dd, J = 13.8, 7.0 Hz, 1H), 
[acid proton not visible due to fast exchange].  
13C NMR (126 MHz, CDCl3) δ = 178.77, 138.80, 138.05, 129.05, 128.85, 128.51, 
128.23, 127.77, 126.61, 53.52, 39.42 ppm.  
HRMS (GC–EI) m/z calculated for C15H14O2 [M]: 226.0990; found 226.0988. 
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The enantiomeric ratio was determined by HPLC analysis using Daicel Chiralpak OD-
3, n-Heptane/iPrOH/TFA = 97.9:2:0.1 (v/v/v), flow rate = 1 mL/min, 25 °C, λ = 210 
nm, tR = 8.08 min (minor) and tR = 9.97 min (major). 
[α]D
25 = 56.0 (c 1.1, CHCl3). Lit
[156]  
 
(S)-2-(o-tolyl)propanoic acid (32e)  
Prepared according to general procedure using 2-o-tolyl-2-
methyl-1,1-bis(trimethylsilyloxy)ethane (31e) (62 mg, 56 µL, 0.2 
mmol) and obtained after extraction as a colorless solid (3 mg, 0.18 
mmol, 91% yield, 96.5:3.5 er).  
1H NMR (501 MHz, CDCl3) δ = 7.29 (d, J = 7.2 Hz, 1H), 7.23–7.14 (m, 3H), 3.99 (q, J 
= 7.1 Hz, 1H), 2.38 (s, 3H), 1.50 ppm (d, J = 7.1 Hz, 3H), [acid proton not visible due 
to fast exchange].  
13C NMR (126 MHz, CDCl3) δ 179.59, 138.33, 135.88, 130.56, 127.21, 126.55, 
126.47, 40.95, 19.63, 17.56 ppm.  
HRMS (GC–EI) m/z calculated for C10H12O2 [M]: 164.0834; found 164.0832. 
The enantiomeric ratio was determined by HPLC analysis using Daicel Chiralpak OD-
3, n-Heptane/iPrOH/TFA = 97.9:2:0.1 (v/v/v), flow rate = 1 mL/min, 25 °C, λ = 210 
nm, tR = 7.05 min (minor) and tR = 8.06 min (major). 
[α]D
25 = 50.9 (c 1.05, CHCl3). Lit
[157]  
 
(S)-3-(o-tolyl)propanoic acid (32f) 
Prepared according to general procedure using 2-m-tolyl-2-methyl-
1,1-bis(trimethylsilyloxy)ethane (31f) (62 mg, 57 µL, 0.2 mmol) and 
obtained after extraction as a colorless solid (29 mg, 0.19 mmol, 
97% yield, 92.5:7.5 er).  
1H NMR (501 MHz, CDCl3) δ = 7.25–7.19 (m, 1H), 7.16–7.03 (m, 3H), 3.72 (q, J = 
7.2 Hz, 1H), 2.35 (s, 3H), 1.51 ppm (d, J = 7.2 Hz, 3H), [acid proton not visible due to 
fast exchange].  
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13C NMR (126 MHz, CDCl3) δ = 167.33, 139.72, 138.38, 128.59, 128.28, 128.16, 
124.58, 45.05, 21.41, 18.16 ppm.  
HRMS (GC–EI) m/z calculated for C10H12O2 [M]: 164.0834; found 164.0832. 
The enantiomeric ratio was determined by HPLC analysis using Daicel Chiralpak OD-
3, n-Heptane/iPrOH/TFA = 97.9:2:0.1 (v/v/v), flow rate = 1 mL/min, 25 °C, λ = 210 
nm, tR = 6.0 min (minor) and tR = 7.64 min (major). 
[α]D
25 = 33.3 (c 0.75, CHCl3). Lit
[157]  
 
(S)-2-(p-Tolyl)propanoic acid (32g) 
Prepared according to general procedure using 2-p-Tolyl-2-
methyl-1,1-bis(trimethylsilyloxy)ethane (31g) (63 mg, 60 µL, 0.2 
mmol) and obtained after extraction as a colorless solid (29 mg, 
0.18 mmol, 88% yield, 95.5:4.5 er).  
1H NMR (501 MHz, CDCl3) δ = 11.38 (s, 1H), 7.20 (d, J = 8.1, 2H), 7.13 (d, J = 8.1, 
2H), 3.68 (q, J = 7.1, 1H), 1.47 ppm (d, J = 7.1, 3H).  
13C NMR (126 MHz, CDCl3) δ = 181.14, 137.04, 136.75, 129.33, 127.43, 44.94, 
21.01, 18.05 ppm.  
HRMS (GC–EI) m/z calculated for C10H12O2 [M]: 164.0835; found 164.0832. 
The enantiomeric ratio was determined by HPLC analysis using Daicel Chiralpak OD-
3, n-Heptane/iPrOH/TFA = 97.9:2:0.1 (v/v/v), flow rate = 1 mL/min, 25 °C, λ = 210 
nm, tR = 6.25 min (minor) and tR = 9.95 min (major). 
[α]D
25 = 42.3 (c 0.6, CHCl3).  
 
 
(S)-2-(2-methoxyphenyl)propanoic acid (32m) 
Prepared according to general procedure using 2-o-methoxyphenyl-
2-methyl-1,1-bis(trimethylsilyloxy)ethane (31m) (73 mg, 65 µL, 0.2 
mmol) and obtained after extraction as a colorless solid (33 g, 0.18 
mmol, 92% yield, 95:5 er).  
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1H NMR (501 MHz, CDCl3) δ = 7.29–7.22 (m, 2H), 6.96 (dt J = 7.5, 1.1 Hz, 1H), 6.89 
(dd, J = 8.7, 1.1 Hz, 1H), 4.09 (q, J = 7.2 Hz, 1H), 3.84 (s, 3H), 1.49 ppm (d, J = 7.2 
Hz, 3H), [acid proton not visible due to fast exchange].  
13C NMR (126 MHz, CDCl3) δ = 156.63, 128.65, 128.65, 128.39, 128.01, 120.89, 
110.77, 55.53, 38.95, 16.79 ppm.  
HRMS (GC–EI) m/z calculated for C10H12O3 [M]: 180.0781; found 180.0781. 
The enantiomeric ratio was determined by HPLC analysis using Daicel Chiralpak OD-
3, n-Heptane/iPrOH/TFA = 97.9:2:0.1 (v/v/v), flow rate = 1 mL/min, 25 °C, λ = 210 
nm, tR = 15.3 min (minor) and tR = 16.5 min (major). 
[α]D
25 = 69.5 (c 1.1, CHCl3). Lit
[158]  
 
(S)-2-(2-chlorophenyl)propanoic acid (32h) 
Prepared according to general procedure using 2-o-chlorophenyl-2-
methyl-1,1-bis(trimethylsilyloxy)ethane (31h) (73 mg, 70 µL, 0.2 
mmol) and obtained after extraction as a colorless solid (35 mg, 0.19 
mmol, 95% yield,95:5 er).  
1H NMR (501 MHz, CDCl3) δ = 7.37 (ddd, J = 17.1, 7.8, 1.6 Hz, 2H), 7.26 (td, J = 7.6, 
1.5 Hz, 1H), 7.21 (td, J = 7.6, 1.8 Hz, 1H), 4.28 (q, J = 7.2 Hz, 1H), 1.53 ppm (d, J = 
7.3 Hz, 3H), [acid proton not visible due to fast exchange].  
13C NMR (126 MHz, CDCl3) δ = 178.76, 137.66, 129.70, 128.53, 128.45, 127.20, 
41.80, 17.31 ppm.  
HRMS (ESI) m/z calculated for C9H8ClO2 [M–H]
-: 183.0218; found 183.0218. 
The enantiomeric ratio was determined by HPLC analysis using Daicel Chiralpak OJ-
3, n-Heptane/iPrOH/TFA = 97.9:2:0.1 (v/v/v), flow rate = 1 mL/min, 25 °C, λ = 210 
nm, tR = 32.2 min (minor) and tR = 35.1 min (major). 
[α]D
25 = 46.2 (c 0.6, CHCl3). Lit
[158]  
 
(S)-2-(3-chlorophenyl)propanoic acid (32i) 
Prepared according to general procedure using 2-m-
chlorophenyl-2-methyl-1,1-bis(trimethylsilyloxy)ethane (31i) (73 
OH
O
Cl
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mg, 69 µL, 0.2 mmol) and obtained after extraction as a colorless solid (32 mg, 0.17 
mmol, 87% yield, 93:7 er).  
1H NMR (501 MHz, CDCl3) δ = 7.32 (bs, 1H), 7.30–7.22 (m, 2H), 7.23–7.18 (m, 1H), 
3.72 (q, J = 7.2 Hz, 1H), 1.52 ppm (d, J = 7.2 Hz, 3H), [acid proton not visible due to 
fast exchange].  
13C NMR (126 MHz, CDCl3) δ = 179.00, 141.57, 134.50, 129.92, 127.85, 127.65, 
125.87, 44.89, 18.05 ppm.  
HRMS (ESI) m/z calculated for C9H8Cl1O2Na1 [M+Na]
+: 207.0183; found 207.0183. 
The enantiomeric ratio was determined by HPLC analysis using Daicel Chiralpak OJ-
3, n-Heptane/iPrOH/TFA = 97.9:2:0.1 (v/v/v), flow rate = 1 mL/min, 25 °C, λ = 210 
nm, tR = 27.3 min (minor) and tR = 31.5 min (major). 
[α]D
25 = 32.9 (c 0.85, CHCl3). Lit
[158]  
 
 
(S)-2-(4-chlorophenyl)propanoic acid (32j) 
Prepared according to general procedure using 2-p-
chlorophenyl-2-methyl-1,1-bis(trimethylsilyloxy)ethane (31j) (73 
mg, 70 µL, 0.2 mmol) and obtained after extraction as a colorless 
solid (29 mg, 0,16 mmol, 79% yield, 95:5 er).  
1H NMR (501 MHz, CDCl3) δ = 7.30 (d, J = 8.1 Hz, 2H), 7.24 (d, J = 8.3 Hz, 2H), 3.71 
(q, J = 6.6 Hz, 1H), 1.49 ppm (d, J = 7.2 Hz, 3H), [acid proton not visible due to fast 
exchange]. 
13C NMR (126 MHz, CDCl3) δ = 180.14, 138.58, 133.18, 129.29, 129.29, 129.05, 
129.05, 45.09, 18.49 ppm. z 
HRMS (ESI) m/z calculated for C9H8Cl1O2Na1 [M+Na]
+: 207.0183; found 207.0183. 
The enantiomeric ratio was determined by HPLC analysis using Daicel Chiralpak OD-
3, n-Heptane/iPrOH/TFA = 97.9:2:0.1 (v/v/v), flow rate = 1 mL/min, 25 °C, λ = 210 
nm, tR = 13.8 min (minor) and tR = 16.38 min (major). 
[α]D
25 = 36.2 (c 0.80, CHCl3). Lit
[158]. 
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(S)-2-methyl-3-phenylpropanoic acid (32k)  
Prepared according to general procedure using 3-benzyl-2-methyl-
1,1-bis(trimethylsilyloxy)ethane (31k) (62 mg, 60 µL, 0.2 mmol) 
and obtained after extraction as a colorless solid (29 mg, 0.18 
mmol, 89% yield, 51:49 er).  
1H NMR (501 MHz, CDCl3) δ = 7.30–7.26 (m, 2H), 7.23–7.17 (m, 3H), 3.08 (dd, J = 
13.8, 6.6 Hz, 1H), 2.80–2.73 (m, 1H), 2.67 (dd, J = 13.8, 8.4 Hz, 1H), 1.17 ppm (d, J 
= 7.2 Hz, 3H), [acid proton not visible due to fast exchange].  
13C NMR (126 MHz, CDCl3) δ = 182.2, 139.2, 129.1, 128.5, 126.5, 41.3, 39.4, 16.6 
ppm.  
HRMS (GC-EI) m/z calculated for C10H12O2 [M]: 164.0835; found 164.0832. 
The enantiomeric ratio was determined by HPLC analysis using Daicel Chiralpak OJ-
3, n-Heptane/iPrOH/TFA = 97.9:2:0.1 (v/v/v), flow rate = 1 mL/min, 25 °C, λ = 210 
nm, tR = 7.58 min (minor) and tR = 8.55 min (major). 
[α]D
25 = –0.0 (c 0.75, CHCl3). 
 
 
(S)-Ibuprofen (32o) 
Prepared according to general procedure using 2-p-
isobutylphenyl-2-methyl-1,1-bis(trimethylsilyloxy)ethane (31o) 
(70 mg, 62 µL, 0.2 mmol) and obtained after extraction as a 
colorless solid (38 mg, 0.18 mmol, 92% yield, 96.5:3.5 er).  
1H NMR (501 MHz, CDCl3) δ = 7.24–7.18 (m, 2H), 7.14–7.06 (m, 2H), 3.71 (q, J = 
7.2 Hz, 1H), 2.45 (d, J = 7.2 Hz, 2H), 1.84–1.77 (m, 1H), 1.50 (d, J = 7.2 Hz, 3H), 
0.90 ppm (d, J = 6.6 Hz, 6H), [acid proton not visible due to fast exchange].  
13C NMR (126 MHz, CDCl3) δ = 180.79, 140.86, 136.96, 129.39, 127.27, 45.05, 
44.94, 30.17, 22.40, 18.11 ppm.  
HRMS (GC-EI) m/z calculated for C13H18O2 [M]: 206.1307; found 206.1309. 
The enantiomeric ratio was determined by HPLC analysis using Daicel Chiralpak OD-
3, n-Heptane/iPrOH/TFA = 97.9:2:0.1 (v/v/v), flow rate = 1 mL/min, 25 °C, λ = 210 
nm, tR = 5.37 min (minor) and tR = 6.11 min (major). 
OH
O
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[α]D
25 = 39.1 (c 1.0, CHCl3). Lit
[158]  
 
(S)-Naproxen (32l) 
Prepared according to general procedure using 2-(6-
methoxynaphthalen-2-yl)-2-methyl-1,1-
bis(trimethylsilyloxy)ethane (31l) (75 mg, 0.2 mmol) and 
obtained after extraction as a colorless solid (41 mg, 0.18 mmol, 90% yield, 93:7).  
1H NMR (501 MHz, CDCl3) δ = 7.74–7.64 (m, 3H), 7.41 (dd, J = 8.5, 1.9 Hz, 1H), 
7.18–7.07 (m, 2H), 3.91 (s, 3H), 3.87 (q, J = 7.3 Hz, 1H), 1.59 ppm (d, J = 7.2 Hz, 
3H), [acid proton not visible due to fast exchange].  
13C NMR (126 MHz, CDCl3) δ = 179.66, 157.72, 134.87, 133.82, 129.30, 128.89, 
127.24, 126.13, 119.05, 105.60, 55.31, 45.12, 18.17 ppm.  
HRMS (GC-EI) m/z calculated for C14H14O2 [M]: 230.0930; found 230.0928. 
The enantiomeric ratio was determined by HPLC analysis using Daicel Chiralpak OD-
3, n-Heptane/iPrOH/TFA = 97.9:2:0.1 (v/v/v), flow rate = 1 mL/min, 25 °C, λ = 210 
nm, tR = 14.9 min (minor) and tR = 17.8 min (major). 
[α]D
25 = 41.2 (c 0.90, CHCl3). Lit
[158]  
 
(S)-Flurbiprofen (32p) 
Prepared according to general procedure using 2-(3-fluoro-4-
phenyl-phenyl)-2-methyl-1,1-bis(trimethylsilyloxy)ethane (31p) 
(70 mg, 0.2 mmol) and obtained after extraction as a colorless 
solid (43 mg, 0.18 mmol, 89% yield, 95:5 er).  
1H NMR (501 MHz, CDCl3) δ = 7.53 (m, 2H), 7.48–7.31 (m, 4H), 7.22–7.11 (m, 2H), 
3.80 (q, J = 7.2 Hz, 1H), 1.57 ppm (d, J = 7.2 Hz, 3H), [acid proton not visible due to 
fast exchange]. 
13C NMR (126 MHz, CDCl3) δ = 178.71, 159.69 (d, J = 248.5 Hz), 140.95 (d, J = 7.6 
Hz), 135.40, 130.91 (d, J = 4.1 Hz), 128.96, 128.94, 128.45, 128.45, 128.21(d, J = 
13.5 Hz), 127.71, 123.66 (d, J = 3.6 Hz), 115.46 (d, J = 23.6 Hz), 44.64, 18.06 ppm. 
19F NMR (471 MHz, CDCl3) δ = -117.39. 
HRMS (GC-EI) m/z calculated for C15H13FO2 [M]: 244.0900; found 244.0895. 
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The enantiomeric ratio was determined by HPLC analysis using Daicel Chiralpak OD-
3, n-Heptane/iPrOH/TFA = 97.9:2:0.1 (v/v/v), flow rate = 1 mL/min, 25 °C, λ = 210 
nm, tR = 8.46 min (minor) and tR = 9.47 min (major). 
[α]D
25 = 29.2 (c 0.95, CHCl3). Lit
[158]  
 
(S)-Fenoprofen (32n) 
Prepared according to general procedure using 2-m-
phenoxyphenyl-2-methyl-1,1-bis(trimethylsilyloxy)ethane 
(31n) (68 mg, 59 µL, 0.2 mmol) and obtained after 
extraction as a colorless solid (35 mg, 0.16 mmol, 76%, 92:8 er).  
1H NMR (501 MHz, CDCl3) δ = 7.36–7.30 (m, 2H), 7.30–7.26 (m, 1H), 7.13–7.08 (m, 
1H), 7.08–7.04 (m, 1H), 7.03–6.97 (m, 3H), 6.88 (ddd, J = 8.1, 2.5, 0.9 Hz, 1H), 3.71 
(q, J = 7.2 Hz, 1H), 1.50 ppm (d, J = 7.2 Hz, 3H), [acid proton not visible due to fast 
exchange].  
13C NMR (126 MHz, CDCl3) δ = 179.56, 157.49, 156.92, 141.68, 129.88, 129.76, 
123.38, 122.35, 118.98, 118.98, 118.22, 117.50, 77.27, 77.01, 76.76, 45.09, 18.09 
ppm.  
HRMS (GC-EI) m/z calculated for C15H14O3 [M]: 242.0943; found 242.0946. 
The enantiomeric ratio was determined by HPLC analysis using Daicel Chiralpak OD-
3, n-Heptane/iPrOH/TFA = 97.9:2:0.1 (v/v/v), flow rate = 1 mL/min, 25 °C, λ = 210 
nm, tR = 15 min (minor) and tR = 17.8 min (major). 
[α]D
25 = 39.1 (c 1.05, CHCl3). Lit
[158]  
 
 
(S)-2-phenylpropanoic acid (32a)  
Prepared according to the general procedure using water as the 
proton source (6 µL, 0.11 mmol, 0.55 equiv.) in CH2Cl2 (2% solution, 
v%) and 2-methyl-2-phenyl-1,1-bis(trimethylsilyloxy)ethane (31a) (59 
mg, 59 µL, 0.2 mmol). The product was obtained after extraction as a colorless liquid 
(27 mg, 0.18 mmol, 82% yield, 95:5 er). 
Analytics matched compound 31a. 
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(S)-Ibuprofen (32o) 
Prepared according to the general procedure using water as 
the proton source (6 µL, 0.11 mmol, 0.55 equiv.) in CH2Cl2 
(2% solution, v%) and 2-p-isobutylphenyl-2-methyl-1,1-
bis(trimethylsilyloxy)ethane (31o) (70 mg, 62 µL, 0.2 mmol) and obtained after 
extraction as a colorless solid (33 mg, 0.17 mmol, 82% yield, 95.5:4.5 er).  
Analytics matched compound 31o. 
 
 General Procedure for the Asymmetric Deuteration of Bis-SKAs 7.2.4
31
17o (2 mol%), CD3OD (1.1 equiv.)
CH2Cl2 (0.2 Μ), RT, 15 min
R1 CO2H
R2 D
OSiMe3
OSiMe3
R1
R2
67
SO2
NH
SO2
Ar
Ar Ar =
17o
 
An oven dried 2 mL vial was charged with disulfonamide 17o (4.0 µmol, 3.2 mg, 2 
mol%), a magnetic stir bar and, under argon atmosphere, dry CH2Cl2 (0.5 mL) and 
bis-silyl ketene acetal 31 (0.2 mmol, 1 equiv.) were added. Then CD3OD (9 µL, 0.22 
mmol, 1.1 equiv.) in CH2Cl2 (2% solution, v%) was added over 15 min via Hamilton 
syringe using a syringe pump (33 µL/min). Afterwards, the reaction mixture was 
acidified with HCl (1M) and extracted with Et2O (3x3 mL), and the combined organic 
phase was dried over MgSO4 and purified by column chromatography 
(CH2Cl2:MeOH, 98:2, v/v). The obtained product (67) was dissolved in HPLC grade 
Hept:iPrOH (1:1, v/v) and directly used for the determination of the enantiomeric 
ratio.  
 
 
 
OH
O
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(S)-2-phenylpropanoic acid (67a)  
Prepared according to general procedure using 2-methyl-2-phenyl-
1,1-bis(trimethylsilyloxy)ethane (31a) (59 mg, 59 µL, 0.2 mmol) and 
obtained after extraction as a colorless liquid (25 mg, 0.16 mmol, 
77% yield, 95.5:4.5 er)  
1H NMR (501 MHz, CDCl3) δ = 7.41–7.28 (m, 4H), 7.27–7.21 (m, 1H), 1.50 ppm (s, 
3H). 
13C NMR (126 MHz, CDCl3) δ = 180.68, 139.77, 139.72, 128.68, 127.61, 127.59, 
127.39, 45.00 (J = 19.2 Hz), 18.01 ppm. 
HRMS (GC-CI) m/z calculated for C9H9DO2: 151.07436; found 151.07435. 
The enantiomeric ratio was determined by HPLC analysis using Daicel Chiralpak OD-
3, n-Heptane/iPrOH/TFA = 97.9:2:0.1 (v/v/v), flow rate = 1 mL/min, 25 °C, λ = 210 
nm, tR = 6.57 min (minor) and tR = 7.62 min (major) 
[α]D
25 = 35.1 (c 1.05, CHCl3). Lit
[159]  
 
(S)-Ibuprofen-d (67b) 
Prepared according to general procedure using 2-p-
isobutylphenyl-2-methyl-1,1-bis(trimethylsilyloxy)ethane (31o) 
(70 mg, 62 µL, 0.2 mmol) and obtained after extraction as a 
colorless solid (40 mg, 0.19 mmol, 94% yield, 95:5 er).  
1H NMR (501 MHz, CD2Cl2) δ = 7.29–7.17 (m, 2H), 7.15–7.05 (m, 2H), 2.45 (d, J = 
7.2 Hz, 2H), 1.85 (dhept, J = 13.6, 6.8 Hz, 1H), 1.46 (s, 3H), 0.90 ppm (d, J = 6.6 Hz, 
6H).  
13C NMR (126 MHz, CDCl3) δ = 178.25, 141.28, 138.43, 129.86, 129.86, 127.77, 
127.77, 49.77 (t [1:1:1], J = 19.9 Hz), 45.50, 30.81, 22.67, 22.67, 18.67 ppm.  
HRMS (GC-CI) m/z calculated for C13H17DO2: 207.1367; found 207.1368. 
The enantiomeric ratio was determined by HPLC analysis using Daicel Chiralpak OD-
3, n-Heptane/iPrOH/TFA = 97.9:2:0.1 (v/v/v), flow rate = 1 mL/min, 25 °C, λ = 210 
nm, tR = 5.37 min (minor) and tR = 6.11 min (major) 
[α]D
25 = 37.9 (c 0.95, CHCl3). Lit
[158]  
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(R)-2-phenylacetic-2-d acid (67c) 
Prepared according to general procedure using 2-(3-fluoro-4-phenyl-
phenyl)-2-methyl-1,1-bis(trimethylsilyloxy)ethane (31r) (70 mg, 79 
µL, 0.2 mmol) and obtained after extraction as a clear liquid (43 mg, 
0.18 mmol, 89% yield, 81:19 er).  
1H NMR (501 MHz, CDCl3) δ = 7.37–7.31 (m, 2H), 7.31–7.27 (m, 3H), 3.64 ppm (t 
[1:1:1], J = 2.2 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ = 176.97, 133.21, 129.36, 129.34, 128.66, 128.66, 
127.36, 40.64 ppm (t [1:1:1], J = 2.2 Hz,).  
HRMS (GC-CI) m/z calculated for C8H7DO2: 137.0587; found 137.0586. 
The enantiomeric ratio was determined by 1H NMR analysis upon derivatization to 
the corresponding Mosher ester (Scheme 1), following the reported procedure for the 
derivatization and the diastereomaric ratio determination.[122] 
[α]D
25 = 0.6 (c 0.60, CHCl3). Lit
[158]  
 
 
Scheme 1. Derivatization sequence for the determination of the enantiomeric ratio. 
 
(R)-2-phenylethan-2-d-1-ol (4u) 
1H NMR (501 MHz, CDCl3) δ = 7.36–7.28 (m, 2H), 7.28–7.20 (m, 3H), 3.87 (dt, J = 
6.6, 0.9 Hz, 2H), 2.86 (ddt, J = 6.6, 4.1, 2.1 Hz, 1H), 1.43 ppm (bs, 1 H). 
 
(R)-2-phenylethyl-2-d (R)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoate (5u) 
1H NMR (500 MHz, CD2Cl2) δ = 7.44–7.39 (m, 3H), 7.39–7.34 (m, 2H), 7.31–7.25 (m, 
2H), 7.25–7.20 (m, 1H), 7.20–7.16 (m, 2H), 4.61–4.44 (m, 2H), 3.44 (s, 3H), 2.99 
ppm (dtt, J = 13.9, 7.1, 1.9 Hz, 1H).   
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 Gram Scale Reaction 7.2.5
 
(S)-32o
95% [4.8 g] 
e.r. = 95:5
no chromatography
OH
O
OH
O
rac -32o
[5.2 g scale]
31o
OSiMe3
OSiMe3
a) LDA (2.1 equiv.)
Me3SiCl (2.2 equiv.)
THF (0.2 Μ) 
–78 °C to RT, 3 h
filtration, no distillation
b) DSI-2c
(1 mol%, 200 mg)
MeOH (1.1 equiv)
CH2Cl2 (0.2 Μ)
RT, 30 min
catalyst recycled
 
A stirring solution of acid rac-32o (5.2 g, 24.7 mmol, 1.0 equiv.) and Me3SiCl (6.9 
mL, 54.3 mmol, 2.2 equiv.) in THF (200 mL) under an atmosphere of dry argon was 
cooled to –78 °C. The freshly prepared LDA solution (54.3 mmol, 1 M, 55 mL 2.2 
equiv.) was added dropwise at –78 °C via canula. The ice bath was removed upon 
complete addition and the reaction solution was stirred for 1 hour at room 
temperature. The reaction mixture was concentrated in vacuo. Hexane (50 mL) was 
added to the residue and the organic layer was filtered under argon. After 
concentration under reduced pressure, the crude product (31o) was dissolved in dry 
CH2Cl2 (60 mL) and a solution of catalyst 17o (200 mg, 1 mol%) in CH2Cl2 (40 mL) 
was added at room temperature. A solution of MeOH (1.1 mL, 32 mmol, 1.1 equiv.) in 
CH2Cl2 (19 mL) was added via syringe pump (0.66 mL/min) in 30 min. The reaction 
mixture was diluted with HCl (1 M, 2 mL), stirred for 5 min, and the organic phase was 
concentrated in vacuo and diluted with Et2O (50 mL). The crude mixture was 
extracted with aq. NaOH (1 M, 3x30 mL). The organic phase was acidified HCl (6 M) 
for 5 min, extracted with CH2Cl2 (3x50 mL), and the solvent was removed under 
reduced pressure to fully recycle catalyst 17o. The aqueous phase was acidified with 
HCl (1 M, 50 mL) and extracted with Et2O (3x50 mL). The combined organic phase 
was dried over MgSO4 and the solvent was removed under reduced pressure to yield 
the desired product 32o as a colorless solid (4.81 g, 23.3 mmol, 95% yield, 95:5 er).  
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 Synthesis and Characterization of DSI Catalysts  7.2.6
 
Compound 48 and 17g were synthetized following the reported procedure [160] 
 
2,6-di(phenanthren-9-yl)-4H-dinaphtho[2,1-d:1',2'-f][1,3,2]dithiazepine 3,3,5,5-
tetraoxide (17g) 
B
OHHO
Pd(OAc)2 (10 mol%)
P(tBu)3 (10 mol%)
K2CO3 (2N)
THF/H2O (1:1, v/v)
30 min, 120°C mw SO2
NH
SO2
17g
84%
SO2
NH
SO2
I
I
48
+
 
In an oven dried microwave vial (5 mL) (S)-3,3′-diiododisulfonimide (48, 100 mg, 
0.15 mmol, 1 equiv.), 9-phenanthracenyl boronic acid (137 mg, 0.45 mmol, 3 equiv.), 
K2CO3 (85 mg, 0.6 mmol, 4 equiv.), Palladium(II)-acetate (3.5 mg, 0.015 mmol, 10 
mol%.) were suspended in THF/water (4 mL, 1:1, v/v) under an atmosphere of dry 
argon. Tri-tert-butylphosphine (1 M, dioxane solution) (0.1 mL, 81 mg, 0.1 mmol) was 
added and the vial was sealed and heated for 30 min at 120 °C in a microwave 
reactor. The reaction was poured into HCl (1 N, 5 mL) and extracted with CH2Cl2 
(3x10mL), and the combined organic layers were washed with water (10 mL) and 
brine (2x10 mL). The organic layer was dried over MgSO4, and the product was 
purified by flash column chromatography (CH2Cl2/MeOH = 100:0 to 98:2). The 
purified product was dissolved in CH2Cl2 (30 mL), acidified with HCl (6 M, 20 mL) and 
the solvent was removed in vacuo to obtain the targeted product 17g as pale yellow 
solid (96 mg, 84% yield). 
Note: Upon acidification, catalyst 17g equilibrates to an unseparable mixture of 3 
rotamers  
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1H NMR (501 MHz, CDCl3) δ = 8.87–8.71 (m, 4H), 8.34–8.17 (m, 2H), 8.17–8.02 (m, 
2H), 8.02–7.92 (m, 2H), 7.92–7.85 (m, 2H), 7.85–7.76 (m, 2H), 7.76–7.35 (m, 14H), 
1.53 ppm (bs, 1H). 
13C NMR (126 MHz, CDCl3) δ = 138.30, 138.25, 138.06, 136.04, 135.48, 135.35, 
135.27, 135.11, 134.88, 134.86, 134.77, 134.75, 134.29, 134.24, 133.91, 133.75, 
133.47, 133.04, 132.98, 132.44, 132.42, 132.28, 132.22, 132.16, 132.07, 131.34, 
131.29, 131.17, 131.13, 130.41, 130.39, 130.36, 130.34, 129.93, 129.81, 129.79, 
128.85, 128.74, 128.68, 128.61, 128.53, 128.48, 128.40, 128.26, 128.24, 127.92, 
127.45, 127.43, 127.14, 127.03, 126.98, 126.94, 126.92, 126.90, 126.88, 126.81, 
126.78, 126.53, 126.50, 126.46, 126.09, 126.01, 123.11, 122.90, 122.87, 122.72, 
122.69 ppm. 
2-(anthracen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (81) 
 
In a vial with stir bar was charged with 1-chloro-anthracene (500 mg, 2.4 mmol, 
1.0 equiv.), anhydrous NaOAc (385 mg, 4.7 mmol, 2.0 equiv.), B2Pin2 (627 mg, 2.5 
mmol, 1.05 equiv.), Pd(dba)2 (13.5 mg, 0.02 mmol, 1 mol%), XPhos (11.2 mg, 0.02 
mmol, 1 mol%). The vial was transferred to a preheated oil bath (110 °C). After 16 h, 
the reaction mixture was cooled, dissolved in CH2Cl2–H2O mixture (1:1, v/v), the 
organic phase separated, the solvent evaporated under vacuum and the product 
isolated by flash chromatography on silica gel by elution with hexanes/CH2Cl2 (9:1 to 
7:3), to obtain 81 (535 mg, 1.8 mmol, 76% yield). 
1H NMR (501 MHz, CDCl3) δ = 9.35 (s, 1H), 8.42 (s, 1H), 8.17–8.05 (m, 3H), 8.04–
7.94 (m, 1H), 7.56–7.36 (m, 3H), 1.48 ppm (s, 12H). 
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13C NMR (126 MHz, CDCl3) δ = 135.98, 134.31, 132.02, 131.98, 131.98, 131.58, 
131.24, 128.97, 127.87, 127.30, 126.61, 125.30, 125.10, 124.54, 83.82, 83.82, 
25.04, 25.04, 25.04, 25.04 ppm. 
HRMS (EI) m/z calculated for C20H21O2B1 [M]: 304.1635; found 304.1637. 
 
2,6-di(anthracen-1-yl)-4H-dinaphtho[2,1-d:1',2'-f][1,3,2]dithiazepine 3,3,5,5-
tetraoxide (17h) 
 
 
In a 25 mL Schlenk flask were placed (S)-48 (387 mg, 0.6 mmol, 1 equiv.), aryl 
boronic ester 81 (545 mg, 1.8 mmol, 3 equiv.), Pd(OAc)2 (10.5 mg, 0.05 mmol, 8 
mol%), 6 mL of THF and 2 M aqueous K2CO3 (6 mL). The reaction flask was 
evacuated and filled with Ar for three times with stirring. P(tBu)3 (94 µl, 0.09 mmol, 15 
mol%) was then added. The reaction mixture was heated at 80 °C until the 
consumption of the starting material (16 h). After the reaction was completed, the 
resulting mixture was acidified with 1 N HCl and extracted with CHCl3 for three times. 
The combined organic phase was dried over MgSO4 followed by filtration and 
evaporation. The crude product was purified by column chromatography 
(DCM:MeOH, 98:2) to give the coupled compound 17h as a solid.  
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1H NMR (501 MHz, CDCl3) δ = 8.42 (s, 1H), 8.23 (d, J = 0.8 Hz, 1H), 8.10–8.00 (m, 
3H), 7.93–7.88 (m, 1H), 7.76 (ddd, J = 8.2, 6.8, 1.2 Hz, 1H), 7.69–7.62 (m, 2H), 7.57 
(dd, J = 8.5, 6.7 Hz, 1H), 7.52 (ddd, J = 8.2, 6.9, 1.3 Hz, 1H), 7.44 (dq, J = 8.7, 0.9 
Hz, 1H), 7.32 (ddd, J = 8.3, 6.5, 1.2 Hz, 1H), 7.17 ppm (ddd, J = 8.1, 6.5, 1.2 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ = 138.49, 136.99, 135.64, 134.97, 134.13, 133.59, 
132.09, 131.83, 131.75, 131.48, 131.09, 130.00, 128.69, 128.64, 128.61, 128.37, 
128.36, 127.70, 126.47, 125.87, 125.59, 125.50, 125.14, 124.42 ppm. 
HRMS (ESI) m/z calculated for C48H28N1O4S2 [M–H]
-: 746.1465; found 746.1470.  
 
 
Synthesis of Tetraphene Derivatives 
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6,7-dibromo-1,4,4a,8a-tetrahydro-1,4-epoxynaphthalene (49) 
 
Under inert conditions 1,2,4,5-tetrabromobenzene (8.0 g, 20.5 mmol, 1.0 equiv.) 
was dissolved in dry toluene (200 mL). Dry furan (10 mL, 137 mmol, 6.8 equiv) was 
added and the solution was cooled down to –30 °C, which led to the precipitation of 
starting compound. n-Butyl lithium (9 mL, 2.4M  in  hexane,  22.6  mmol)  was  added  
dropwise  during  20  minutes.  Following an additional 15 min stirring at –30 °C, the 
mixture was warmed to 25 °C and MeOH (1 ml) was added. The solution was 
washed with water (30 mL) and brine (30 mL),  the  organic  layer  was  dried  with  
MgSO4  and  all  solvents  were  evaporated under vacuum.  The  brownish  raw  
product  was  applied  onto silica gel via dichloromethane and subjected to column 
chromatography (hexanes/EtOAc, 10:1) to yield a yellowish oil, which upon cooling 
crystallized to give a colourless solid (4.1 g, 66%). 
1H NMR (501 MHz, CDCl3) δ = 7.48 (s, 2H), 7.03–6.97 (m, 2H), 5.68–5.65 ppm (m, 
2H). 
13C NMR (126 MHz, CDCl3) δ = 150.2, 150.2, 142.7, 142.7, 125.5, 125.5, 120.7, 
120.7, 81.8 81.8 ppm. 
 
2,3-dibromonaphthalene (50) 
 
TiCl4 (8.5 mL, 75 mmol) was added dropwise to a stirred suspension of Zn-dust (8.5 
g, 125 mmol) in THF (150 mL) at 0 °C under Ar carefully. (Caution: Violent reaction) 
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The resulting mixture was heated to reflux for 5 min then cooled to 0 °C again. 
Compound 49 (4 g, 13.2 mmol, 1 equiv.) was added in THF solution (15 mL) and the 
mixture was heated at reflux for an additional 3 h. After cooling to 25 °C, it was 
poured on ice cold aqueous HCl (0.1 M, 300 mL), followed by extraction with CH2Cl2. 
The organic phase was washed with water (30 mL) and brine (30mL), dried, MgSO4 
and filtered. After removal of the solvent under reduced pressure, purification by 
column chromatography (hexanes) gave 50 as white crystals (3.5 g, 92% yield). 
1H NMR (500 MHz, CDCl3) δ = 8.14 (s, 2H), 7.73 (dd, J = 6.2, 3.2, 2H), 7.51 ppm (dd, 
J = 6.3, 3.2, 2H). 
13C NMR (125 MHz, CDCl3) δ =133.0, 132.2, 132.2, 127.2, 127.2, 126.9, 126.9, 
122.0, 122.0 ppm. 
In agreement with literature data.[161]  
3-bromo-2-naphthaldehyde (51) 
 
iPrMgCl⋅LiCl (1.3M in THF, 5.0 mL, 6.8 mmol, 1.0 equiv.) was added dropwise to a 
solution of compound 50 (1.86 g, 1.75 mmol) in THF (50 mL) at 0 °C under Ar in 10 
min. After stirring for 90 min at 0 °C, DMF (3 mL, 38.7 mmol, 6 equiv.) was added 
and the mixture stirred for an additional 15 min at 0 °C. The mixture was treated with 
water (100 mL) and the aqueous mixture extracted with EtOAc. The organic phase 
was washed with water (50 mL) and brine (30 mL), dried over MgSO4 and filtered. 
The solvent was removed under reduced pressure, and the crude product was 
purified by column chromatography (hexanes/EtOAc, 20:1) giving 51 as a colorless 
solid (692 mg, 45% yield). 
Experimental Section 
 
 
153 
 
 
1H NMR (500 MHz, CDCl3) δ = 10.51 (s, 1H), 8.47 (s, 1H), 8.13 (s, 1H), 8.00–7.94 
(m, 2H), 7.82–7.78 (m, 1H), 7.64 (ddd, J = 8.2, 6.8, 1.3 Hz, 1H), 7.58 ppm (ddd, J = 
8.2, 6.8, 1.3 Hz, 1H). 
 13C NMR (125 MHz, CDCl3) δ = 192.1, 137.1, 132.7, 132.1, 131.7, 130.7, 130.2, 
130.1, 127. 6, 127.6, 127.1, 120.7 ppm. 
In agreement with literature data.[162] 
Synthesis of 3-Aryl-2-naphthaldehyde Derivatives (52a–52c) 
 
In an oven dried microwave vial (5 mL) 51 (1 equiv.), boronic acid (1.2 equiv.), 
CsF (2.8 equiv.), tetrakis(triphenylphosphine)palladium(0) (5 mol%.) were suspended 
in DME (0.5 M) under an atmosphere of dry argon. The vial was sealed and heated 
for 1 h at 120 °C in a microwave reactor. The reaction was poured into water (5 mL) 
and extracted with EtOAc (3x10mL), and the combined organic layers were washed 
with brine (2x10 mL). The organic layer was dried over MgSO4, and the product was 
purified by flash column chromatography (hexanes/EtOAc = 100:0 to 80:20). The 
targeted product as a colorless solid. 
3-phenyl-2-naphthaldehyde (52a)  
 Prepared according to general procedure for 3-aryl-2-
naphthaldehyde derivatives using 3-bromo-2-naphthaldehyde (51) 
(70 mg, 0.3 mmol) and obtained after extraction as a colorless solid 
(63 mg, 0.28 mmol, 96% yield). 
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1H NMR (500 MHz, CDCl3) δ = 10.13 (s, 1H), 8.58 (s, 1H), 8.07–8.01 (m, 1H), 7.93–
7.89 (m, 1H), 7.88 (s, 1H), 7.65 (ddd, J = 8.1, 6.8, 1.3 Hz, 1H), 7.58 (ddd, J = 8.2, 
6.9, 1.3 Hz, 1H), 7.54–7.43 ppm (m, 6H). 
3-(3,4-dimethylphenyl)-2-naphthaldehyde (52b) 
Prepared according to general procedure for 3-aryl-2-
naphthaldehyde derivatives using 3-bromo-2-naphthaldehyde (51) 
(70 mg, 0.3 mmol) and obtained after extraction as a colorless 
solid (70 mg, 0.28 mmol, 90% yield). 
1H NMR (501 MHz, CDCl3) δ = 10.07 (s, 1H), 8.49 (s, 1H), 7.96 (dd, J = 8.2, 1.1 Hz, 
1H), 7.82 (dd, J = 8.4, 1.0 Hz, 1H), 7.79 (s, 1H), 7.56 (ddd, J = 8.2, 6.9, 1.3 Hz, 1H), 
7.49 (ddd, J = 8.2, 6.9, 1.3 Hz, 1H), 7.42–7.37 (m, 1H), 7.22–7.16 (m, 1H), 7.13 (dd, 
J = 7.7, 2.1 Hz, 1H), 2.32–2.27 ppm (m, 6H). 
 
3-(3,5-bis(trifluoromethyl)phenyl)-2-naphthaldehyde (52c) 
Prepared according to general procedure for 3-aryl-2-
naphthaldehyde derivatives using 3-bromo-2-naphthaldehyde 
(51) (70 mg, 0.3 mmol) and obtained after extraction as a 
colorless solid (76 mg, 0.20 mmol, 69% yield). 
1H NMR (501 MHz, CDCl3) δ = 10.10 (s, 1H), 8.57 (s, 1H), 8.14–8.05 (m, 1H), 7.98–
7.92 (m, 2H), 7.90 (d, J = 1.6 Hz, 2H), 7.84 (s, 1H), 7.72 (ddd, J = 8.2, 6.9, 1.3 Hz, 
1H), 7.67 ppm (ddd, J = 8.1, 6.9, 1.3 Hz, 1H). 
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Synthesis of 2-(Bromoethynyl)-3-arylnaphthalene Derivatives (53a–53c) 
 
Step 1: CBr4 (2.5 equiv.) was added to a solution of PPh3 (5 equiv.) in DCM (6 ml) 
and the resulting mixture was stirred for 10 min at 0°C. A solution of 3-aryl-2-
naphthaldehyde (52a–52c) (1 equiv.) in DCM (4 ml) was slowly introduced and 
stirring was continued for 1 h at 0°C. The reaction was then quenched with brine (20 
mL), the aqueous layer was repeatedly extracted with DCM (3x 20 mL), and the 
combined organic layer were dried with MgSO4 and evaporated. The residue was 
purified with chromatography (hexanes/EtOAc, 95:5). The intermediate 
dibromocompound (A–C) was directly subjected to the following synthetic step.  
Step 2: A solution of DBU (58 µl) in DMSO (2 ml) was added to a cooled solution of 
dibromide (A–C) (50 mg) in DMSO (20 ml) at such rate to mantain the internal 
temperature below 15 °C. The resulting mixture was stirred for 1 h before the 
reaction was quenched with aq HCl at 0°C. 
 
2-(bromoethynyl)-3-phenylnaphthalene (53a) 
Prepared according to general procedure for 2-(bromoethynyl)-3-
arylnaphthalene derivatives using 3-phenyl-2-naphthaldehyde (52a)  
(38 mg, 0.16 mmol) and obtained after two steps as a pale yellow 
solid (38 mg, 0.12 mmol, 75% yield). 
Intermediate A: 1H NMR (501 MHz, CDCl3) δ = 8.16 (s, 1H), 7.93 – 7.88 (m, 1H), 
7.88 – 7.83 (m, 1H), 7.82 (s, 1H), 7.56 – 7.39 (m, 6H), 7.31 ppm (d, J = 1.0 Hz, 1H). 
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1H NMR (501 MHz, CDCl3) δ = 8.11 (s, 1H), 7.85 – 7.77 (m, 3H), 7.69 – 7.61 (m, 2H), 
7.54–7.43 (m, 4H), 7.44–7.37 ppm (m, 1H). 
 
2-(bromoethynyl)-3-(3,4-dimethylphenyl)naphthalene (53b) 
Prepared according to general procedure for 2-(bromoethynyl)-
3-arylnaphthalene derivatives using 3-(3,4-dimethylphenyl)-2-
naphthaldehyde (52b)  (26 mg, 0.10 mmol) and obtained after two 
steps as a pale yellow solid (38 mg, 0.07 mmol, 75% yield). 
1H NMR (501 MHz, CDCl3) δ = 8.10 (d, J = 0.8 Hz, 1H), 7.85–7.77 (m, 3H), 7.52–
7.43 (m, 3H), 7.41 (dd, J = 7.7, 2.0 Hz, 1H), 7.23 (d, J = 7.7 Hz, 1H), 2.36 (s, 3H), 
2.34 ppm (s, 3H). 
 
2-(3,5-bis(trifluoromethyl)phenyl)-3-(bromoethynyl)naphthalene (53c) 
Prepared according to general procedure for 2-
(bromoethynyl)-3-arylnaphthalene derivatives using 3-(3,5-
bis(trifluoromethyl)phenyl)-2-naphthaldehyde (52c)  (36 mg, 0.10 
mmol) and obtained after two steps as a pale yellow solid (38 
mg, 0.12 mmol, 69% yield). 
1H NMR (501 MHz, CDCl3) δ = 8.17–8.15 (m, 1H), 8.15–8.12 (m, 2H), 7.94–7.90 (m, 
1H), 7.90–7.83 (m, 3H), 7.61–7.53 ppm (m, 2H). 
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Synthesis of 6-Bromo-tetraphene Derivatives (54a–54c) 
 
In an oven dried microwave vial (5 mL) 2-(bromoethynyl)-3-arylnaphthalene 
derivatives (53a–52c) (1 equiv.) and  AuCl (20 mol%) were dissolved in toluene 
(0.5 M) under an atmosphere of dry argon. The vial was sealed and heated for 1 h at 
120 °C in a microwave reactor. The reaction was directly concentrated under 
reduced pressure and the crude reaction mixture was purified by flash column 
chromatography (hexanes/EtOAc = 100:0 to 95:5). The targeted product as pale 
yellow solid. 
6-bromo-tetraphene (54a) 
Prepared according to general procedure for 6-bromo-tetraphene 
derivatives (54a–54c) using 2-(bromoethynyl)-3-phenylnaphthalene 
(53a)  (31 mg, 0.10 mmol) and obtained after column 
chromatography as a pale yellow solid (20 mg, 0.1 mmol, 65% yield). 
1H NMR (501 MHz, CDCl3) δ = 9.18 (s, 1H), 8.86 (s, 1H), 8.81 (d, J = 8.2 Hz, 1H), 
8.19–8.11 (m, 2H), 8.04 (s, 1H), 7.79–7.74 (m, 1H), 7.71 (ddd, J = 8.4, 7.1, 1.4 Hz, 
1H), 7.66–7.58 ppm (m, 3H). 
 
6-bromo-2,3-bis-methyl-tetraphene and 6-bromo-3,4-dimethyl-tetraphene (54b) 
Prepared according to general procedure for 
6-bromo-tetraphene derivatives (54a–54c) 
 using 2-(bromoethynyl)-3-(3,4-
dimethylphenyl)naphthalene (53b)  (32 mg, 0.10 
mmol). The desired regioisomers could not be separated by column chromatography. 
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After repeated attempts to purify the compounds, the final products could not be 
recovered as they fully decomposed (the compounds are unstable in the presence of 
oxygen and light).  
2,4-bis-trifluoromethyl-6-bromo-tetraphene (54c) 
The desired product was not formed and only starting 
material was recovered. Increasing the AuCl catalyst loading, 
the reaction time or the temperature led to decomposition to 
undefined by-products. 
 
Boronic acid 82 
 
A two-necked 25 mL flask was charged with 6-bromo-tetraphene (54a) (20 mg, 
0.1 mmol) under argon. Dry THF (3 mL) was added, and the solution was cooled to 
78 °C. To this solution was added n-butyllithium (40 µL, 2.5 M, 0.1 mmol) dropwise. 
The solution was stirred at -78 °C for 2 h whereupon trimethyl borate (16 µg, 0.15 
mmol) dissolved in 1 mL of dry THF was added dropwise through the second 
dropping funnel. The solution was allowed to warm to room temperature overnight. 
The crude reaction was checked via 1H-NMR, however the desired compound was 
not identified and exclusively highly unsoluble solids were obtained. 
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Synthesis of DSI 17o 
 
65d (2.5 equiv.)
Pd(OAc)2 (10 mol%)
P(tBu)3 (10 mol%)
K2CO3 (2N)
THF/H2O, 120°C mw
SO2
NH
SO2
17o
SO2
NH
SO2
I
I
48
 
Compound 64d was synthetized following a modification of the reported 
procedure.[163] 
 
2-(3,5-dimethylphenyl)benzaldehyde (61d) 
In a oven dried 20 mL microwave vial under an atmosphere of dry 
argon 2-bromobenzaldehyde 58 (1.0 g, 5.4 mmol, 1 equiv.), 3,5-
dimethylphenyl boronic acid 60 (0.97 g, 6.5 mmol, 1.2 equiv.), cesium 
fluoride (2.3 g, 15.1 mmol, 2.8 equiv.) and 
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tetrakis(triphenylphosphine)palladium(0) (0.313 g, 0.27 mmol, 5 mol%) were added 
and suspended in degassed 1,2–DME (10 mL). The vial was sealed and heated at 
120 °C for 1 hour in a microwave reactor. The reaction mixture was diluted with 
EtOAc (30 mL) and water (30 mL) and extracted with EtOAc (3×20 mL). The 
combined organic layers were dried over MgSO4, concentrated under reduced 
pressure and the crude product was purified by flash column chromatography 
(Hexanes/EtOAc = 100:0 to 95:5) to obtain 61d as a colorless solid (1.06 g, 5.0 
mmol, 93% yield). 
1H NMR (501 MHz, CDCl3) δ = 9.99 (d, J = 0.8 Hz, 1H), 8.01 (dd, J = 7.8, 1.5 Hz, 
1H), 7.62 (td, J = 7.5, 1.5 Hz, 1H), 7.47 (tt, J = 7.6, 1.1 Hz, 1H), 7.44 (dd, J = 7.7, 1.2 
Hz, 1H), 7.08 (s, 1H), 7.00 (s, 2H), 2.46–2.31 ppm (m, 6H).  
13C NMR (126 MHz, CDCl3) δ 192.89, 146.49, 138.16, 137.80, 133.90, 133.59, 
130.83, 129.86, 128.19, 127.68, 127.51, 21.45 ppm.  
HRMS (GC–EI) m/z calculated for C15H14O [M]: 210.1041; found 210.1039. 
 
2-(2,2-dibromovinyl)-3',5'-dimethyl-1,1'-biphenyl (62d) 
CBr4 (4.20 g, 12.6 mmol, 2.5 equiv.) was added portion wise to a 
solution of PPh3 (6.7 g, 25.0 mmol, 5.0 equiv.) in CH2Cl2 (20 mL) and 
the resulting yellow mixture was stirred for 10 min at 0 °C. A solution 
of 2-(3,5-dimethylphenyl)benzaldehyde (61d; 1.06 g, 5.0 mmol, 1.0 
equiv.) in CH2Cl2 (20 mL) was added dropwise and stirring was continued for an 
additional 1 h at 0 °C. The reaction was then quenched with brine and the aqueous 
layer was extracted with CH2Cl2 (3x20 mL). The combined organic layers were dried 
over MgSO4, concentrated under reduced pressure and the crude product was 
purified by flash column chromatography (Hexanes/EtOAc = 100:0 to 95:5) to obtain 
62d as a colorless solid (1.60 g, 88% yield) 
1H NMR (501 MHz, CDCl3) δ = 7.73–7.65 (m, 1H), 7.43–7.32 (m, 3H), 7.23 (s, 1H), 
7.02 (s, 1H), 6.95 (s, 2H), 2.38 ppm (s, 6H). 
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13C NMR (126 MHz, CDCl3) δ = 141.17, 139.87, 137.62, 137.59, 132.86, 132.03, 
131.80, 129.62, 129.04, 128.97, 128.43, 128.33, 127.29, 126.78, 90.23, 21.25 ppm.  
HRMS (GC–EI) m/z calculated for C16H14Br2 [M]: 363.9460; found 363.9457. 
 
2-(bromoethynyl)-3',5'-dimethyl-1,1'-biphenyl (63d) 
A solution of DBU (1.4 mL, 9.8 mmol, 3.0 equiv.) in DMSO (20 
mL) was added to a cooled solution of 62d (1.2 g, 3.3 mmol, 1.0 
equiv.) in DMSO (30 ml) at such rate to maintain the internal 
temperature below 15 °C. The resulting mixture was stirred at 15 °C 
for 1 h before the reaction was quenched with aq. HCl (1M) at 0°C. The aqueous 
layer was extracted with CH2Cl2 (3 x 20 mL) and the combined organic layers were 
washed with sat. aq. NaHCO3 solution (20 mL), water (10 mL) and brine (2x10 mL). 
Afterwards, the organic layer was dried over MgSO4, the solvent was removed under 
reduced pressure to obtain 63d the as colorless solid (703 mg, 75% yield) without 
further purification. 
1H NMR (501 MHz, CDCl3) δ = 7.55 (dt, J = 7.6, 1.0 Hz, 1H), 7.38 (dd, J = 3.9, 0.9 
Hz, 2H), 7.31–7.23 (m, 1H), 7.23–7.18 (m, 2H), 7.02 (m, 1H), 2.41–2.35 ppm (m, 
6H). 
HRMS (GC–EI) m/z calculated for C15H13Br [M]: 284.0197; found 284.0195. 
 
9-Bromo-1,3-dimethyl-phenanthrene (64d) 
In an oven-dried 5 mL microwave vial under an atmosphere of dry 
argon, AuCl (102 mg, 0.44 mmol, 20 mol%) and 63d (630 mg, 2.2 
mmol, 1.0 equiv.) in toluene (3 mL) were heated at 100°C for 1 h. The 
mixture was then adsorbed on silica gel and purified by flash 
chromatography (Hexanes/EtOAc = 9:1 to 8:2) to obtain 64d as a colorless solid (576 
mg, 91% yield). 
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1H NMR (501 MHz, CDCl3) δ = 8.73–8.64 (m, 1H), 8.39–8.29 (m, 2H), 8.26 (s, 1H), 
7.73–7.62 (m, 2H), 7.29 (s, 1H), 2.69 (s, 3H), 2.57 ppm (s, 3H). 
13C NMR (126 MHz, CDCl3) δ = 136.41, 134.03, 131.40, 130.22, 130.17, 130.05, 
129.17, 127.97, 127.23, 127.16, 126.85, 123.10, 120.75, 120.62, 22.10, 19.69 ppm. 
HRMS (GC–EI) m/z calculated for C16H13Br [M]: 284.0201; found 284.0195. 
 
1,3-dimethyl-phenanthren-9-yl boronic acid (65d) 
An oven dried two-necked 100 mL flask was charged with 64d (570 
mg, 2.0 mmol, 1.0 equiv.) under an atmosphere of dry argon. Dry THF 
(20 mL) was added and the resulting solution was cooled to –78 °C 
and n-butyllithium (0.8 mL, 2.6 M in hexane, 2 mmol, 1.0 equiv.) was 
added dropwise. The reaction mixture was stirred at –78 °C for 1 h and a solution of 
trimethyl borate (0.34 mL, 312 mg, 3 mmol, 1.5 equiv.) in dry THF (10 mL) was 
added dropwise. The solution was allowed to warm to room temperature overnight. 
The reaction was quenched with aq. HCl (1 M, 5 mL), concentrated under reduced 
pressure to 50% of its original volume and poured into H2O. The resulted biphasic 
solution was extracted with Et2O (2 x 50 mL). The ethereal solution was washed 
twice with H2O and concentrated under reduced pressure. The tageted product 65d 
was obtained after filtration as a colorless solid (375 mg, 76% yield). 
1H NMR (501 MHz, d8-THF) δ = 8.64 (ddd, J = 19.4, 8.2, 1.5 Hz, 2H), 8.34 (m, 2H), 
7.47 (m, 2H), 7.22 (s, 1H), 2.68 (s, 3H), 2.49 ppm (s, 3H), [acid proton not visible due 
to fast exchange].  
13C NMR (126 MHz, d8-THF) δ = 135.98, 134.86, 134.40, 131.35, 130.20, 129.97, 
129.48, 129.07, 127.88, 125.56, 125.35, 122.52, 120.11, 21.19, 18.94 ppm. 
HRMS (ESI) m/z calculated for C16H14BO2 [M–H]
-: 249.1092; found 249.1096. 
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2,6-bis(1,3-dimethylphenanthren-9-yl)-4H-dinaphtho[2,1-d:1',2'-
f][1,3,2]dithiazepine 3,3,5,5-tetraoxide (17o) 
In an oven dried microwave vial (5 mL) (S)-3,3′-
diiododisulfonimide 48 (320 mg, 0.5 mmol, 1 equiv.), 65d (330 
mg, 1.5 mmol, 3 equiv.), K2CO3 (273 mg, 2.0 mmol, 4 equiv.), 
Palladium(II)-acetate (11 mg, 0.05 mmol, 0.1 equiv, 10 mol%.) 
were suspended in THF/water (4 mL, 1:1, v/v) under an 
atmosphere of dry argon. Tri-tert-butylphosphine (1M, dioxane 
solution) (0.1 mL, 81 mg, 0.1 mmol) was added and the vial was 
sealed and heated for 30 min at 120 °C in a microwave reactor. 
The reaction was poured into HCl (1N, 5 mL) and extracted with CH2Cl2 (3 x 10mL), 
and the combined organic layers were washed with water (10 mL) and brine (2x10 
mL). The organic layer was dried over MgSO4, and the product was purified by flash 
column chromatography (CH2Cl2/MeOH = 100:0 to 98:2). The purified product was 
dissolved in CH2Cl2 (30 mL),acidified with HCl (6 M, 20 mL) and the solvent removed 
in vacuo to obtain the targeted product as pale yellow solid (365 mg, 91% yield).  
Note: Upon acidification, catalyst 17o equilibrates to an unseperable mixture of 3 
rotamers (1.7:49:3.4).  
1H NMR (501 MHz, CDCl3) δ = 8.82–8.72 (m, 2H), 8.41 (d, J = 4.4 Hz, 2H), 8.28–
8.17 (m, 2H), 8.10–7.98 (m, 4H), 7.80–7.69 (m, 2H), 7.69–7.46 (m, 8H), 7.46–7.28 
(m, 6H), 2.80–2.68 (m, 6H), 2.64–2.54 ppm (m, 6H). 
13C NMR (126 MHz, CDCl3) δ 138.28, 138.25, 138.04, 137.98, 136.21, 136.06, 
136.04, 135.98, 135.87, 135.45, 135.40, 135.12, 135.08, 135.00, 134.81, 134.76, 
134.74, 134.39, 134.37, 134.35, 134.32, 134.21, 134.06, 133.87, 133.54, 133.34, 
132.71, 132.62, 132.23, 132.17, 132.13, 132.01, 130.62, 130.59, 130.55, 130.01, 
129.98, 129.95, 129.90, 129.86, 129.83, 129.81, 128.61, 128.59, 128.56, 128.53, 
128.51, 128.39, 128.30, 128.24, 128.22, 128.12, 128.08, 127.94, 127.91, 126.95, 
126.68, 126.66, 126.49, 126.44, 126.25, 126.21, 126.16, 125.84, 125.70, 123.88, 
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123.86, 123.58, 123.50, 123.39, 123.37, 123.14, 123.11, 120.61, 120.58, 22.12, 
22.11, 19.94, 19.91 ppm. 
HRMS (ESI) m/z calculated for C52H36N1O4S2 [M–H]
-: 802.2102; found 802.2091. 
Synthesis of DSI-17p 
 
65e (2.5 equiv.)
Pd(OAc)2 (10 mol%)
P(tBu)3 (10 mol%)
K2CO3 (2N)
THF/H2O, 120°C mw
SO2
NH
SO2
17p
SO2
NH
SO2
I
I
48
 
2-(3,5-dimethylphenyl)-4-methylbenzaldehyde (61e) 
In a oven dried 20 mL microwave vial under an atmosphere of dry 
argon 2-bromo-4-methylbenzaldehyde 57 (1.0 g, 5.4 mmol, 1 equiv.), 
3,5-dimethylphenyl boronic acid 60 (0.97 g, 6.5 mmol, 1.2 equiv.), 
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cesium fluoride (2.3 g, 15.1 mmol, 2.8 equiv.) and 
tetrakis(triphenylphosphine)palladium(0) (0.313 g, 0.27 mmol, 5 mol%) were added 
and suspended in degassed 1,2–DME (10 mL). The vial was sealed and heated at 
120 °C for 1 hour in a microwave reactor. The reaction mixture was diluted with 
EtOAc (30 mL) and water (30 mL) and extracted with EtOAc (3×20 mL). The 
combined organic layers were dried over MgSO4, concentrated under reduced 
pressure and the crude product was purified by flash column chromatography 
(Hexanes/EtOAc = 100:0 to 95:5) to obtain 61e as a colorless solid (1.13 g, 5.0 
mmol, 93% yield). 
1H NMR (501 MHz, CDCl3) δ =  9.96 (s, 1H), 7.95 (d, J = 7.9 Hz, 1H), 7.33–7.22 (m, 
3H), 7.09 (s, 1H), 7.01 (s, 2H), 2.47 (s, 3H), 2.40 ppm (s, 6H).  
13C NMR (126 MHz, CDCl3) δ = 192.43, 144.40, 137.93, 133.29, 131.27, 129.61, 
128.45, 127.97, 127.97, 127.49, 77.27, 77.01, 76.76, 21.82, 21.35, 21.30 ppm.  
HRMS (GC–EI) m/z calculated for C15H14O [M]: 224.1201; found 224.1203. 
 
2-(2,2-dibromovinyl)-3',5,5'-trimethyl-1,1'-biphenyl (62e) 
CBr4 (4.18 g, 12.6 mmol, 2.5 equiv.) was added portion wise to a 
solution of PPh3 (6.7 g, 25.0 mmol, 5.0 equiv.) in CH2Cl2 (20 mL) and 
the resulting yellow mixture was stirred for 10 min at 0 °C. A solution 
of 2-(3,5-dimethylphenyl)-4-methylbenzaldehyde (61e; 1.06 g, 5.0 
mmol, 1.0 equiv.) in CH2Cl2 (20 mL) was added dropwise and stirring was continued 
for an additional 1 h at 0 °C. The reaction was then quenched with brine and the 
aqueous layer was extracted with CH2Cl2 (3x20 mL). The combined organic layers 
were dried over MgSO4, concentrated under reduced pressure and the crude product 
was purified by flash column chromatography (Hexanes/EtOAc = 100:0 to 95:5) to 
obtain 62e as a colorless solid (1.83 g, 95% yield) 
1H NMR (501 MHz, CDCl3) δ = 7.63 – 7.57 (m, 1H), 7.22 – 7.13 (m, 3H), 7.01 (s, 1H), 6.94 
(s, 2H), 2.38 (s, 3H), 2.37 (s, 6H). 
13C NMR (126 MHz, CDCl3) δ = 141.17, 139.87, 137.62, 137.59, 132.86, 132.03, 
131.80, 129.62, 129.04, 128.97, 128.43, 128.33, 127.29, 126.78, 90.23, 21.25 ppm. 
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2-(bromoethynyl)-3',5,5'-trimethyl-1,1'-biphenyl (63e) 
A solution of DBU (1.0 mL, 14.4 mmol, 3.0 equiv.) in DMSO (30 
mL) was added to a cooled solution of 62e (1.8 g, 3.3 mmol, 4.8 
equiv.) in DMSO (30 ml) at such rate to maintain the internal 
temperature below 15 °C. The resulting mixture was stirred at 15 °C 
for 1 h before the reaction was quenched with aq. HCl (1M) at 0°C. The aqueous 
layer was extracted with CH2Cl2 (3 x 20 mL) and the combined organic layers were 
washed with sat. aq. NaHCO3 solution (20 mL), water (10 mL) and brine (2x10 mL). 
Afterwards, the organic layer was dried over MgSO4, the solvent was removed under 
reduced pressure to obtain 63e the as colorless solid (850 mg, 59% yield) without 
further purification. 
1H NMR (501 MHz, CDCl3) δ =  7.44 (d, J = 7.8 Hz, 1H), 7.21–7.18 (m, 3H), 7.08 
(ddd, J = 7.9, 1.8, 0.8 Hz, 1H), 7.03–6.99 (m, 1H), 2.61 (s, 3H), 2.38 ppm (s, 6H). 
 
 
9-Bromo-1,3,6-trimethyl-phenanthrene (64e) 
In an oven-dried 5 mL microwave vial under an atmosphere of 
dry argon, AuCl (217 mg, 0.94 mmol, 20 mol%) and 63e (1400 mg, 
4.7 mmol, 1.0 equiv.) in toluene (5 mL) were heated at 100°C for 1 h. 
The mixture was then adsorbed on silica gel and purified by flash 
chromatography (Hexanes/EtOAc = 9:1 to 8:2) to obtain 64e as a colorless solid (600 
mg, 43% yield). 
1H NMR (501 MHz, CDCl3) δ = 8.47 (s, 1H), 8.33–8.30 (m, 1H), 8.23 (d, J = 8.4 Hz, 
1H), 8.18 (d, J = 0.8 Hz, 1H), 7.52–7.48 (m, 1H), 7.28 (s, 1H), 2.68 (s, 3H), 2.64 (s, 
3H), 2.56 ppm (s, 3H). 
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1,3,6-trimethyl-phenanthren-9-yl boronic acid (65e) 
An oven dried two-necked 100 mL flask was charged with 64e 
(500 mg, 1.7 mmol, 1.0 equiv.) under an atmosphere of dry argon. 
Dry THF (20 mL) was added and the resulting solution was cooled to 
–78 °C and n-butyllithium (0.7 mL, 2.4 M in hexane, 1.7 mmol, 1.0 
equiv.) was added dropwise. The reaction mixture was stirred at –78 °C for 1 h and a 
solution of trimethyl borate (0.28 mL, 260 mg, 2.5 mmol, 1.5 equiv.) in dry THF (10 
mL) was added dropwise. The solution was allowed to warm to room temperature 
overnight. The reaction was quenched with aq. HCl (1 M, 5 mL), concentrated under 
reduced pressure to 50% of its original volume and poured into H2O. The resulted 
biphasic solution was extracted with Et2O (2 x 50 mL). The ethereal solution was 
washed twice with H2O and concentrated under reduced pressure. The tageted 
product 65e was obtained after filtration as a colorless solid (320 mg, 75% yield). 
1H NMR (501 MHz, CDCl3) δ = 8.56–8.48 (m, 1H), 8.42–8.31 (m, 1H), 8.28 – 8.18 
(m, 1H), 7.72 – 7.62 (m, 1H), 7.52–7.41 (m, 1H), 7.36–7.28 (m, 1H), 7.18 (d, J = 11.1 
Hz, 1H), 2.78–2.67 (m, 3H), 2.67–2.51 (m, 6H). 
The product is highly unsoluble in CHCl3, therefore 
13C-NMR spectra was not 
informative. 
 
2,6-bis(1,3,6-trimethylphenanthren-9-yl)-4H-dinaphtho[2,1-d:1',2'-
f][1,3,2]dithiazepine 3,3,5,5-tetraoxide (17p) 
In an oven dried microwave vial (5 mL) (S)-3,3′-
diiododisulfonimide 48 (69 mg, 0.1 mmol, 1 equiv.), 65e (112 
mg, 0.4 mmol, 3 equiv.), K2CO3 (58 mg, 0.4 mmol, 4 equiv.), 
Palladium(II)-acetate (2.4 mg, 0.01 mmol, 0.1 equiv, 10 mol%.) 
were suspended in THF/water (4 mL, 1:1, v/v) under an 
atmosphere of dry argon. Tri-tert-butylphosphine (1M, dioxane 
solution) (0.02 mL, 21 mg, 0.1 mmol) was added and the vial 
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was sealed and heated for 30 min at 120 °C in a microwave reactor. The reaction 
was poured into HCl (1N, 5 mL) and extracted with CH2Cl2 (3 x 10mL), and the 
combined organic layers were washed with water (10 mL) and brine (2x10 mL). The 
organic layer was dried over MgSO4, and the product was purified by flash column 
chromatography (CH2Cl2/MeOH = 100:0 to 98:2). The purified product was dissolved 
in CH2Cl2 (30 mL),acidified with HCl (6 M, 20 mL) and the solvent removed in vacuo 
to obtain the targeted product as pale yellow solid (69 mg, 78% yield).  
Note: Upon acidification, catalyst 17p equilibrates to an unseperable mixture of 3 
rotamers.  
1H NMR (501 MHz, CDCl3) δ = 8.58–8.50 (m, 2H), 8.39 (d, J = 5.5 Hz, 2H), 8.24 (d, J 
= 7.7 Hz, 2H), 8.18 (d, J = 2.2 Hz, 2H), 8.06 (d, J = 8.1 Hz, 2H), 8.05–8.00 (m, 2H), 
7.97–7.90 (m, 2H), 7.80–7.68 (m, 2H), 7.59–7.45 (m, 4H), 7.40 (q, J = 7.7, 6.9 Hz, 
3H), 7.35–7.27 (m, 3H), 7.23–7.18 (m, 1H), 2.79–2.64 (m, 6H), 2.66–2.47 (m, 12H). 
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 Asymmetric α-Aminomethylation for the Direct Synthesis of 7.3
Unprotected β-Amino Acids  
 
 Synthesis of Aminomethylating Reagents 7.3.1
N-(methoxymethyl)-1,1,1-trimethyl-N-(trimethylsilyl)silanamine (38) 
NaH (1 equiv.)
THF, 0 °C
N
H
TMSTMS OMeCl+ OMeN
TMS
TMS
 
A solution of n-BuLi (4.8 mL, 2.2 M, 10.5 mmol, 1.05 equiv.) was added dropwise 
at 0 °C to a stirred solution of hexamethyldisilazane (2.1 mL, 10 mmol, 1.0 equiv.) in 
THF (200 mL) under argon atmosphere and the mixture was stirred for 30 min. 
Chloromethyl methyl ether (0.8 mL, 10 mmol, 1 equiv.) was added dropwise to the 
cooled and stirred mixture, and stirring was continued for 2 h at 0 °C. The solvent 
was removed by evaporation and the resulting residue was filtered to remove the 
lithium chloride, which was rinced by n-hexane. After removal of the solvent, 
distillation of the liquid residue gave pure 38 (1.8 g, 8.6 mmol, 89% yield), bp 67-68 
°C (50 mBar). 
1H NMR (501 MHz, CD2Cl2) δ = 4.27 (s, 2H), 3.14 (s, 3H), 0.13 ppm (s, 18H).  
13C NMR (126 MHz, CD2Cl2) δ = 81.23, 53.77, (6x) 2.08 ppm.  
 
 
N-((benzyloxy)methyl)-1,1,1-trimethyl-N-(trimethylsilyl)silanamine (80) 
NaH (1 equiv.)
THF, 0 °C
N
H
TMSTMS OCl+ ON
TMS
TMS  
A solution of n-BuLi (4.8 mL, 2.2 M, 10.5 mmol, 1.05 equiv.) was added dropwise 
at 0 °C to a stirred solution of hexamethyldisilazane (2.1 mL, 10 mmol, 1.0 equiv.) in 
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THF (200 mL) under argon atmosphere and the mixture was stirred for 30 min. 
Chloromethyl benzyl ether (10 mmol, 1 equiv.) was added dropwise to the cooled 
and stirred mixture, and stirring was continued for 2 h at 0 °C. The solvent was 
removed by evaporation and the resulting residue was filtered to remove the lithium 
chloride, which was rinced by n-hexane. After removal of the solvent, distillation of 
the liquid residue gave pure 80, bp 39–42 °C (4.5 x 10-2 mBar). 
1H NMR (501 MHz, CD2Cl2) δ = 7.29–7.23 (m, 2H), 7.17–7.12 (m, 2H), 7.08–7.03 (m, 
1H), 4.33 (s, 2H), 4.24 (s, 2H), 0.19 ppm (s, 18H). 
13C NMR (126 MHz, CD2Cl2) δ = 139.42, 129.15, 128.42, 128.22, 127.58, 127.40, 
79.54, 68.57, (6x) 2.00 ppm.  
 
 
 Synthesis and Characterization of bis-Silyl Ketene Acetals 7.3.2
General Procedure B:  
OTMS
OTMS
OH
O
R1
R2
R1
R2
LDA (2.2 equiv.)
THF, –78 °C to rt
TMS-Cl
(2.1 equiv.)+
 
A stirring solution of acid (1.0 equiv.) and Me3SiCl (2.1 equiv.) in THF (0.5 M) 
under an atmosphere of argon was cooled to –78 °C. The LDA solution (2.2) was 
added via cannula. The cooling bath was removed after complete addition and the 
reaction solution was stirred for 1 hour at room temperature. The reaction mixture 
was concentrated in vacuo, and then hexane (50 mL) was added to the residue and 
was filtered under an atmosphere of argon. After concentration under reduced 
pressure, the crude product was purified by distillation under reduced pressure to 
afford the bis-silyl ketene acetals as colorless liquids, which were stored in Schlenk 
flasks under an atmosphere of argon at 4 °C.  
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2,2,6,6-tetramethyl-4-(2-phenylethylidene)-3,5-dioxa-2,6-disilaheptane (31q) 
Prepared according to general procedure B using 3-
phenylpropanoic acid (1.5 g, 10 mmol) and obtained after 
distillation (bp = 69–70 °C at 1.0 x 10-2 mBar) as colorless liquid 
(1.5  g, 5.0 mmol, 50 % yield). 
1H NMR (501 MHz, CD2Cl2) δ = 7.28–7.22 (m, 2H), 7.22–7.17 (m, 2H), 7.17–7.10 (m, 
1H), 3.76 (t, J = 7.3 Hz, 1H), 3.27 (d, J = 7.3 Hz, 2H), 0.23 (s, 9H), 0.20 (s, 9H).  
13C NMR (126 MHz, CD2Cl2) δ = 151.92, 143.94, 129.03, 128.67, 128.66, 128.37, 
125.93, 82.32, 31.92, 0.75, 0.14 ppm.  
 
2,2,6,6-tetramethyl-4-(3-phenylpropylidene)-3,5-dioxa-2,6-disilaheptane (31s) 
Prepared according to general procedure B using 4-
phenylbutanoic acid (3.9 g, 20.0 mmol) and obtained after 
distillation (bp = 86–88 °C at 7.8 x 10-2 mbar) as colorless liquid. 
1H NMR (501 MHz, CD2Cl2) δ = 7.15–7.04 (m, 2H), 7.04–6.92 (m, 3H), 3.38 (t, J = 
7.1 Hz, 1H), 2.49–2.31 (m, 2H), 2.10–1.95 (m, 2H), 0.02 (s, 9H), 0.00 (s, 9H).  
 
 
2,2,6,6-tetramethyl-4-pentylidene-3,5-dioxa-2,6-disilaheptane (31t) 
Prepared according to general procedure B using hexanoic acid 
(2.3 g, 20.0 mmol) and obtained after distillation (bp = 41–42 °C 
at 5.7 x 10-2 mbar) as colorless liquid. 
1H NMR (501 MHz, CD2Cl2) δ = 3.53 (t, J = 7.1 Hz, 1H), 1.89 (q, J = 7.1 Hz, 2H), 
1.36–1.17 (m, 4H), 0.95–0.84 (m, 3H), 0.21 (s, 9H), 0.18 ppm (s, 9H).  
13C NMR (126 MHz, CD2Cl2) δ = 150.83, 83.87, 33.45, 25.24, 22.78, 14.35, 0.66, 
0.06 ppm.  
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4-ethylidene-2,2,6,6-tetramethyl-3,5-dioxa-2,6-disilaheptane (31u) 
Prepared according to general procedure B using propanoic acid (1.0 
g, 13.5 mmol) and obtained after distillation (bp = 65-68 °C at 20 mBar) 
as colorless liquid (2.3  g, 13.4 mmol, 79 % yield). 
1H NMR (501 MHz, CD2Cl2) δ = 3.36 (q, J = 6.5 Hz, 1H), 1.25 (d, J = 6.5 Hz, 3H), 
0.02 (s, 9H), 0.00 (s, 9H).  
13C NMR (126 MHz, CD2Cl2) δ = 151.33, 77.42, 10.38, 0.69, 0.08 ppm.  
 
4-(2-(4-methoxyphenyl)ethylidene)-2,2,6,6-tetramethyl-3,5-dioxa-2,6-disilahepta-
ne (31v) 
Prepared according to general procedure B using 3-(4-
methoxyphenyl)propanoic acid (3.6 g, 20 mmol) and 
obtained after distillation (bp = 108–110 °C at 4.8 *10-2 
mBar) as colorless liquid. 
1H NMR (501 MHz, CD2Cl2) δ = 7.20–7.03 (m, 2H), 6.86–6.75 (m, 2H), 3.83–3.70 (m, 
4H), 3.20 (d, J = 7.3 Hz, 2H), 0.23 (s, 9H), 0.21 (s, 9H).  
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 General procedure for the α-Aminomethylation of bis-SKAs 7.3.3
General Procedure C 
OTMS
OTMS
71s or 71t (1 mol%)
pentane (0.2 Μ)
–60 °C, 3 days
then MeOH/H2O
O
OH
R1R1 +
1.0 equiv.
OMeN
TMS
TMS
1.2 equiv.
NH2
31 38 68
 
An oven dry 2 ml vial was charged with imidodiphosphate 71s or 71t as the 
cataylst (0.2 µmol, 0.5 mg, 1 mol%), a magnetic stir bar and, under argon 
atmosphere, dry pentane (0.1 mL) and bis-silyl ketene acetal 31 (0.024 mmol, 1.2 
equiv.) were added. The reaction mixture was cooled down to the desired 
temperature, and then N-(methoxymethyl)-1,1,1-trimethyl-N-(trimethylsilyl)silanamine 
38 (0.02 µL, 1.0 equiv.) was added. After 3 days, the targeted product 68 was 
precipitated with water (0.1 mL) and directly dissolved with water/MeOH (0.5 mL, 1:1, 
v/v). The aqueous phase was extracted with Et2O (2x 1 mL) in order to remove the 
catalyst. The water was evaporated under reduced pressure to obtainthe desired 
product as a colorless solid in >99% purity (analyzed by 1H-NMR). The obtained 
product was dissolved in HPLC grade water:MeCN (1:1, v/v) and directly used for the 
determination of the enantiomeric ratio.  
 
3-amino-2-phenylpropanoic acid (68r)  
Prepared according to general procedure C using 2,2,6,6-
tetramethyl-4-(2-phenylethylidene)-3,5-dioxa-2,6-disilaheptane (31r) 
(5.5 mg, 0.02 mmol) using catalst 71s and obtained after extraction 
as a colorless solid (91% yield, 91:9 er).  
1H NMR (501 MHz, CDCl3) δ = 7.26–7.15 (m, 3H), 7.14–7.10 (m, 2H), 3.86 (t, J = 7.5 
Hz, 1H), 3.37 (dd, J = 13.1, 7.6 Hz, 1H), 3.13 ppm (dd, J = 13.1, 7.4 Hz, 1H).  
13C NMR (126 MHz, CDCl3) δ = 174.6, 134.3, 129.6, 128.9, 128.9, 128.3, 128.3, 
48.5, 41.1 ppm.  
OH
O
NH2
Experimental Section 
 
 
174 
 
 
The enantiomeric ratio was determined by HPLC analysis using Daicel Chirobiotic 
T2, water:methanol = 50:50 (v/v), flow rate = 1 mL/min, 25 °C, λ = 210 nm, tR = 11.1  
min (minor) and tR = 17.1 min (major). 
 
3-amino-2-benzylpropanoic acid (68q)  
Prepared according to the general procedure using 2,2,6,6-
tetramethyl-4-(2-phenylethylidene)-3,5-dioxa-2,6-disilaheptane 
(31q) (5.6 mg, 0.02 mmol) using catalst 71s and obtained after 
precipitation as a colorless solid (5.0 mg, 0.019 mmol, 95 % yield, 96:4 er).  
1H NMR (501 MHz, D2O) δ = 7.45 – 7.34 (m, 2H), 7.35 – 7.27 (m, 3H), 3.16 – 3.06 
(m, 1H), 3.06 – 2.98 (m, 2H), 2.94 – 2.80 (m, 2H). 
13C NMR (126 MHz, D2O) δ = 179.52, 138.48, 128.96, 128.96, 128.69, 128.69, 
126.75, 46.90, 40.63, 36.15 ppm.  
The enantiomeric ratio was determined by HPLC analysis using Daicel Chirobiotic 
T2, water:methanol = 50:50 (v/v), flow rate = 1 mL/min, 25 °C, λ = 210 nm, tR = 6.3  
min (minor) and tR = 7.9 min (major) 
 
3-amino-2-phenylpropanoic acid (68w)  
Prepared according to the general procedure using 4-ethylidene-2,2,6,6-
tetramethyl-3,5-dioxa-2,6-disilaheptane (31w) (4.1 mg, 0.02 mmol) using 
catalst 71t and obtained after precipitation as a colorless solid (95% NMR 
yield, 82.5:17.5 er).  
1H NMR (501 MHz, D2O) δ = 3.17 (ddd, J = 14.0, 6.9, 1.1 Hz, 1H), 2.66 (dd, J = 14.0, 
7.6 Hz, 1H), 2.40 (h, J = 7.3 Hz, 1H), 0.9 ppm (d, J = 7.1 Hz, 3H). 
13C NMR (126 MHz, D2O) δ = 181.67, 42.37, 39.25, 15.13 ppm.  
The enantiomeric ratio was determined by HPLC analysis after derivatization of the 
obtained product to the corresponding    
HPLC analysis using Chiralpak ID-3, n-heptane:i-PrOH = 80:20 (v/v), flow rate = 1 
mL/min, 25 °C, λ = 210 nm, tR = 4.5  min (major) and tR = 4.9 min (minor) 
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3-amino-2-phenylpropanoic acid (68s)  
Prepared according to the general procedure using 2,2,6,6-
tetramethyl-4-(3-phenylpropylidene)-3,5-dioxa-2,6-disilaheptane 
(31s) (6.1 mg, 0.02 mmol) using catalst 71s and obtained after 
extraction as a colorless solid (91% NMR yield, 95.5:4.5 er).  
1H NMR (501 MHz, CDCl3) δ = 7.35–7.27 (m, 2H), 7.27–7.19 (m, 3H), 3.14–3.05 (m, 
1H), 3.05–2.96 (m, 1H), 2.67–2.52 (m, 2H), 2.52–2.44 (m, 1H), 1.92–1.81 (m, 1H), 
1.80–1.70 ppm (m, 1H).  
13C NMR (126 MHz, CDCl3) δ = 180.47, 141.87, 128.69, 128.51, 126.21, 45.03, 
41.07, 32.50, 31.89 ppm.  
The enantiomeric ratio was determined by HPLC analysis using Daicel Chirobiotic 
T2, water:methanol = 50:50 (v/v), flow rate = 1 mL/min, 25 °C, λ = 210 nm, tR = 8.0  
min (minor) and tR = 10.2 min (major). 
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 Synthesis and Characterization of IDPi Catalysts 7.3.4
BrBr
Br
Br
Br
+
OH
OH
R
R
R
Ar
N
O
O
P
N
ArSO2
C8F17
O
O
P
N
Ar O2S
C8F17
H
Ar
Cl
P
N
Cl
Cl
S
C8F17
OO
1. , Et3N
PhMe, rt
2. HMDS
3. 120 °C
R
Ar =
83 84a–d
85a–d71s–w
Br
Br
N
Bn
Et
Et
EtCl (2 mol%)
NaOHaq (50%)
DMSO, rt, 5 h
procedure D, E o F
1. Pd(PPh3)4 (10 mol%)
K2CO3, dioxane, 
85 °C, 16 h
2. HCl (6.0 M)
80 °C
 
 
7.3.4.1 Procedure for derivatization of 2,7-dibromo-9H-fluorene 
 
Br
Br
Br
Br
83
Br
Br+
N
Bn
Et Et
EtCl (2 mol%)
NaOHaq (50%)
DMSO, rt, 5 h
 
2',7'-dibromospiro[cyclopentane-1,9'-fluorene] (83) 
Aq. NaOH (50%, 110 mmol, 5.5 equiv.) was added dropwise to the mixture of 2,7-
dibromo-9H-fluorene (6.5 g, 20 mmol, 1.0 equiv.) and benzyltriethylammonium 
chloride (91.1 mg, 0.4 mmol, 2 mol%) in DMSO (10 mL) under argon at rt (NOTE: 
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rapid color change from yellow to red). After the subsequent addition of 1,4-
dibromobutane (2.4 mL, 20 mmol, 1.0 equiv.) (NOTE: color change from red to 
beige), the reaction was stirred for 5 hours at rt. Then, water (30 mL) and toluene (30 
mL) were added and the organic layer was separated, dried over MgSO4 and 
concentrated under reduced pressure. The crude product was purified by column 
chromatography (hexanes) to yield 2',7'-dibromospiro[cyclopentane-1,9'-fluorene] 83 
as a light yellow solid (5.4 g, 14.2 mmol, 71%). 
1H NMR (501 MHz, CDCl3) δ = 7.55–7.50 (m, 4H), 7.44 (dd, J = 8.1, 1.8 Hz, 2H), 
2.18–2.10 (m, 4H), 2.10–2.00 ppm (m, 4H). 
13C NMR (126 MHz, CDCl3) δ = 156.01, 156.01, 137.44, 137.44, 130.01, 130.01, 
126.31, 126.31, 121.57, 121.57, 120.99, 120.99, 57.90, 39.65, 39.65, 26.92, 26.92 
ppm.  
 
7.3.4.1 Derivatization of 2',7'-Dibromospiro[cyclopentane-1,9'-fluorene] 
 
Procedure D 
2'-bromo-7'-methylspiro[cyclopentane-1,9'-fluorene] (84a) 
 
n-BuLi (2.54 M in hexanes, 2.1 equiv.) was added dropwise to a solution of 2',7'-
dibromospiro[cyclopentane-1,9'-fluorene] 83 (1.0 equiv.) in THF (0.2 M) at –78 °C 
and the reaction mixture was allowed to stir at this temperature for 15 min. Methyl 
iodide (1.0 equiv., neat) was added to the reaction mixture dropwise over 10 min. 
The reaction was allowed to stir and warm to room temperature overnight. The 
reaction was quenched with sat. NH4Cl(aq) solution. After 5 min, the reaction mixture 
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was diluted with diethyl ether. The aqueous layer was extracted with diethyl ether 
(x3). The combined organic layers were washed with sat. Na2S2O4(aq) solution until 
the organic phase turn to transparent, then washed with brine, dried with magnesium 
sulfate, concentrated under reduced pressure, and the solid residue was purified by 
flash column chromatography (SiO2, dichloromethane/methanol = 95:5).  
1H NMR (501 MHz, CDCl3) δ = 7.57–7.48 (m, 3H), 7.42 (dd, J = 8.0, 1.8 Hz, 1H), 
7.24–7.20 (m, 1H), 7.17–7.11 (m, 1H), 2.42 (s, 3H), 2.25–1.91 ppm (m, 8H).  
13C NMR (126 MHz, CDCl3) δ = 156.51, 154.34, 138.73, 137.97, 135.96, 129.81, 
127.87, 126.34, 123.74, 120.72, 120.67, 119.53, 57.77, 39.91, 27.11, 22.00 ppm. 
 
 
 
Procedure E 
2'-bromo-7'-butylspiro[cyclopentane-1,9'-fluorene] (84b) 
 
n-BuLi (2.54 M in hexanes, 2.1 equiv.) was added dropwise to a solution of acid 
(1.0 equiv.) in THF (0.2 M) at –78 °C and the reaction mixture was allowed to stir at 
room temperature overnight. The reaction was quenched with sat. NH4Cl(aq) solution. 
After 5 min, the reaction mixture was diluted with diethyl ether. The aqueous layer 
was extracted with diethyl ether (x3). The combined organic layers were washed with 
sat. Na2S2O4(aq) solution until the organic phase turn to transparent, then washed with 
brine, dried with magnesium sulfate, concentrated under reduced pressure, and the 
solid residue was purified by flash column chromatography (SiO2, 
dichloromethane/methanol = 95:5).  
1H NMR (501 MHz, CDCl3) δ = 7.67–7.46 (m, 3H), 7.41 (dd, J = 7.8, 1.8 Hz, 1H), 
7.21 (d, J = 1.5 Hz, 1H), 7.14 (dd, J = 7.7, 1.5 Hz, 1H), 2.66 (td, J = 8.0, 3.1 Hz, 2H), 
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2.19–2.01 (m, 8H), 1.70–1.58 (m, 2H), 1.44–1.34 (m, 2H), 0.95 ppm (t, J = 7.3 Hz, 
3H).  
 
 
Procedure D 
2'-bromo-7'-(tert-butyl)spiro[cyclopentane-1,9'-fluorene] (84c) 
 
n-BuLi (2.54 M in hexanes, 2.1 equiv.) was added dropwise to a solution of acid 
(1.0 equiv.) in THF (0.2 M) at –78 °C and the reaction mixture was allowed to stir at 
this temperature for 15 min. tert-Butyl iodide (1.0 equiv., neat) was added to the 
reaction mixture dropwise over 10 min. The reaction was allowed to stir and warm to 
room temperature overnight. The reaction was quenched with sat. NH4Cl(aq) solution. 
After 5 min, the reaction mixture was diluted with diethyl ether. The aqueous layer 
was extracted with diethyl ether (x3). The combined organic layers were washed with 
sat. Na2S2O4(aq) solution until the organic phase turn to transparent, then washed with 
brine, dried with magnesium sulfate, concentrated under reduced pressure, and the 
solid residue was purified by flash column chromatography (SiO2, 
dichloromethane/methanol = 95:5).  
1H NMR (501 MHz, CDCl3) δ = 7.51 (d, J = 7.9 Hz, 1H), 7.46–7.42 (m, 2H), 7.37–
7.32 (m, 2H), 7.30 (dd, J = 8.0, 1.8 Hz, 1H), 2.13–1.92 (m, 8H), 1.30 ppm (s, 9H). 
13C NMR (126 MHz, CDCl3) δ = 156.61, 153.66, 151.33, 138.49, 135.86, 129.64, 
126.18, 124.10, 120.63, 120.54, 119.53, 119.09, 64.39, 57.84, 39.78, 26.91, 25.35, 
14.19, 14.19, 14.19 ppm.  
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7.3.4.2 Suzuki Coupling of 2-Bromo-7-alkyl-9H-fluorene and MOM-
protected (S,S)-BINOL 
 
OH
OH
R
R
B
OMOM
OMOM
B
R
Br
O
O
O
O
+
1. Pd(PPh3)4 (10 mol%)
K2CO3, dioxane,
85 °C, 16 h
2. HCl (6.0 M)
MeOH/THF/CHCl3 (1:1:1)
80 °C
84a-e 85a-e86  
To a flame dried two-neck round-bottom flask with a condenser was added (S)-
2,2'-(2,2'-bis(methoxymethoxy)-1,1'binaphthyl-3,3'- diyl)bis(4,4,-5,5-tetramethyl-1,3,2-
dioxaborolane) 86 (0.5 mmol, 1.0 equiv), 2-bromo fluorenyl derivative 84a–e (1.1 
mmol, 2.2 equiv) and tetrakis(triphenylphosphine)palladium (0.05 mmol, 0.1 equiv). 
After degassing the reaction mixture with argon for 20 min, toluene/ethanol/methanol 
(3:2:1, v/v/v, 0.15 M) and K2CO3 (3 mmol, 6 equiv.) were sequentially added. The 
mixture was then heated to 110 °C and stirred at that temperature for 16 h. After 
cooling the reaction to room temperature, the reaction mixture was extracted with 
EtOAc (3x), the combined organic phase was dried over MgSO4 and concentrated 
under reduced pressure. Subsequently, the solid was dissolved in dioxane and HCl 
in dioxane was added. This mixture was stirred at room temperature until the starting 
material was consumed (as monitored by TLC analysis). The reaction was then 
evaporated under reduced pressure. The resulting residue was purified by column 
chromatography (EtOAc:hexanes = 1:5) to afford the targeted compound 85a–e as a 
colorless solid. 
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(S)-3,3'-bis(2'-methylspiro[cyclopentane-1,9'-fluoren]-7'-yl)-[1,1'-binaphthalene]-
2,2'-diol (85a) 
Prepared according to the representative procedure on a 
0.5 mmol scale for (S)-2,2'-(2,2'-bis(methoxymethoxy)-
1,1'binaphthyl-3,3'- diyl)bis(4,4,-5,5-tetramethyl-1,3,2-
dioxaborolane) 86 with 2'-bromo-7'-
methylspiro[cyclopentane-1,9'-fluorene] (84a) (345.0 mg, 1.1 
mmol) to give the title compound 85a as an off-white solid. 
1H NMR (501 MHz, CDCl3) δ = 8.08 (s, 2H), 7.98–7.93 (m, 2H), 7.81–7.75 (m, 4H), 
7.69 (dd, J = 7.8, 1.6 Hz, 2H), 7.63 (d, J = 7.6 Hz, 2H), 7.41 (ddd, J = 8.1, 6.7, 1.4 
Hz, 2H), 7.34 (ddd, J = 8.1, 6.7, 1.3 Hz, 2H), 7.30–7.27 (m, 1H), 7.20–7.13 (m, 2H), 
2.45 (s, 6H), 2.24–2.05 (m, 16H). 
13C NMR (126 MHz, CDCl3) δ = 154.94, 154.94, 154.52, 154.52, 150.16, 150.16, 
139.35, 139.35, 137.52, 137.52, 136.48, 136.48, 135.97, 135.97, 132.97, 132.97, 
131.16, 131.16, 131.13, 131.13, 129.52, 129.52, 128.40, 128.40, 128.23, 128.23, 
127.62, 127.62, 127.19, 127.19, 124.42, 124.42, 124.28, 124.28, 124.14, 124.14, 
123.67, 123.67, 119.52, 119.52, 119.29, 119.29, 112.71, 112.71, 57.64, 57.64, 
39.92, 39.92, 39.87, 39.87, 27.03, 27.03, 27.03, 27.03, 21.88, 21.88 ppm.  
 
((Perfluoro-n-decyl)sulfonyl)phosphorimidoyl trichloride (76) 
 
In a Schlenk flask under Argon equipped with a magnetic stirring bar connected to 
a two-neck flask containing NaOH pellets and a vacuum pump in this order, a mixture 
of sulfonamide 75 (600.0 mg, 1 mmol, 1.0 equiv) and PCl5 (270.0 mg, 1.3 mmol, 1.3 
equiv) was heated to 140 °C under Argon for 2 h. The reaction was monitored by 1H, 
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19F, and 31P NMR to ensure full consumption of sulfonamide. Removal of the excess 
amount of PCl5 by prolonged evacuation in vacuum afforded the title compound  76 
in quantitative yield as colorless solid, which was stored in a Schlenk flask under 
argon. 
19F NMR (471 MHz, CD2Cl2) δ = -81.10, -112.32, -120.23, -121.65, -121.82, -121.82, 
-121.82, -122.04, -122.86, -126.30 ppm.  
31P NMR (203 MHz, CD2Cl2) δ = 16.89 ppm. 
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7.3.4.3 General Procedure for IDPi synthesis 
 
In a Schlenk tube under argon, a suspension of 3,3′-substituted (S,S)-BINOL 
(1.05 mmol, 2.1 equiv.) in toluene (2.5 mL) was treated with phosphorimidoyl 
trichloride 87 (1.05 mmol, 2.1 equiv.) and then NEt3 (1.12 mL, 8.0 mmol, 16 equiv.). 
The reaction mixture was stirred for 15 min at r.t., until neat hexamethyldisilazane 
(HMDS, 104 µL, 0.5 mmol, 1 equiv.) was added dropwise. The reaction mixture was 
stirred for additional 15 min at r.t., the Schlenk tube was subsequently sealed and 
heated to 120 °C for 3 days. After cooling to r.t., aq. HCl (10%) was added and the 
mixture was extracted with DCM or Et2O. The combined organic layers were washed 
with brine, dried over MgSO4 and concentrated under reduced pressure. The crude 
material was purified by column chromatography on silica gel (hexane/MTBE 
90:10→80:20→70:30→60:40→50:50 and/or 0.5−5% EtOAc in DCM) to afford the 
desired product as a salt. The corresponding IDPi Brønsted acids (S,S)-71s–w were 
obtained after acidification in DCM or Et2O with aq. HCl (6 M) and evaporation of the 
solvent followed by drying under high vacuum as typically off-white solids.  
(S,S)-(71s) 
Prepared according to the general 
procedure on a 0.1 mmol scale 
(with respect to HMDS) and purified 
by column chromatography 
(hexane/EtOAc, 95:5). Colorless 
solid. 
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1H NMR (501 MHz, CDCl3) δ = 8.02 (d, J = 7.9 Hz, 4H), 7.95 (d, J = 8.3 Hz, 2H), 7.85 
– 7.79 (m, 2H), 7.76 (d, J = 8.5 Hz, 2H), 7.67 – 7.61 (m, 2H), 7.58 – 7.52 (m, 2H), 
7.49 – 7.46 (m, 2H), 7.40 (d, J = 7.8 Hz, 2H), 7.37 – 7.29 (m, 6H), 7.22 – 7.15 (m, 
6H), 7.10 (s, 2H), 7.00 – 6.93 (m, 6H), 6.58 (d, J = 8.1 Hz, 2H), 6.53 (d, J = 8.0 Hz, 
2H), 6.42 (dd, J = 8.1, 1.6 Hz, 2H), 2.33 (d, J = 3.0 Hz, 12H), 2.23 – 1.86 (m, 22H), 
1.77 (dd, J = 12.8, 6.9 Hz, 2H), 1.35 – 1.14 ppm (m, 12H). 
19F NMR (471 MHz, CDCl3) δ = -80.78, -110.28 – -112.60 (m), -120.00 (d, J = 53.4 
Hz), -121.48, -122.01 (d, J = 58.6 Hz), -122.79 (d, J = 17.9 Hz), -126.18 ppm (d, J = 
15.4 Hz). 
31P NMR (203 MHz, CDCl3) δ =  -16.67 ppm. 
 
(S,S)-(71v) 
Prepared according to the 
general procedure on a 0.1 
mmol scale (with respect to 
HMDS) and purified by column 
chromatography (hexane/EtOAc, 
95:5). Colorless solid. 
1H NMR (501 MHz, CDCl3) δ = 7.93 (s, 2H), 7.89 – 7.79 (m, 1H), 7.76 – 7.61 (m, 2H), 
7.59 – 7.50 (m, 1H), 7.46 (dd, J = 8.1, 3.6 Hz, 2H), 7.41 (d, J = 1.6 Hz, 1H), 7.34 (d, J 
= 7.8 Hz, 2H), 7.32 – 7.28 (m, 3H), 7.26 – 7.20 (m, 6H), 7.17 – 7.11 (m, 6H), 7.09 (s, 
2H), 7.02 (d, J = 1.6 Hz, 2H), 6.93 – 6.82 (m, 6H), 6.39 (d, J = 7.9 Hz, 2H), 2.50 (td, J 
= 7.5, 5.5 Hz, 8H), 2.27 – 1.75 (m, 22H), 1.63 – 1.39 (m, 16H), 1.31 – 1.14 (m, 12H), 
0.83 (t, J = 7.3 Hz, 6H), 0.77 ppm (t, J = 7.3 Hz, 6H). 
19F NMR (471 MHz, CDCl3) δ = -80.79, -109.52 – -112.99 (m), -119.95 (dt, J = 31.1, 
13.7 Hz), -121.39, -121.94 (d, J = 33.4 Hz), -122.72, -126.15 ppm (d, J = 14.4 Hz).  
31P NMR (203 MHz, CDCl3) δ = -16.65 ppm. 
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(S,S)-(71t) 
Prepared according to the 
general procedure on a 0.1 mmol 
scale (with respect to HMDS) 
and purified by column 
chromatography (hexane/EtOAc, 
95:5). Colorless solid. 
1H NMR (501 MHz, CDCl3) δ = 8.08–7.99 (m, 4H), 7.96 (d, J = 8.3 Hz, 2H), 7.85–
7.79 (m, 2H), 7.76 (d, J = 8.5 Hz, 2H), 7.64 (ddd, J = 8.5, 6.7, 1.4 Hz, 2H), 7.55 (ddd, 
J = 8.2, 5.8, 2.2 Hz, 2H), 7.49 (d, J = 1.6 Hz, 2H), 7.46–7.38 (m, 3H), 7.37–7.29 (m, 
8H), 7.23–7.13 (m, 8H), 6.97 (s, 2H), 6.62 (d, J = 8.0 Hz, 1H), 6.54–6.44 (m, 3H), 
2.25–2.01 (m, 22H), 1.83–1.58 (m, 4H), 1.29 ppm (d, J = 1.3 Hz, 36H).  
19F NMR (471 MHz, CDCl3) δ = -80.79, -109.52 – -112.99 (m), -119.95 (dt, J = 31.1, 
13.7 Hz), -121.39, -121.94 (d, J = 33.4 Hz), -122.72, -126.15 ppm (d, J = 14.4 Hz).  
31P NMR (203 MHz, CDCl3) δ = -16.69 ppm. 
 
(S,S)-(71w) 
Prepared according to the general 
procedure on a 0.1 mmol scale 
(with respect to HMDS) and 
purified by column 
chromatography (hexane/EtOAc, 
95:5). Colorless solid. 
1H NMR (501 MHz, CDCl3) δ =  8.04 (d, J = 9.3 Hz, 4H), 7.98 (d, J = 8.2 Hz, 2H), 
7.87–7.82 (m, 2H), 7.80 (d, J = 8.5 Hz, 2H), 7.71–7.65 (m, 2H), 7.64 – 7.50 (m, 18H), 
7.50–7.27 (m, 28H), 7.01 (s, 2H), 6.72 (d, J = 8.0 Hz, 2H), 6.63 (d, J = 7.9 Hz, 2H), 
6.53 (dd, J = 7.9, 1.5 Hz, 2H), 2.23 (dd, J = 12.6, 6.0 Hz, 2H), 2.19 – 1.92 (m, 22H), 
1.88 – 1.74 (m, 6H). 
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19F NMR (471 MHz, CDCl3) δ =  -80.81 (t, J = 9.9 Hz), -110.41 – -112.49 (m), -119.95 
(d, J = 56.1 Hz), -121.44, -121.96 (d, J = 56.1 Hz), -122.74, -126.18 ppm (d, J = 15.3 
Hz).  
31P NMR (203 MHz, CDCl3) δ = -16.46 ppm. 
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